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1. Bone, implant failure and the significance of the bone-implant 
interface 
 
In recent years, implant materials have gained growing importance in all areas of medicine 
[1]. The placement of endosseous implants has improved the quality of life for millions of 
people [2]. It is estimated that over 500,000 total joint replacements, primarily hips and 
knees, and between 100,000 and 300,000 dental implants are used each year in the United 
States [2]. The success of endosseous implants depends on acquiring and retaining stable 
fixation of the device in the surrounding bone. Load bearing implants in orthopedics have to 
sustain complex mechanical loads without failure under rather corrosive environmental 
conditions. Furthermore, permanent implants, e.g. joint prostheses or dental implants, which 
are designed for service throughout the lifetime of the patient, have to bond tightly to the 
surrounding bone [3].  Unfortunately, the current average lifetime of an orthopedic implant is 
only 15 years [1]. Stable fixation largely depends on obtaining intimate apposition of bone to 
the implant, a fact that has lead to renewed focus on biomimetic surface coatings [1]. 
Biomimetic materials are capable of eliciting specific cellular responses and directing new 
tissue formation mediated by biomolecular recognition [4]. Biomimetic cell carriers are one of 
the key strategies applied for bone tissue engineering [5;6]. Bone tissue engineering 
concepts have focused on two approaches: the use of three-dimensional matrices as cell-
free conduits to guide bone ingrowth from the surrounding bone or as carriers for seeded 
cells for in vitro or in vivo bone formation [7]. The fabrication of materials to provide 
appropriate scaffolding that is conducive to cell attachment and maintenance of cell function 
is a key strategy [5]. To achieve an increase in the lifetime of permanent implants requires 
investigating and understanding the remodeling properties of the bone, the implant materials, 
and the bone-implant interface structure. 
1.1. Bone 
In order to use the potential of biomimesis in the design of cell carriers for bone tissue 
engineering, the basic principles of structure and development of the skeleton have to be 
studied [8]. The knowledge of bone physiology has continuously increased in recent years. A 
complete review is beyond the scope of this thesis, but can be found in [9]. The following 
facts are of significance for a better understanding of the chapters ahead: The composition of 
bone varies with age, anatomical location, general health, and nutritional status. In general, 
bone mineral accounts for 50-70% of adult bone, the organic matrix, mainly collagen, for 
about 20-40%, water for about 5-10% and lipids for about 1-5% by volume [10]. Bone mineral 
is mostly in the form of hydroxyapatite [Ca10(PO4)6(OH)2], which provides rigidity and strength 
for skeletal and load-bearing functions. The hydroxyapatite in bone consists of small crystals 
Chapter 1                                                                          Introduction and Goals of the Thesis 
- 3 - 
(about 20 nm) and contains impurities, including carbonate and magnesium [10;11]. The 
adult skeleton consists 80% of compact (or cortical) bone, which contains channel systems 
for nerve fibers and blood vessels, and 20% of trabecular (or spongy) bone, which is filled 
with bone marrow. Mature bone is termed lamellar bone and consists of both of trabecular 
and compact bone, while new bone, which is formed e.g. during fracture repair, is woven 
bone. Woven bone is a relatively disorganized array of collagen and mineralization patterns, 
which becomes lamellar bone through the process of remodeling [10;11]. 
As bone is a living tissue, the biological response to implanted materials is a key factor to 
improve the osseointegration process. This biological response can be influenced by 
stimulating the four different cell types found in bone: osteoblasts, osteocytes, bone lining 
cells and osteoclasts [9;12]. Osteoblasts are responsible for the formation and organization 
of the extracellular matrix of bone and its subsequent mineralization [12]. Osteoblasts 
express relatively high amounts of alkaline phosphatase, which plays a role in bone 
mineralization and represents an early marker of osteoblastic differentiation [13]. 
Osteoclasts, which are large multinucleated cells, cause bone resorption [12;14]. Osteocytes 
are derived from osteoblasts and are involved in the transduction of mechanical stimulus into 
biochemical signals, thereby orchestrating bone remodelling and tissue repair [12]. Bone 
lining cells are inactive cells that cover bone surfaces and undergo neither bone formation 
nor resorption [12]. 
1.2. Significance of the bone implant interface 
When attempting to regenerate bone via the conduction of bone into biomaterials [7], the 
conduit material is implanted adjacent to bone tissue. Cells from the tissue begin to invade 
and populate the material, lay down new matrix, and eventually form new bone. Following 
implantation of a biomaterial in bone, events analogous to those that occur during fracture 
healing will occur, including the formation of a hematoma between bone and implant as a 
scaffold for the infiltration of cells [2;15]. A short overview is given in Fig. 1, adopted from [2]: 
First proteins from blood and other tissue fluids will adsorb to the surface (a) mediating 
adhesion of cells such as inflammatory and connective tissue cells (b). These cells stimulate 
the invasion of osteoprogenitor cells that will differentiate to osteoblastic cells by exposure to 
adequate growth factors (c). These osteoblastic cells are capable of forming new bone (d). 
With time, the newly formed bone will be remodeled by osteoclasts to mature, lamellar bone, 
which further stabilizes the implant (e).  
 
Chapter 1                                                                          Introduction and Goals of the Thesis 
- 4 - 
 
Fig.  1:  Schematic representation of the events occurring at the bone-implant interface.        
a: Protein adsorption from blood and tissue fluids. b: Inflammatory and connective tissue 
cells approach the implant. c: Formation of an afibrillar mineralized layer and adhesion of 
osteogenic cells. d: Bone deposition on both the bone and the implant surfaces.                    
e: Remodelling of newly formed bone by osteoclasts (adopted with modifications from  [2]).  
 
The response of the host to the implant material ideally culminates in an intimate apposition 
of bone to the biomaterial. Two crucial steps have been identified for this intimate contact to 
occur and additionally minimize conditions that would lead to the formation of a fibrous 
capsule: first, the adhesion of the desired type of cells, mediated by adsorbed proteins [16] 
and, second, the recruitment of osteogenic cells and their differentiation to osteoblasts by 
adequate cytokines [2]. 
The strategy applied in this thesis intended to create biomaterial surfaces suitable for specific 
stimulation of cells when implanted into bony tissue. In the following, a short review of key 
factors for the control of cell-biomaterial interactions at the bone-implant interface is given. 
1.3. Hydroxyapatite as biomaterial for bone replacement 
One important strategy to decrease the rate of implant failure would be to use biomaterials 
with similar mechanical properties to bone [5]. Current therapies for bony defects include the 
autologous bone graft, which is still the gold-standard, although it has its anatomical 
limitations and carries a risk of infection [5]. Despite the wide use of biodegradable polymers 
and hydrogels as cell carriers for the engineering of bone and cartilage [17], they are not 
suitable for application in load-bearing sites due to their lack of mechanical competence. 
Natural and synthetic ceramic materials provide an acceptable alternative for medical 
purposes [8;18]. By the mid-1980s ceramic materials had reached clinical use in a variety of 
orthopedic and dental applications [19]. Different types of bioceramics, including calcium 
phosphates, alumina, and bioactive glasses, are reviewed and classified with focus on the 
type of attachment to bone in [20]. Bioactive ceramics, such as hydroxyapatite (HA), 
tricalcium phosphate (TCP), and certain compositions of silicate and phosphate glasses 
(bioactive glasses) react with physiological fluids and through cellular activity to form 
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tenacious bonds to hard tissue [20]. Synthetic hydroxyapatite ceramics began to be routinely 
used as porous implants [19], powders, and coatings on metallic prostheses to provide 
bioactive fixation [21-23].  The presence of sparingly soluble HA led to osteoconduction, a 
tissue response in which bone grew along the coating and formed a mechanically strong 
interface responsible for the long-term reliability of the implant [20]. Enhanced protein 
adsorption relative to other hard-tissue replacement materials is considered responsible for 
the good osseointegration properties of HA ceramics [24]. The variety of degradation rates of 
calcium phosphate ceramics in vivo broadens the spectrum of applications even further [25].  
To summarize, synthetic hydroxyapatite is a biocompatible, bioactive and osteoconductive 
material that comprises sufficient mechanical strength for application in load-bearing sites 
[19] and resembles the inorganic phase of bone [26]. Solid discs (Fig. 2) provided by the 
Friedrich-Baur-Research-Institute for Biomaterials (Bayreuth, Germany) were used as 
models for our studies on surface modification methods to gain control of the events at the 
bone-implant interface. 
 
Fig.. HA ceramic after sintering: BSE- image of surface, photo of HA disk, µ-RAMAN spectra of HA surface
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Fig.  2: Hydroxyapatite ceramic disc, manufactured by the Friedrich-Baur Research Institute 
for biomaterials (Bayreuth, Germany). From left to right: SEM image of the surface of a disc, 
photo and µ-Raman spectrum of the surface. The discs were used as model surfaces for the 
investigation of surface modification methods. 
 
1.4. Strategies to influence bone cell response to biomaterials 
The development of biomaterials for tissue engineering applications has recently focused on 
the design of biomimetic materials that are capable of eliciting specific cellular responses [4]. 
As outlined above, the integration of materials into bone tissue takes place at the material-
tissue interface and is often determined by initial cell and substrate interactions [4]. This is 
also true for biomimetic materials. The quality of interaction is greatly influenced by the 
surface properties of the implant materials [27]. A promising strategy is to combine 
hydroxyapatite surfaces that comprise osteoconductive properties with cell-specific signals to 
control and improve the osseointegration of implants [15;28]; this is an approach that 
requires knowledge about the signals capable of influencing cellular response to a material. 
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1.4.1. Roughness of implant surfaces 
The cell response to a material surface is strongly influenced by the roughness of the 
surface [29]. However, general trends on the influence of surface roughness on cell 
adhesion, proliferation, or differentiation can hardly be extracted from literature [30;31]. 
Divergent results are reported for cell response to surface roughness that may be explained 
by a strong dependency on the particular material, the type of cell, and the culture conditions. 
1.4.2. Cell adhesion and enhancement of osteogenesis by RGD peptides 
In general, cell adhesion to biomaterials is mediated by integrins, heterodimeric 
transmembrane cell receptors comprised of non-covalently bound α- and β- subunits, which 
selectively bind to different extracellular matrix (ECM) proteins and are often cell type 
specific [32]. Since the identificaction of the tripeptide sequence arginine-glycine-aspartic 
acid (RGD) as the integrin binding site of ECM proteins such as fibronectin [33], a plethora of 
small peptide analogues has been synthesized and applied for surface coatings in order to 
enhance osteoblast adhesion to orthopedic biomaterials [34;35]. In addition to the stimulation 
of osteoblast adhesion, RGD coated biomaterials promoted cell proliferation as well as bone 
formation [36]. RGD coating of hydroxyapatite by adsorption [37;38] or covalent binding 
[35;39] significantly improved cell attachment and osteogenesis of various cell types.  
1.4.3. Stimulation of bone formation: growth factors 
Bone contains a variety of growth factors that are capable of stimulating both cell proliferation 
and osteoblastic differentiation [40]. Therefore, various growth factors have been 
supplemented to bone cell cultures in order to investigate their influence on osteogenesis [5]. 
Classes of growth factors that are produced by osteoblasts include transforming growth 
factor-β (TGF-β), bone morphogenetic proteins (BMPs), insulin-like growth factors (IGFs) and 
fibroblast growth factors (FGFs) [40]. TGF-β is involved in the stimulation of collagen I 
production, the main component of the ECM of bone. However, its effects on matrix 
mineralization and differentiation of osteoblastic progenitor cells are conflicting, depending on 
the cell type, the differentiation state, and the culture conditions [41;42]. IGFs present the 
most abundant growth factors produced by osteoblasts and are involved in bone formation 
as well as resorption [40]. FGFs stimulate osteoblast proliferation and promote bone growth 
[40]. Furthermore, they play key roles during physiological and pathological conditions, such 
as wound healing, skeletal repair, neovascularization, and tumor growth [40].  
The BMPs were discovered in the late 1960s when evidence surfaced that the implantation 
of demineralized bone at ectopic sites caused an induction of extraskeletal bone 
development [43]. To date, more than 15 BMPs have been identified [44]. All of the BMPs, 
except BMP-1, belong to the TGF-β superfamily and share significant sequence homology in 
the carboxy-terminal region with a conserved pattern of seven cysteine residues [40]. BMPs 
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are strongly involved in tissue morphogenesis and regeneration [45] and therefore have 
strong therapeutic potential [46]. 
1.4.4. Bone Morphogenetic Protein-2 (BMP-2)  
Among the members of the TGF-β superfamily, BMP-2 has gained the most interest as a 
prominent factor for osteoblastic differentiation and bone repair [47]. BMP-2 up-regulates 
differentiation in pre-existing osteoblasts and additionally induces the commitment of a 
variety of cell types, including mesenchymal cells, to the osteoblastic pathway [47;48]. To 
utilize these effects following surgery, a product containing BMP-2 has recently gained 
approval by the authorities: Induct Os® (Wyeth Pharma), an implantable collagen sponge 
loaded with BMP-2. 
BMP-2 is a disulfide-linked homodimeric protein, whose structure, mechanisms of action, 
receptor binding, and therapeutic potential for bone repair and regeneration have been 
extensively investigated [46;49-52]. BMP-2 signaling requires binding to cell surface 
receptors, which consist of two types of receptor serine/threonine-kinases [52]. The concept 
of localized delivery of BMP-2 to the bone-implant interface was implemented by adsorbing 
BMP-2 to implant materials in a variety of in vivo approaches in different animal models 
[53-57]. Adsorbed BMP-2 successfully stimulated osseointegration and new bone formation 
compared to non-biomimetic implant surfaces in these studies. The cellular response, 
however, is highly dependent on the duration of exposure to BMP-2 [58]. Therefore, covalent 
immobilization of BMP-2 at the bone-implant interface is expected to further improve 
osseointegration compared to adsorbed factor [59].  
1.4.5. Inhibition of bone resorption    
As mentioned before, in addition to the bone-forming osteoblasts, osteoclasts have an 
equally important role in the formation of the skeleton and regulation of its mass [14]. Among 
others, parathyroid hormone and 1,25-dihydroxyvitamin D3 are osteoclastogenic agents that 
are involved in the stimulation of osteoclastic differentiation and  the regulation of bone 
resorption [14]. An imbalance in skeletal turnover leads to osteoporosis, a disease that is 
currently treated by suppressing osteoclast formation with estrogen and suppressing 
osteoclast activity with calcitonin and bisphosphonates [28].  
Bisphosphonates are currently the most important class of anti-resorptive agents used in the 
treatment of metabolic bone diseases, including tumor-associated osteolysis and 
hypercalcemia, Paget’s disease, and osteoporosis [60]. Bisphosphonates are pyrophosphate 
analogues in which the oxygen bridge has been replaced by a carbon atom with various side 
chains (Fig. 3) [28].  
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Fig.  3: General structure of a geminal bisphosphonate. R1 being –H, –OH, -NH2 or -Cl. 
 
Their cellular and molecular mechanisms of action on osteoclasts depends on the structure 
of the respective derivative [60]: After internalization to osteoclastic cells, the simple 
bisphosphonates (BPs), such as clodronate and etidronate, are metabolized to methylene-
containing analogues of ATP that exhibit cytotoxic effects on osteoclasts [61]. The nitrogen-
containing bisphosphonates (N-BPs), such as pamidronate and alendronate, interact with the 
mevalonate-pathway as inhibitors of the farnesyl diposphate synthase, thus limiting the 
production of cholesterol and isoprenoids [61]. However, bisphosphonate action seems not 
to be limited to osteoclasts. Further pharmacological actions of bisphosphonates including 
effects on osteoblastic differentiation in vitro and in vivo have been reported [62-64]. 
 
1.5. Drug immobilization on hydroxyapatite surfaces 
Calcium phosphate cements, including hydroxyapatite, have been successfully employed as 
drug delivery systems, delivering adsorbed or incorporated substances such as antibiotics, 
analgesics, and anti-inflammatory drugs to the skeleton [65;66]. In general, hydroxyapatite 
exhibits a strong ability to adsorb proteins [67;68]. However, to provide a controlled and 
sustainable influence on cell behavior over that of soluble or slowly released proteins or 
drugs it seems beneficial to develop biomaterial surfaces with covalently immobilized ligands 
[59;69;70]. One of the reasons may be that the activity of proteins immobilized on solid 
surfaces, including glass, plastics, and polymer films, exceeds that of adsorbed or soluble 
protein [71-74]. 
1.5.1 Current approaches for covalent and adsorptive binding to hydroxyapatite 
So far, only a few attempts to covalently immobilize biomolecules on the surface of HA 
particles or implant materials have been reported. One approach primarily used to bond 
polymers to the inorganic HA in composite materials by grafting hexamethylene diisocyanate 
to the HA surface has also been used to immobilize drugs on HA surfaces [75-78]. A second 
approach introduced amine groups on the surface through aminosilanization. The 
aminosilanization procedure is well-established for glass, silica, metal, and metal oxide 
materials [79-84] and has been employed for HA ceramic particles [85]. Particles modified 
with aminopropyl-triethoxysilane were determined to be non-toxic to a variety of cells in a 
biocompatibility screening [86]. Furthermore, silanized hydroxyapatite was used for the 
immobilization of RGD peptides and promoted cell adhesion and differentiation [39;87]. Other 
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approaches for surface functionalization utilize compounds comprising strong adsorptive 
binding to hydroxyapatite surfaces: Compounds such as phosphates [88], amino acids [89], 
polyglutamate motifs [90], and polyelectrolytes, such as polyacids [38], have been utilized to 
create a platform for covalent binding of growth factors and RGD peptides in order to 
stimulate cells.  
1.5.2 Bisphosphonates: adsorption to hydroxyapatite and targeting to bone 
Among other bone bonding motifs [91], bisphosphonates (Fig. 3) are a class of substances 
characterized by a high affinity for bone and hydroxyapatite [92;93]. The capacity of 
bisphosphonates to accumulate in bone is a consequence of their high affinity to 
hydroxyapatite due to bi- or tridentate interactions depending on the structure of the 
respective derivative [94]. The phosphonic acids and the functions in position R1 (Fig. 4; if 
-OH or -NH2) are involved in the formation of bonds to hydroxyapatite [95]. The influence of 
the chemical structure of bisphosphonate derivatives on the bone binding affinity and 
additionally on the growth of hydroxyapatite crystals are reviewed in [93]. This strong affinity 
is utilized to immobilize bisphosphonates on inorganic material surfaces aiming to stimulate 
cells at the bone-implant interface, which, in the case of pamidronate and ibandronate, 
improved the osseointegration in vivo and stimulated the osteoblastic differentiation in 
vitro [96-98].  
Much more common and established is the use of bisphosphonates in drug targeting to 
bone. Due to their pharmacokinetic properties [99], bisphosphonates are ideal candidates for 
targeting to bone and calcified tissues, which has been demonstrated by the development of 
bone-targeted drug delivery systems, such as bisphosphonate-conjugated 
proteins [100-103].   
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2. Drug targeting and tissue distribution of nanoparticles 
 
Drug targeting is of particular interest in the field of cancer chemotherapy, as it can increase 
anti-tumor efficacy and restrict the delivery of the chemotherapeutic agents to the tumor site 
while reducing systemic side effects [104;105]. This is also true for bone tissue for which 
numerous malignancies are known that are hard to treat. Here, targeting concepts including 
bisphosphonates, tetracyclines and polyaminoacids are employed [91;103]. Furthermore, 
bisphosphonates have been proven to be effective in the treatment of malignant skeletal 
diseases characterized by enhanced osteoclastic bone resorption [106]. 
Current research areas in drug targeting include the development of carriers to allow 
alternative dosing routes, new therapeutic targets, such as blood vessels, and targeted 
therapeutics that are more specific in their activity [107]. One strategy is to associate 
antitumor drugs with colloidal nanoparticles prepared from degradable polymers in order to 
overcome non-cellular and cellular mechanisms of drug resistance and to increase the 
selectivity of drugs towards cancer cells while reducing their toxicity towards healthy 
tissues [105].  
Targeting can be achieved either passively, as a result of physical or chemical characteristics 
of the carrier (“passive targeting”), or actively, by specifically including a recognition moiety 
into the carrier (“active targeting”) [108]. Nanoscale devices (100 nm or below) carrying 
chemotherapeutic drugs can extravasate from blood vessels and even diffuse through the 
tissue and enter tumor cells [109]. Intravenously injected nanoparticles accumulate in 
cancerous tissue, which can be explained by a passive diffusion or convection across the 
leaky, hyperpermeable tumor vasculature [105]. The defective vasculature, a result of rapid 
vascularization, coupled with poor lymphatic drainage allows for an enhanced permeation 
and retention effect (EPR), a critical advantage of colloidal carrier based therapies [107]. 
However, the usefulness of conventional nanoparticles is limited by their massive capture by 
macrophages of the mononuclear phagozyte system (MPS), which can be avoided by the 
use of hydrophilic coatings (“stealth™ particles”) [105].  
Active, tumor-specific targeting uses strategies that exploit differences between malignant 
and healthy cells: inactive drugs that are activated in cancerous cells by specific mechanisms 
(“prodrugs”) [107] or selective ligands for cell-specific receptors [108]. A variety of targeting 
motifs have been successfully used including antibodies interacting with tumor-specific 
antigens, folate-conjugated systems, vascular endothelial growth factor (VEGF) for targeting 
tumor neovasculature, and galactosamine for liver-cell targeting [110-116]. 
Furthermore, improvements in the delivery of selected drugs were achieved by incorporating 
them into nanoparticles, such as overcoming solubility restrictions for poorly soluble drugs 
(paclitaxel), avoiding toxic side effects (doxorubicin), and prolonging circulation in the 
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bloodstream for substances with short half-lives (5-fluorouracil) [107]. Once the particles 
have successfully been deposited in the tumor, they kill cancer cells by releasing their drugs 
and function as a stationary source, depending on the characteristics of the tumor type, 
carrier, and incorporated drug [109], leading to higher local drug concentrations compared to 
drugs applied as solutions [117]. 
2.1. Multicellular tumor spheroids – an in vitro tumor model   
The factors influencing drug transport through tissues are of key interest for the development 
of delivery strategies to tumors [117]. In addition to mathematical simulations of drug 
transport processes [118;119], in vitro models for tumors are providing a rapid alternative to 
investigate drug distribution and transport limitations in a three-dimensional cellular context 
[117;120;121]. The models used for in vitro investigation of tumor growth, anticancer drug 
effects, and drug distribution include in vitro cultivated tumor biopsies, multilayered post-
confluent cell cultures, and multicellular tumor spheroids (MCTS) [120-124]. 
3D cultures can mimic the specific biochemical and morphological features found in the 
corresponding tissue in vivo. In comparison to conventional cultures, cells in the 3D 
environment resemble the in vivo situation more closely with regard to the gene expression 
and biological behavior of the cells [123]. The multicellular tumor spheroids (MCTS) provide 
an excellent model, as they are easily prepared from a variety of cell lines [125], are tunable 
in size within a certain range, and have a well defined geometry [122;123].   
 
Fig.  4: Schematic presentation of the similarities of a tumor (in vivo) and a spheroid (in vitro) 
[120]. 
 
Additionally, tumor characteristics, such as limited nutrition supply in the avascular state, can 
be perfectly mimicked by the spheroid model (Fig. 4) [120], in contrast to a monolayer culture 
in vitro [122]. Their ease of preparation makes the spheroids suitable for high throughput 
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screening approaches in drug testing [124]. In addition to the rapid screening of new 
anticancer drugs, the spheroid model allows for the investigation of novel particulate drug 
delivery systems. Their distribution and retention in the tumor model can be investigated by 
means of confocal microscopy, allowing for observations of particles in intact, living 
spheroids and the determination of particle distribution throughout the cell aggregates 
(Fig. 5). 
 
 
 
Fig. 5: Confocal image of GFP-expressing tumor cells (HCT-116) in a spheroid with 
extracellular fluorescent nanoparticles (orange) and intracellular nanoparticles (yellow). 
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3. Goals of the Thesis 
 
To control the events at the bone-implant interface by selective adhesion and direct 
stimulation of cells is still a great challenge. The focus of the first part of this thesis was to 
develop and characterize methods for the immobilization of cell stimulating factors on 
hydroxyapatite surfaces, intending to create functionalized surfaces of solid hydroxyapatite 
discs or particles (Fig. 6).  
 
Controlled interactions                                         
of cells and biomaterial:
(adhesion, differentiation,             
resorption...)
Bioactive molecules
linker molecules
surface functionalization
Hydroxyapatite ceramic
 
Fig.  6: Immobilization of bioactive molecules in order to control the interactions with cells. 
 
To achieve specific interactions between a surface and cells by attaching adhesion peptides 
to a surface, it is a prerequisite to suppress unspecific cell adhesion by the creation of inert 
surfaces [29]. Therefore, we grafted poly(ethylene glycol) (PEG) to ceramic discs that were 
activated for further conjugation steps by the well-established  aminosilanization procedure 
[85]. The synthesis of a suitable PEG derivative (PEG acetaldehyde) was adopted from the 
literature. PEG-modified hydroxyapatite surfaces were characterized by contact angle 
measurements and X-ray photoelectron spectroscopy (XPS). Cell adhesion was studied by 
using rat marrow stromal cells (rMSC) (Chapter 2). 
The next objective was to establish a method to assess the efficacy of protein attachment to 
surfaces by various immobilization procedures. In order to detect very low levels of protein 
on the surfaces, we used proteins labeled with radioisotopes. We identified lysozyme as 
suitable model protein due to similarities in its physico-chemical characteristics compared to 
some growth factors, such as BMPs [126], and the well-known mechanism of enzymatic 
action [127] and analytics thereof [128]. A radiolabeling procedure with 125I was established 
for lysozyme and a procedure from the literature was employed to label BMP-2. Products 
were characterized with a focus on structural fragmentation due to the labeling procedure 
and the adsorption of lysozyme to ceramic discs was studied (Chapter 3). 
Tethering cytokines to the material surface via PEG is a common principle to enhance 
stability and biological performance of the respective biomolecules [72]. Therefore, a further 
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challenge was to immobilize a protein on the silanized ceramic discs employing PEG 
acetaldehyde of varying molecular weights as homobifunctional spacers. The potential of 
PEG-grafted ceramic discs to suppress the adsorption of lysozyme was explored and the 
impact of the immobilization method on the stability of the attached protein was determined 
by assessing the enzymatic activity of lysozyme (Chapter 4). 
Although immobilization by PEG spacers seemed to be promising with regard to the stability 
of the attached proteins, immobilization on the surface by smaller spacers might be favorable 
due to the ease of preparation and amount of attached growth factor. Therefore, we 
evaluated the aminosilanization procedure in combination with carbodiimide coupling 
chemistry in order to immobilize proteins on the surface of HA ceramic discs. In addition to 
the silanization procedure, a novel method for the creation of functional groups on HA 
ceramic surfaces using the aminobisphosphonates alendronate and pamidronate as 
anchoring molecules was evaluated. Lysozyme was used to assess the amount of 
immobilized protein and the impact of coupling chemistry on enzymatic activity. The potential 
of immobilized BMP-2 for the stimulation of cells was then investigated by the effects on the 
osteoblastic differentiation of C2C12 mouse myoblasts (Chapter 5). 
To gain a deeper insight into the bisphosphonate-mediated surface functionalization, an 
adsorption study of the bisphosphonate pamidronate on hydroxyapatite powder particles was 
performed. Through these experiments, we intended to determine the type of adsorption and 
the suitability of surface immobilized bisphosphonate as anchoring molecule for further 
conjugation steps. In order to control the amount of attached molecules, we determined the 
number of surface amine groups and the range of concentration dependency. In addition, the 
precipitation of calcium phosphate in the presence of pamidronate was evaluated as 
alternative route to obtain functionalized particles (Chapter 6). 
In addition to their usefulness in surface functionalization, bisphosphonates are interesting 
tools for drug targeting to bone and calcified tissues, due to their pharmacokinetic 
characteristics. Drug targeting is of particular interest in the treatment of cancer. Therefore, in 
a second part of the thesis, the interactions of fluorescent model nanoparticles with a three-
dimensional cell culture model were investigated by means of confocal laser scanning 
microscopy. The objective was to establish a method for the rapid determination of uptake 
and distribution of particles as models for drug carriers inside a three-dimensional cell 
context as an alternative to the conventional time-consuming cryo-sections (Chapter 7). 
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1. Introduction 
Hydroxyapatite ceramics are suitable bone replacement materials, as they resemble the 
natural inorganic phase of bone and provide adequate mechanical strength. Coatings of 
metal implants with hydroxyapatite (HA) enhanced bone integration in vivo [1-4] and 
hydroxyapatite culture surfaces improved the differentiation of rat marrow stromal cells to 
osteoblasts when compared to titanium and glass-ceramic in vitro [5]. 
A promising strategy to improve the osseointegration of biomaterials in general is to control 
the interactions at the bone-implant interface by using surface modifications, such as 
adhesive peptides, to promote the adhesion of osteoprogenitor cells, or the local delivery of 
growth factors, to stimulate cell differentiation and enhance healing and fixation. 
Beneficial effects on the osseointegration have been reported when therapeutic proteins, 
such as BMP-2 and TGF-β [6], were simply adsorbed to the surface of implant materials. 
Due to the short biological half-life and lack of long-term stability of proteins, controlled 
release devices have been developed to provide suitable release kinetics for prolonged 
stimulation [7]. But, considering the therapeutic potential of those factors and their lack of 
tissue selectivity, the covalent immobilization of the proteins would offer better control of the 
amount and distribution of the proteins delivered to the bone-implant interface and prevent 
uncontrolled desorption [8].   
Compared to the numerous studies dealing with surface modifications of metal and metal 
oxide implants, only few approaches have been explored for the modification of the surface 
properties of hydroxyapatite by means of covalent bonding: Hydroxyapatite powder particles 
have been conjugated to polymers to form composite materials by either using organic 
isocyanates, e.g. hexamethylenediisocyanate (HMDI) [9-12], or silane coupling agents 
[13;14]. Both methods use the hydroxyl groups present at the surface for covalent bonding. 
The silane coupling method has major advantages compared to the isocyanate method: Due 
to the formation of silane layers, the number of functional groups that can be introduced is 
not limited by the number of hydroxyl groups present at the surface. Biocompatibility 
screening of silane-treated hydroxyapatite powders revealed no toxic effects of the silane 
layers [15]. Recently, adhesive peptides (RGD) were successfully immobilized at the surface 
of porous hydroxyapatite cylinders after treatment with aminopropyltriethoxysilane (APTES), 
promoting increased cell attachment over 24h compared to pure hydroxyapatite 
surfaces [16]. 
When growth factors are immobilized, it is crucial to prevent conformational changes during 
grafting reactions and to retain the biological activity of the proteins. Covalent bonding by the 
use of suitable spacer molecules, such as poly(ethylene glycol) (PEG), would lead to 
increased stability and to a potentiated and prolonged in vivo response, which has been 
demonstrated for TGF-β2 [17]. Additionally, PEG-grafted surfaces have been reported to 
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improve the stability of adsorbed fibronectin, thus promoting cell adhesion and 
spreading [18]. Furthermore, complete shielding of a surface by dense PEG layers would 
lead to the suppression of unspecific protein adsorption and cell adhesion [19] and may, 
thus, allow for controlled interactions with the molecules immobilized at the terminal ends of 
the PEG chains.  
Therefore, as a first step, it was our goal to modify the surface properties of hydroxyapatite 
ceramic discs, as a model system, by aminosilanisation and subsequently to attach PEG. 
Methoxy-terminated PEG-acetaldehyde (MPEGAc) was used as a model compound for 
conjugation to the surface. The silanized discs were grafted with Methoxy-terminated PEG 
(MPEG) of varying molecular weight and the resulting surfaces were characterized by 
contact angle measurements and X-ray photoelectron spectroscopy (XPS). The impact of the 
chemical surface modifications on cell adhesion was investigated using rat marrow stromal 
cells (rMSC). 
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2. Materials and Methods 
2.1. Materials 
The ceramic discs were prepared from a commercially available powder (Merck, Germany), 
as follows: the powder was heat-treated at 700 °C t o reduce the specific surface and then 
added to a butanolic solution of waxes, PEG 400 and 1,4-butanediol (binder and humidity 
storage for granulation and pressing). The suspension was stirred and subsequently dried in 
a rotary evaporator. The powder was sieved to < 500 µm and granulated in a tubular mixer. 
The resulting granulate was uniaxially pressed at 80 MPa. The so obtained discs (30 mm 
diameter and approx. 2 mm thickness) were sintered at 1300 °C for 1 hour in air with a 
heating rate of 450 °K/h. The ceramic discs had a d ensity of 99 % of the theoretical density 
and consisted of pure phase HA. 
Aminopropyltriethoxysilane (APTES) was purchased from Aldrich and freshly distilled prior to 
use. Methoxy-terminated PEGs of varying molecular weights (Mw=750, 2000 and 5000 Da) 
were purchased from Sigma. 
2.2. Polymer synthesis 
Methoxy-terminated PEG acetaldehyde diethylacetal was synthesized following a procedure 
of Bentley et al. to provide a stable intermediate [20]. The polymers were characterized by 
1H-NMR spectroscopy and gel permeation chromatography (GPC).  
2.3. Surface modification 
HA ceramic discs were washed with ethanol immediately before use. The aminosilanisation 
of the discs was performed in dry toluene. The reaction was performed in an argon 
atmosphere and APTES was used at a concentration of 1.5%. After 4h, the samples were 
thoroughly rinsed with toluene and chloroform. The density of amino groups on the discs was 
determined to be approximately 1 nmol/cm², using a colorimetric method described by Puleo 
et al. [21]. 
MPEG acetaldehyde diethylacetals were hydrolyzed to the corresponding acetaldehydes in 
0.1N hydrochloric acid at 50°C. The polymers were c onjugated to the silanized ceramic discs 
by reductive amination in a 0.1M sodium tetraborate solution at pH=9.3 (Fig. 1). The 
polymers were used in 1000-fold molar excess relative to the amino groups present on the 
surface. The discs were rinsed with distilled water and dried. 
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Fig. 1: Surface modification of HA ceramic discs: Grafting of MPEG acetaldehyde to 
aminosilanized ceramic discs by “reductive amination”. 
 
2.4. Surface characterization 
Contact angle measurements were carried out on an optical contact angle device (OCA 20; 
dataphysics, Filderstadt; Germany). Three discs of each modification were analyzed by 
seeding drops of 2µl of distilled water on five different points on each disc. 
The XPS measurements were performed on a Phi 5700 XPS system (Physical electronics, 
Ismaning; Germany) using an Al
 
Kα source. For each sample, a survey scan was carried out 
with a step-size of 0.8 eV and the excited photoelectrons were analyzed at a take-off angle of 
90° relative to the surface.  
2.5. Cell adhesion study 
Rat bone marrow was isolated from the femur and tibia of 6 weeks old (150-200g) male 
Sprague-Dawley rats following a protocol from Dobson et al. [22]. Freshly isolated bone 
marrow cells were resuspended in primary medium (10% FCS, 1% Penicillin/Streptomycin, 
0.5% L-glutamine and minimal essential medium, alpha modification). The cells were left to 
adhere for 3 days before non-adherent cells were removed and the adherent cells were 
further cultured in humidified atmosphere with 5% CO2 at 37°C.  On day 7 or 8 after isolation 
(80% confluency) the cells were trypsinized, resuspended in medium supplemented with 
10% serum and seeded at a density of 10,000 cells /cm² on the discs, which corresponds to 
20% confluency. After incubation for 3h, unattached cells were removed by rinsing with PBS. 
Adherent cells were fluorescently stained with Calcein AM (Biotium, Hayward, USA). For cell 
number assessment, photographs over the entire diameter were taken using a 4-fold 
magnification and the cells were counted either manually or using the ImageJ program 
(http://rsb.info.nih.gov/ij/, version 1.31).  
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3. Results and Discussion 
3.1. Polymer synthesis 
We synthesized MPEG acetaldehyde diethylacetal as a stable derivative that can be stored 
and easily hydrolysed to the corresponding acetaldehyde immediately before use. Using the 
chosen synthesis route, more than 80% of the hydroxyl groups became acetals, as 
determined by integration of the respective signals in the 1H-NMR-spectra (Tab. 1). The 
acetal group was completely cleaved by acidic hydrolysis to result in the respective 
acetaldehyde, as analyzed by 1H-NMR-spectroscopy according to [20] (data not shown). 
 
 
POLYMER YIELD [%] ACETAL  GROUPS [%] (1H-NMR spectroscopy) 
MPEG Acetal, Mw= 750 Da 25 87 
MPEG Acetal, Mw= 2000 Da 50 83 
MPEG Acetal ,Mw= 5000 Da 87 88 
 
Tab. 1: MPEG derivatives; the content of acetal groups was determined to be more than 80% 
for the 3 MPEG acetaldehyde diethylacetals used in this study.  
 
 
GPC analysis of the polymers prior to and after derivatization revealed no major changes in 
chain length due to cleavage, oxidation or the formation of dimers (Fig. 2). The slight 
increase in molecular weight due to the conjugation of the acetaldehyde diethylacetal groups 
to the polymer chains caused a shorter retention time on the GPC column. For the low 
molecular weight derivative (MPEG 750), this effect is clearly visible (Fig. 2A). For MPEG 
2000 only a minor difference in retention time was observed (Fig. 2B), while the relative 
increase in molecular weight after the reaction was too small in the case of MPEG 5000 to 
result in a shorter retention time on the column (Fig. 2C). 
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Fig. 2: GPC chromatograms of methoxy-poly(ethylene glycol) (Mw=750 [A], 2000 [B] and 
5000 Da [C]) and the respective acetaldehyde diethylacetal derivatives. The black 
linescorrespond to MPEG prior to synthesis and the dotted line to the corresponding 
acetaldehyde diethylacetal. 
 
 
 
3.2. Surface characterization 
3.2.6. Contact angle 
The contact angle measurements of unmodified and PEGylated ceramics revealed 
differences in hydrophobicity (Fig. 3). The formation of a hydrophobic aminosilane layer at 
the ceramic surface caused the contact angle between water and the discs to increase 
significantly from 35° to 65°. When attaching MPEGA c, a hydrophilic polymer, to the amino 
groups on the surface of the ceramic, the surfaces performed differently depending on the 
molecular weight of the attached polymer. Following grafting of the 750 and 2000 Da 
derivatives, contact angle values similar to the silanized surface were measured (65°). The 
polymer chains - although hydrophilic - were not capable of changing the hydrophobic 
character of the surface caused by the silane layer. In contrast, binding of the 5000 Da 
polymer resulted in a significantly lower contact angle measurement (47°), that is, the longer 
polymer chains of MPEG 5000 were capable of changing the hydrophobic character of the 
aminosilanized discs. 
Chapter 2                                                             PEGgrafted hydroxyapatite ceramic surfaces 
                                                                                                                                                     
- 30 - 
0
10
20
30
40
50
60
70
80
unmodified
ceramic
silanized
ceramic
MPEG 750
grafted
MPEG 2000
grafted
MPEG 5000
grafted
Co
n
ta
ct
an
gl
e 
[°]
Co
n
ta
ct
an
gl
e 
[°]
Co
n
ta
ct
an
gl
e 
[°]
Co
n
ta
ct
an
gl
e 
[°]
 
Fig. 3: Contact angles of modified and unmodified ceramic discs. Significant differences 
(p<0.05) between the groups were marked with .    
 
 
3.2.7. X-ray photoelectron spectroscopy (XPS) 
To characterize the modified discs more precisely, the elemental composition of the 
uppermost surface layers was determined by XPS (Tab. 2). All surfaces contained the 
elements Ca, P, O, C, Si and N in varying amounts. The Ca/P ratio obtained for the 
unmodified ceramic discs was 1.8, which is close to the theoretical ratio for hydroxyapatite 
(1.67). After the silanization, the content of Si and N increased due to the formation of the 
silane layer.  
When comparing the unmodified and modified ceramic discs, the calcium content in the 
uppermost surface layers decreased after surface grafting with APTES and the respective 
MPEGAcs.  Initially, the uppermost layers contained 14.7 % Ca (unmodified ceramic), which 
was reduced with increasing PEG chain length to 7.7 % for MPEG 5000-grafted ceramic), 
indicating a gradually progressive coverage of the surfaces. When looking at the O/C ratio of 
the MPEG-grafted discs, a shift towards the theoretical O/C ratio of a pure PEG surface 
occurred with increasing molecular weight of the attached polymer chains, indicating again 
that the thickness of the created MPEG-layer was linked to the molecular weight of the 
respective polymer. 
These data also demonstrate that the MPEG coatings were thinner than the XPS probe 
depth (10nm), as the elements present only in the pure ceramic surface, such as Ca and P, 
were still detected. 
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Sample % O % C % Si % N % Ca % P O/C 
Unmodified ceramic 49.2 21.8 0.9 1.1 14.7 8.3 2.3 
Silanized ceramic 39.3 38.2 3.4 2.2 10.0 6.9 1.0 
MPEG-750 grafted 
ceramic 
44.9 30.8 2.9 1.7 11.0 8.0 1.5 
MPEG-2000 grafted 
ceramic 
40.2 39.4 1.8 1.9 9.5 7.0 1.0 
MPEG-5000 grafted 
ceramic 
32.0 50.0 3.0 1.5 7.7 5.8 0.6 
PEG (theoretical) 34 66     0.5 
 
Tab. 2: Elemental composition of the uppermost surface layers determined by XPS survey 
scans and O/C ratio calculated from the data. 
 
 
 
3.3 Cell adhesion study 
Rat marrow stromal cells (rMSC) were seeded onto discs modified with MPEG 750 and 
MPEG 5000 to investigate whether the surface modifications had any impact on the 
adhesion behavior of cells. Again, the discs performed differently depending on the 
molecular weight of the attached MPEG derivative (Fig. 4).  
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Fig. 4:  Adhesion of rat marrow stromal cells on unmodified ceramic discs and PEGylated 
ceramic discs. The values represent the number of attached cells/seeded cells. 
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After 3h, 80% of the initially seeded cells adhered to the unmodified ceramic discs. The cell 
adhesion to surfaces grafted with 750 Da MPEG chains remained unchanged. In contrast, 
only 43% of cells adhered to the surface coated with 5000 Da MPEG. This indicated that 
more effective surface shielding was achieved using the derivative of higher molecular 
weight. 
In our model system, which was based on introducing a certain density of amino groups at 
the surface and varying the molecular weight of the attached polymer, the characteristics of 
the resulting surfaces were dependent on the molecular weight of the grafted MPEG 
derivative. Thus, low molecular weight PEG would be a suitable spacer molecule for protein 
attachment in cases where interactions with the surface of the material are desired. When 
the avoidance of non-specific interactions between cells and material is preferable, complete 
shielding from unspecific protein adsorption would be necessary. For this purpose, a higher 
molecular weight PEG could be a suitable spacer. A more densely packed PEG layer could 
potentially be created by varying the reaction conditions for reductive amination [23]. 
 
 
 
4. Conclusion 
The surfaces of hydroxyapatite ceramic discs were successfully modified by using APTES to 
create an amino group-containing layer. MPEG derivatives of varying molecular weights 
were synthesized and covalently attached to the amino groups present at the surface. The 
MPEG-grafted surfaces performed differently with regard to hydrophobicity and adhesion of 
rMSCs, dependent on the molecular weight of the respective polymer. This represents the 
first step towards covalent bonding of proteins by the application of PEG as a spacer 
molecule.  Methods for the immobilization of proteins by using bifunctional PEGs are under 
investigation. 
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Abstract 
Aiming for immobilization of proteins on the surface of hydroxyapatite (HA) ceramic discs 
analytical methods were searched to determine even trace amounts of protein and compare 
different surface modification strategies with regard to their efficacy in protein immobilization. 
The use of radiolabeled compounds provides a possibility to overcome the detection limits of 
other established methods and additionally gather quantitative information. Therefore, the 
goal was to establish a procedure for radioactive labeling of lysozyme and BMP-2 using the 
chloramine-T method. In “cold” experiments, the iodination was determined to be successful 
for lysozyme without affecting protein integrity. In contrast, BMP-2 was either destroyed by 
the oxidizing agent chloramine-T or lost in the preparation process due to strong adsorption 
to reaction vessels or the column used for purification. Lysozyme was then radiolabeled, 
purified to result in a specific activity > 95 %, and an adsorption study on HA ceramic discs 
was carried out. In our study, dependent on the concentration of the feed solution 0.1 – 1 µg 
of lysozyme adsorbed to the ceramic discs. The protein mass per disc was reduced to 0.05 - 
0.1 µm after washing the discs with a surfactant. Significant differences were determined. For 
lysozyme, the demonstrated procedure will be suitable for the investigation of protein 
immobilization, while for BMP-2 alternative methods have to be established. 
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1. Introduction 
Localized delivery of growth factors to the bone-implant interface is a promising strategy to 
improve healing and fixation of implants in the surrounding tissue [1]. For some growth 
factor, such as BMP-2, deposited on a surface or released from a delivery device, the 
amount and release kinetics are of particular interest as the cellular response is strongly 
dependent on the dose of growth factor and the duration of exposure [2]. 
To characterize surface modifications such as protein adsorption and immobilization several 
methods are described in literature. Surface roughness and orientation of macromolecules 
such as proteins on a surface can be investigated by atomic force microscopy (AFM) [3]. 
Using X-ray photoelectron spectroscopy (XPS) information about the elemental composition 
of the uppermost layers of a surface can be obtained [4]. Proteins adsorbed or attached to a 
surface can be identified by means of Time-of-flight secondary ion mass spectroscopy (Tof-
SimS) [5]. While all these methods provide excellent qualitative data, they are not suited for 
quantifying the amount of protein present on a materials surface. Although some authors 
were successful in using protein assays such as the BCA assay for the detection of surface 
immobilized proteins [6], the protein amount on some surfaces is below the detection limit of 
the method. An alternative method to analyze even traces of protein is provided by 
radiolabeled compounds that can be prepared by a variety of well-established methods using 
isotopes, such as 14C, 125I or 3H [7]. In order to use the primary amines of the proteins for 
covalent attachment to the surface, methods such as the Bolton-Hunter-method or the 14C-
methylation, were not appropriate for our purposes and therefore the chloramine-T method 
was chosen [7]. By the chloramine-T method aromatic rings of tyrosine and histidine residues 
are halogenated. For the proteins that were intended to be immobilized on the ceramic 
surfaces, lysozyme and bone morphogenetic protein-2 (BMP-2) [8], radiolabeling with the 
chloramine-T method is described in literature [9-11].  
To assure that lysozyme and BMP-2 were not affected by the procedure, the reaction was 
first carried out under “cold” conditions with the non radioactive isotope 126Iodine and the 
product was characterized by high performance liquid chromatography combined with mass 
spectrometry (HPLC-MS) for lysozyme and matrix assisted laser desorption/ionization time of 
flight mass spectroscopy (MALDI-ToF) for BMP-2. The objective was to establish a 
procedure that would allow for quantitative analysis of proteins on the surface of ceramic 
discs and furthermore for comparison of different techniques for protein immobilization. 
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2. Materials and Methods 
2.1. Materials 
Sodium hydrogen phosphate, sodium dihydrogen phosphate, trichloroacetic acid, lysozyme 
(50.000 units/mg) and sinapic acid were bought from Sigma-Aldrich (Steinheim, Germany). 
0.1 M hydrochloric acid, potassium chloride (KI) and chloramine-T were purchased from 
Merck (Darmstadt, Germany). 125Iodide - as alkaline solution of NaI (37 MBq/ml) - and PD 10 
columns were purchased from Amersham Biosciences (Freiburg, Germany). Sodium 
dodecylsulfate (SDS) and phosphate-buffered saline (PBS) were obtained from Invitrogen 
(Karlsruhe, Germany). Acetonitrile for high performance liquid chromatography (HPLC) was 
purchased from Mallinckrodt Baker (Griesheim, Germany). Bone Morphogenetic Protein-2 
(BMP-2) was produced by Scil Proteins (Halle, Germany). Water was of double distilled 
quality. Hydroxyapatite (HA) ceramic discs were provided by the Friedrich-Baur-Research 
Institute for Biomaterials (Bayreuth, Germany). The ceramic discs had a density of 99 % of 
the theoretical density and consisted of phase pure, crystalline hydroxyapatite (HA). All 
reagents were of analytical grade and used as received unless otherwise noted. To reduce 
protein adsorption, all materials (glass vials, eppendorf cups) in contact with protein solution 
has been pre-treated with Sigmacote™ (Sigma-Aldrich, Steinheim, Germany) following 
manufacturer’s instructions. 
2.2. Iodination of lysozyme  
2.2.1. Iodination of lysozyme 
Lysozyme was labeled using the chloramine-T method. To establish the procedure of 
radiolabeling, iodide (KJ) and lysozyme were used in different stoichiometric relations (1:1, 
3:1, 5:1 and 1:100; the last being the conditions for radiolabelling as a content of 0.1 % of 
labeled product allows for quantitative analysis). For the preparation of a 1 mg/ml lysozyme 
solution 2 µl of an aequous KJ solution were added to 1 ml of a 1 mg/ml solution of lysozyme 
in PBS. After the addition of 100 µl of a 0.2 mg/ml chloramine-T solution, the mixture was 
shaken for 10 min. In order to stop the reaction, 100 µl of a 4 mg/ml sodium metabisulfite 
solution was mixed and shaken with the lysozyme solution for 2 min.  
2.2.2. Purification of labeled protein: Size exclusion chromatography (SEC) 
The resulting solution was purified using a PD-10 column, Sephadex G-25 M (Amersham 
Biosciences, Uppsala, Sweden) and lysozyme was eluted using a phosphate-buffered saline 
(PBS) pH 7.4.  Different sample volumes were used to determine the elution method 
resulting in the highest protein concentration after SEC. Fractions of 1 ml were collected and 
the protein concentration was determined by UV-spectroscopy at 274 nm (Uvikon 941, 
Kroton Inc., Munich, Germany). To assure that the fractions were free of Iodide, 2-3 drops of 
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a silver nitrate solution were added to aliquots of the fractions and the precipitate was 
checked for the presence of yellow silver iodide. 
2.2.3. High performance liquid chromatography coupled with mass spectrometry 
(HPLC-MS) 
For HPLC-MS analysis, samples were analyzed using an Agilent 1100 HPLC system with 
degasser, binary pump, autosampler, column oven and diode array detector (all from Agilent, 
Waldbronn, Germany), coupled with a TSQ7000 mass spectrometer (ThermoQuest, San 
Jose, CA, USA) with API2-source (capillary temperature: 300 °C, spray voltage: 4 kV).  A 
mixture of 68 % solvent A (acetonitrile + 0.1 % TFA) and 32 % solvent B (distilled water + 0.1 
% TFA) served as a mobile phase at a flow rate of 0.2 ml/min for 20 min. For the next 4 min 
a linear gradient of 32-95 % solvent B in solvent A was carried out and for additional 4 min 
the content of B in A was decreased to 32 % again and kept constant for further 2 min. 30 µl 
of the samples were separated using a C18 reversed phase analytical column (Jupiter, 2 mm 
X 250 mm) from Phenomenex (Aschaffenburg, Germany). The XCALIBUR® software 
package (TermoQuest, San Jose, CA, USA) was used for data acquisition and analysis. 
2.3. Iodination of BMP-2 
2.3.1. Iodination of BMP-2 
The iodination of BMP-2 was carried out as described by Yamamoto et al. [9]. 126I was used 
as non radioactive isotope to analyze if BMP-2 was destroyed by the reaction procedure. 4 µl 
of an aequous KI solution (5 mg/ml) were added to 90 µl of BMP-2 solution (5 mg/ml) in 5 
mM glutamic acid, 2.5 wt% glycine, 0.5 wt% sucrose, and 0.01 wt% Tween 80 (pH 4.5). 
Then, 0.2 mg/ml of chloramine-T in 0.5 M potassium phosphate-buffered solution (pH 7.5) 
containing 0.5 M sodium chloride (100 µl) was added to the solution mixture. After agitation 
at room temperature for 2 min, 100 µl of phosphate-buffered saline solution (PBS, pH 7.4) 
containing 0.4 mg of sodium metabisulfate were added to the reaction solution to stop the 
iodination.  
2.3.2. Purification of labeled protein: Anion exchange chromatography 
The reaction mixture was passed through an anionic-exchange column (Dowex 1 X 8, mesh 
size 200-400, packed in 2.5 ml syringe) to remove the uncoupled, free I molecules from the 
I-labeled BMP-2. Fractions of 0.5 ml were collected and analyzed by UV-spectroscopy at 
278 nm (Uvikon 941, Kroton Inst., Munich, Germany). The column chromatography was first 
carried out with lysozyme (100 µl of a lysozyme solution (5 mg/ml) + 100 µl of the 
chloramine-T solution + 100 µl of sodium metabisulfite solution) to determine the protein rich 
fractions and then BMP-2 after the reaction with Iodine was passed through a column. 
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2.3.3. Characterization of labeled protein: MALDI-ToF 
The spectra were recorded on a HP G2030A MALDI-ToF MS system (HP G 2025A MALDI-
ToF MS spectrometer from Hewlett Packard, Germany). 
1 ml of a BMP-2 solution in 10 mM hydrochloric acid (1 mg/ml) and 3 ml of freshly prepared 
solution of sinapic acid in a mixture of 70% (v/v) acetonitrile and 30% (v/v) methanol 
(10 mg/ml) were mixed and dropcasted as one layer onto the MALDI sample target. For the 
fractions of the column chromatography, BMP-2 samples were frieze dried and dissolved in 
10 mM hydrochloric acid to a concentration of 1 mg/ml before mixed with 3 volumes of 
freshly prepared solution of sinapic acid in a mixture of 70% (v/v) acetonitrile and 30% (v/v) 
methanol (10 mg/ml).  
2.4. Adsorption of 125I-lysozyme to hydroxyapatite ceramic discs 
2.4.1. Radioiodination of lysozyme 
For the preparation of a 1 mg/ml lysozyme solution 2.00 µl Na125I (1.5-2 MBq) were added to 
1 ml of a 1 mg/ml solution of lysozyme in PBS. After the addition of 100 µl of a 0.2 mg/ml 
chloramine-T solution, the mixture was shaken for 10 min. In order to stop the reaction, 
100 µl of a 4 mg/ml sodium metabisulfite solution were mixed and shaken with the lysozyme 
solution for 2 min. The reaction mixture was passed through a PD-10 column and eluted with 
PBS. Fractions of 1 ml were collected and checked for γ-ray activity using a NaI(Tl)-
Scintillation-Detector (Ortec, Oak Ridge, USA) calibrated with a 137Cs standard source 
(Amersham Biosciences, Freiburg, Germany). The GammaVision-32 software package 
(Version 5.2; Ortec, Oak Ridge, USA) was used for data analysis. The fraction of highest 
protein concentration (Fraction “4”, 4th ml of eluent), was used for the adsorption 
experiments.  
2.4.2. Determination of specific protein bound radioactivity 
25 µl of the protein rich fractions (3, 4 and 5) were diluted with 2 ml of water and submitted to 
scintillation to determine the total activity of the samples (100 %). In order to determine the 
protein bound activity, 50 µl of the protein rich fractions (3, 4 and 5) were precipitated in 
Eppendorf cups in 1 ml of a solution of 10 % trichloroacetic acid and left on ice for 30 min. 
The precipitates were separated by centrifugation and 500 µl of the supernatant were diluted 
with 1.5 ml water and submitted to scintillation. The activity measured here was due to free, 
non-protein bound activity. Values of specific protein bound activity were calculated as 100 – 
x %, whereas 100 % is the activity of the protein solution and x encodes the activity of the 
supernatant after precipitation of the proteins.    
2.4.3. Adsorption and washing procedure 
To establish a washing procedure to distinguish between reversibly bound protein and 
“immobilized” protein, hydroxyapatite ceramic discs (n=3) were incubated with 2 ml of a 
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solution of 10 µg/ml 125I-lysozyme over night. Samples were washed 5 times with 2 ml of 
water or 2 ml of a solution of 1 % SDS in PBS. The washing solutions were analyzed for 
γ-ray activity and the samples were measured after all 5 washing steps had been performed.  
2.4.4. Adsorption of 125I-lysozyme to HA ceramic discs  
Hydroxyapatite ceramic discs (n=3) were immersed in 2 ml PBS buffer containing varying 
amounts of 125I-lysozyme (1, 10, 25, 50 µg) and left to adsorb overnight. The ceramic 
samples were first washed with water, activity was determined and in a second step washed 
with a solution of 1 % SDS in PBS and activity was determined again (Fig. 1) to distinguish 
between weekly bound and irreversibly adsorbed lysozyme. A standard curve was prepared 
using different dilutions of labeled lysozyme according to [12]. 
 
1% SDS in PBS 
(2 ml, 15 min)
set into new vial     
125I-lysozyme in 2 ml    
PBS buffer (pH =7.4)   
24h, RT     
ddH2O     
(2ml, 15min)     
set into new vial    
determination 
of γ-activity 
determination 
of γ-activity
HA ceramic disc
 
Fig. 1: Schematic setup for the adsorption experiments of 125I- lysozyme on HA ceramic discs 
using different concentrations of 125I-lysozyme. 
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3. Results 
3.1. Iodination of lysozyme 
To separate iodinated protein from free iodide after labeling of lysozyme, a size exclusion 
chromatography (SEC) procedure was established. Different sample volumes were used in 
order to obtain a concentrated protein solution, ideally with the complete lysozyme in one 
fraction. The fractions collected after SEC were analyzed by UV-spectroscopy for absorption 
at 278 nm. The preparation method using 1 ml of sample volume resulted in the highest 
protein concentration in one fraction (fraction 4, Fig. 2). Consequently, to obtain even more 
concentrated protein solutions less sample volume has to be used. Unfortunately, this was 
not possible due to poor solubility of lysozyme in the reaction buffer. Therefore, the elution 
procedure with 1 ml of sample volume and fraction 4 were used for further experiments. 
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Fig.  2: SEC of lysozyme with starting with different sample volumes: 1 ml ( ), 2 ml ( ) 
and 3 ml ( ). Fractions of 1 ml were collected and the content of lysozyme was determined 
by UV-spectroscopy at 278 nm. 
 
After SEC, iodinated lysozyme in fraction 4 was analyzed with focus on changes in molecular 
weight due to the substitution of 1H by 125I or fragmentation. As 0.1 % of radiolabeled 
lysozyme per total protein would be enough for the detection of proteins on ceramic surfaces, 
lysozyme was iodinated in a ratio of 1:1000 and the product was characterized by HPLC-MS 
(Fig. 3). The spectrum displayed only signals of molecule ions corresponding to the mass of 
unmodified lysozyme (2385.8 Da for the 5+ and 2862.7 Da for the 4+ adduct) (Fig. 3) due to 
the detection limits of the HPLC-MS method. Fragments due to oxidation were not detected. 
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a) 
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Fig.  3: HPLC-MS of iodinated lysozyme (ratio 1000:1): a) HPLC chromatogram, UV-detector 
(274 nm) b) mass spectrum of the main peak (retention time 14:33 min) displaying masses of 
a 4+ lysozyme and 5+ lysozyme. 
 
 
To investigate if the reaction would happen in general an excess of iodide was used in a 
stoechiometric ratio of iodide to lysozyme of 5:1. The product of this reaction was purified by 
SEC and fraction 4 was analyzed by HPLC-MS (Fig. 4). In the HPLC-chromatogram 
(Fig. 4 a), 4 separate peaks with retention times varying from 13 to 16 min were found. The 
mass of the substances of each peak were analyzed and revealed that peak 1 corresponded 
to mono-iodinated lysozyme (Fig. 4 b), peak 2 corresponded to double-iodinated lysozyme 
(Fig. 4 c), peak 3 corresponded to lysozyme with three iodine per molecule (Fig. 4 d), and 
peak 4 corresponded to a mixture of lysozyme with three or four iodine per molecule 
(Fig. 4 e). Again signals of lower molecular weight fragments were not detected. Although the 
results are not exactly quantitative, the single-iodinated lysozyme seems to be the main 
product obtained according to the HPLC-chromatogram. 
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Fig.  4: HPLC-MS of iodinated lysozyme (ratio 1:5): a) HPLC chromatogram, UV-detector 
(274 nm); b)-e) mass spectra of peaks 1 to 4 displaying masses of 4-fold and 5-fold charged 
lysozyme substituted with 1-4  iodines.  
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3.2. Iodination of BMP-2 
The iodination of BMP-2 was performed as described in the literature [9]. BMP-2 was 
separated from free iodide using anion exchange chromatography. Lysozyme was used as a 
control in advance to determine the protein containing fractions. Fractions of 0.5 ml were 
collected. For lysozyme three protein rich fractions were detected by UV-spectroscopy (2, 2.5 
and 3). The total amount of lysozyme in fraction 1 to 5 corresponds to 97 % of protein 
amount that was submitted to the column. For BMP-2 less than 30 % of the total protein 
amount were eluted from the column as quantified by UV-spectroscopy. 
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Fig.  5: Protein concentration in the fractions after anion exchange chromatography: while 
lysozyme showed a clear elution profile with three protein rich fractions ( ), BMP-2 was 
hardly eluted from the column ( ). 
 
MALDI-ToF analysis was carried out to assess changes in the molecular mass of the protein 
caused by the labeling procedure (Fig. 6). First, the spectrum of native BMP-2 was prepared 
displaying two peaks of the masses of 14059 and 27952 Da which correspond to a subunit of 
BMP-2 and to the dimeric, disulfide-linked BMP-2, respectively (Fig. 6 a). Fraction 2 and 3 
collected after anion exchange chromatography were investigated by MALDI-ToF. In these 
fractions, hardly any signals were detected (Fig. 6 b, c) as indicated by the low abundance. 
Furthermore, in fraction 2 (Fig. 6 b) small signal of the mass of native BMP-2 were detected 
among other signals that were probably fragments, while in fraction 3 (Fig. 6 c) a signal of 
the mass of native BMP-2 was not found, suggesting that the protein was destroyed by the 
labeling procedure. 
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Fig. 6: MALDI-ToF analysis of a) native BMP-2 b) fraction 2 and c) fraction 3 after anion 
exchange chromatography. 
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3.3. Radioiodination of lysozyme and adsorption to ceramic discs 
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Fig. 7: a) Relative protein content determined by UV-spectroscopy in the protein rich 
fractions after size exclusion chromatography. Fraction 4 contains 70 % of total protein.       
b) Specific, protein bound activity of the protein rich fraction (3.-5. ml) after passing the 
reaction mixture through a SEC-column. 
 
Intending to use the protein in fraction 4 of the size exclusion chromatography the 
concentration of the protein rich fractions was determined by quantitative UV-spectroscopy 
and the protein content was calculated. The fraction 4 was a solution of 700 µg/ml lysozyme 
(Fig. 7 a). Lysozyme was then labeled with 125I and the specific “protein bound” activity of 
lysozyme in the protein rich fractions 3-5 was determined. Precipitation of the labeled protein 
revealed that at least 95 % of the γ-activity in fraction 4 was protein bound (Fig. 7 b). 
 
The fraction 4 was used at different dilutions for studying the adsorption of lysozyme to 
hydroxyapatite ceramic discs: Ceramic discs were immersed in a protein solution (5 µg/ml) 
and adsorbed over night. On the next day the samples were washed 5 times, one half of the 
samples with distilled water, the other half with 1 % SDS in PBS (Fig. 8 a). The washing 
solutions were analyzed for γ-ray activity: In the first washing step, the SDS solution 
contained 10 fold more activity indicating a higher amount of protein that was washed off. In 
the following washing steps, the SDS solution contained less activity than water. The 
remaining γ-activity on the ceramic samples that had been washed 5 times was determined 
(Fig. 8 b). Washing with water led to a significantly higher activity, indicating that a higher 
amount of labeled lysozyme remained on the discs. 
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Fig. 8: Investigation of a washing protocol for protein coated ceramic samples (n=3):            
a) activity in the washing solutions determined at step 1, 3 and 5 after washing the samples 
with  1 % SDS in PBS ( ) and ddH2O ( ). 
b) activity on ceramic samples after 5 washing steps perfomed with H2O and 1 % SDS. 
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Fig.  9: Amount of lysozyme adsorbed to HA ceramic discs (n=3) after washing the samples 
with 2 ml of ddH2O ( ) and 1 % SDS in PBS ( ). 
 
The adsorption of lysozyme on HA ceramic surfaces from solutions with different protein 
concentration resulted in different amounts of protein on the ceramic discs (Fig. 9). The 
amount ranged from 0.1 to 1 µg per ceramic sample. After washing the samples with a 
solution of 1 % SDS in PBS the amount of protein was decreased to 50 -100 ng per sample 
for all experimental groups. Differences between the experimental groups after SDS washing 
were not significant. 
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4. Discussion 
The radioactive labeling of lysozyme and BMP-2 was intended to provide a method suitable 
for the detection of trace amounts of the proteins on the surfaces and for the characterization 
of surface modification methods with regard to their efficacy in retaining the protein on the 
ceramic surfaces. 
Iodination of lysozyme by the chloramine-T method resulted in iodinated protein with different 
degrees of iodination. A maximum degree of substitution of 4 iodines per lysozyme molecule 
was found reflecting the 3 tyrosine residues and 1 histidine residue per protein molecule as 
possible targets for iodination. Labeling lysozyme in a ratio of protein to iodide of 1000:1 
iodinated product was not detectable by HPLC-MS analysis, but the results assured that the 
protein was not affected by the oxidation reaction as no degradation products were detected. 
Using 125I for labeling a purification protocol was established resulting in a concentrated 
solution of 125I-lysozyme with a specific protein bound activity of > 95 %.   
Although the method for labeling of BMP-2 derives from the literature the protein was 
obviously destroyed by the procedure, probably due to oxidation by chloramine-T. Therefore 
alternative methods have to be established for the investigation of surface immobilized 
BMP-2, such as the indirect determination of active BMP-2 by the use of cells that respond to 
BMP-2 by the expression of a specific marker in a dose-dependent manner [13;14].  
For further characterization of the adsorption of 125I-lysozyme to the ceramic surfaces a 
washing procedure was established to distinguish between weakly and strongly adsorbed 
protein. Using distilled water the washing solution contained only 7 % of the activity that 
could be removed by washing the samples with 1 % SDS in PBS. This profound difference 
occurred only in the first washing step while in the following steps significant differences 
between water and SDS were not detected. After treating the ceramic samples 5 times with 
water a significantly higher amount of activity remained compared to samples treated 5 times 
with SDS. Therefore it was assumed that by treating the samples with distilled water only 
weakly bound protein could be removed while by washing with SDS strongly adsorbed 
lysozyme was removed. Therefore, the following experimental set up was chosen for further 
characterizations of protein adsorption: Ceramic discs with adsorbed protein were washed 
with water and the γ-activity was counted. Then the samples were washed with SDS and 
γ-activity was counted again. 
125I-lysozyme adsorbed to the ceramic discs in a concentration dependent manner. However, 
after rinsing the samples with SDS the remaining mass of lysozyme on the samples did not 
differ significantly.  This indicates that lysozyme adsorbs to the surface of HA ceramic discs, 
but can almost completely be removed by a surfactant, which can probably be utilized to 
distinguish adsorbed protein from chemically immobilized protein. This would allow for the 
evaluation of different procedures for the immobilization of proteins. 
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5. Conclusion 
Radiolabeling of lysozyme with 125Iodine was successful without destroying the protein. By 
using the labeled compound quantitative measurements of protein on the surface of HA 
ceramic discs was possible. A washing procedure to distinguish between reversibly bound 
and strongly adsorbed lysozyme was established. This experimental set up allows for 
investigation and comparison of different methods for protein immobilization on the surfaces. 
Labeling of BMP-2 with the chloramine-T method was not successful in contrast to reports in 
the literature.  
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Abstract 
A promising strategy to control the osseointegration of biomaterials such as hydroxyapatite 
(HA) ceramics is the local delivery of growth factors to the bone-implant interface. However, 
when simply adsorbing the factors to the surfaces, uncontrolled desorption may occur and 
unspecific protein adsorption may mask the cytokines thus limiting the control of cell 
stimulation. These limitations may be overcome by tethering cytokines to a surface by the 
use of poly(ethylene) glycol (PEG). Therefore, hydroxyapatite surfaces were modified by 
silanization and subsequent attaching of PEG. The adsorption of lysozyme to PEG 
monomethylether-grafted surfaces was investigated and PEG acetaldehyde was used for 
covalent attachment of the protein. Surfaces were characterized by contact angle 
measurements and X-ray photoelectron spectroscopy. PEGylation did not suppress the 
adsorption of lysozyme to the ceramic surfaces: nitrogen content on surfaces after protein 
adsorption was 5 to 7 % of the chemical composition and significant differences between 
PEGgrafted and unmodified ceramics were not determined. The amount of adsorbed and 
attached protein was determined using radiolabeled lysozyme: By immobilization, 90 ng of 
lysozyme were deposited compared to 30 ng that adsorbed to pure HA surfaces. The 
enzymatic activity of lysozyme on the discs was not affected by covalent attachment.  
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1. Introduction 
Surface design of biomaterials for implants plays a fundamental role in biology and medicine, 
as the surface properties of a material determine its interactions with the biological 
environment [1]. Grafting poly(ethylene glycol) (PEG) onto a surface is probably the most 
common method towards controlling protein adsorption and consequently cell response [2]. 
In most cases PEGylation is used to reduce protein adsorption intending to achieve specific 
interactions of cells with material [3]. Contradictory results are reported in the literature 
concerning the optimal length and density of PEG chains for effective “surface shielding”. 
Relatively short PEG chains (Mw = 750-2000 Da) have been found to provide full resistance 
to bioadhesion whereas other studies emphasize the need for long chains (>10000 Da) or 
branched polymer structures [4-6]. Not only the type of PEG but also size and charge of the 
particular protein influence the shielding efficacy [7]. Attaching linear PEG molecules, the 
chain density on a surface was reported to be more important than chain length [8-10]. So, 
for every particular combination of surface type, PEG derivative and grafting reaction, the 
optimal reaction conditions have to be determined. Besides complete shielding, PEG-grafted 
biomaterials exhibited additional advantages: intermediate interfacial PEG densities were 
shown to enhance cell adhesion [11], to improve the acceptance of hydrophobic materials by 
cells [12] and poly(ethylene glycol)-poly(lactic acid) (PEG-PLA) diblock copolymers promoted 
the osteoblastic differentiation of marrow stromal cells [13]. Tethering cytokines to material 
surfaces is another application of PEG towards preserving stability and enhancing biological 
efficacy [14] by avoiding direct contact with a material’s surface which might lead to reduced 
activity [15]. Despite the promising potential of this strategy, until now few studies have 
investigated the covalent immobilization of growth factors or proteins via PEG spacers to 
materials. TGF-ß2, TGF-ß1 and bFGF were tethered to collagen or acrylate hydrogels with 
retention of their biological activity [16-18]. Concerning solid surfaces, EGF tethered to glass 
slides retained its biological activity in contrast to adsorbed EGF [19].  Defined interactions of 
cells and biomaterial are of particular importance for the events at the bone-implant interface 
in order to achieve rapid healing and long-term fixation [20] which is favored by 
hydroxyapatite coatings [21] and localized delivery of growth factors [22]. Combining 
hydroxyapatite surfaces that would allow for specific interactions with cells via chemically 
immobilized growth factors would be a promising strategy to control and improve the 
osseointegration of implants. Unfortunately, there are no reports in the literature if the PEG 
tethering strategy can be used to modify HA surfaces as well. Therefore, we modified HA 
ceramic surfaces by aminosilanization and subsequent attachment of linear 
PEGacetaldehyde monomethylether and investigated their potential to prevent unspecific 
adsorption of proteins. To allow for the immobilization of proteins PEG acetaldehyde was 
chosen as homobifunctional derivative. Lysozyme served as a model protein to investigate 
the suitability for protein attachment.  
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2. Materials and Methods 
2.1. Materials 
Hydroxyapatite (HA) ceramic discs were provided by the Friedrich-Baur-Research Institute 
for Biomaterials (Bayreuth, Germany). The discs had a density of 99 % of the theoretical 
density and consisted of crystalline, phase pure HA. The discs were 12 mm in diameter and 
2 mm thick. 
Aminopropyltriethoxysilane (APTES) was purchased from Sigma-Aldrich (Steinheim, 
Germany) and freshly distilled prior to use. Toluene was purchased from Merck (Darmstadt, 
Germany) and dried by azeotropic distillation prior to use. Ethanol, sodium hydrogen 
phosphate, sodium dihydrogen phosphate, sodium cyanoborohydride, sodium citrate, 
lysozyme (50.000 units/mg), polyethylene glycol (PEG) of molecular weight (2000, 4000 Da; 
denoted as PEG 2k and PEG 4k) and polyethylene glycol monomethylether (mPEG) (750, 
2000 and 5000 Da) were bought from Sigma-Aldrich (Steinheim, Germany). 0.1 M 
hydrochloric acid, sodium tetra borate decahydrate, sodium carbonate and chloramine T 
were purchased from Merck (Darmstadt, Germany). Alkaline solution of Na125I (37 MBq/ml) 
and PD-10 columns were purchased from Amersham Biosciences (Freiburg, Germany). 
Sodium dodecylsulfate (SDS) and phosphate-buffered saline (PBS) were purchased from 
Invitrogen (Karlsruhe, Germany). P-nitrophenyl penta-N-acetyl-ß-chitopentaoside (PNP-
(GlcNAC)5) was purchased from Seikagaku Corp. (Tokyo, Japan). β-N-
acetylglucosaminidase from Jack Beans was purchased from Sigma-Aldrich (Steinheim, 
Germany). Deuterated solvents for NMR-spectroscopy, chloroform, dimethylene sulfoxid 
(CDCl3 , DMSO-d6) were obtained from Deutero GmbH (Kastellaun, Germany). All reagents 
were of analytical grade and used as received unless something different is stated. 
2.2. Surface modification of HA ceramics 
2.2.4. Aminosilanization 
HA ceramic discs were washed with 5 ml ethanol immediately prior to use. The 
aminosilanization of the discs was carried out in dry toluene. Briefly, 12 ceramic discs 
(diameter 12 mm) were placed in a three-necked glass reaction vessel with flat bottom 
(diameter 10 cm). 40 ml of dry toluene were added and the temperature was increased to 
120° C. Freshly distilled aminopropyltriethoxysilan e (APTES) was then added to result in a 
1.5% (v/v) concentration and the reaction was held at 120° C for 4 hours in argon 
atmosphere (Argon 4.6, Linde AG, Pullach, Germany). After 4 hours, the samples were 
thoroughly rinsed with 3 ml toluene and 3 ml chloroform and dried under vacuum.  
2.2.5. Synthesis of PEG acetaldehyde diethylacetal and mPEG acetaldehyde diethylacetal 
PEG acetaldehyde diethylacetal was synthesized following a procedure of Bentley et al. as a 
stable intermediate that could be stored and hydrolyzed to gain the corresponding aldehyde 
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immediately before the attachment to the surface [23]. The polymers were characterized by 
1H-NMR spectroscopy. The 1H-NMR spectra were recorded after dissolving 10-20 mg 
polymer in CDCl3 or d6-DMSO on Avance 300 NMR-spectrometer (Bruker, Rheinstetten, 
Germany). The spectra displayed the characteristic PEG backbone absorption at 3.51 ppm 
and the ethyl triplet absorption at 1.11 ppm and the acetal triplett at 4.55 ppm. Integration of 
the acetal triplett relative to the PEG backbone peak allowed for the determination of the 
degree of substitution of several preparations of PEG acetaldehyde diethylacetal to be 80-
95%. 
2.2.6. Stability of PEG acetaldehydes under conditions for protein attachment 
PEG acetaldehydes were prepared by heating a stirred solution of the respective PEG 
acetaldehyde diethylacetal in aqueous HCl (0.1 M; pH 1) at 50°C for 20 min as described in 
[23]. In a typical experiment, 250 - 500 mg PEG-derivative and 10 ml of hydrochloric acid 
were used. After cooling to room temperature, the pH was carefully adjusted to 6 by drop 
wise adding of 5% aqueous sodium bicarbonate to the rapidly stirred solution. The resulting 
solution was saturated with NaCl and extracted with methylene chloride (3x). The extract was 
dried over Na2SO4 and filtered, and the filtrate was evaporated under vacuum to a final 
volume of 10 ml.  Addition of cold ethyl ether precipitated the PEG derivative which was 
collected by vacuum filtration and dried under vacuum at room temperature. The degree of 
substitution was determined by 1H-NMR spectroscopy in CDCl3 using TMS as standard. The 
1H-NMR spectra displayed the characteristic PEG backbone absorption at 3.51 ppm and the 
aldehyde singlett at 9.57 ppm. To assess the stability of the aldehyde under surface grafting 
conditions, mPEG acetaldehyde was stirred in sodium tetraborate solution (0.1 M; pH 9.3) 
over night in the presence of sodium cyanoborohydride. The 1H-NMR spectra were recorded 
on a Avance 300 NMR-spectrometer (Bruker, Rheinstetten, Germany).  
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Scheme 1: Surface functionalization and grafting of mPEG acetaldehyde to silanized HA 
ceramic discs. 
 
2.2.7. Attaching of PEG acetaldehydes to the surface 
mPEG acetaldehyde diethylacetals and PEG acetaldehyde diethylacetals were hydrolyzed to 
the corresponding acetaldehydes in 0.1 M hydrochloric acid at 50°C. The polymers were 
conjugated to the silanized ceramic discs by reductive amination in a 0.1 M sodium tetra 
borate solution at pH=9.3 (scheme 1). For the reaction conditions a protocol from the 
literature was followed [24]. The polymers were used in 100-fold molar excess relative to the 
amino groups present on the surface. The discs were rinsed with distilled water and dried 
under vacuum.  
2.3. X-ray photoelectron spectroscopy 
The surface composition of the ceramic discs before and after adsorption of lysozyme was 
determined by X-ray photoelectron spectroscopy (XPS) on a Phi 5700 XPS system (Physical 
electronics, Ismaning, Germany) using an AlKα source. Increase in nitrogen content in the 
uppermost surface layers was considered as a measure of lysozyme adsorption when 
compared to the composition of the respective surface before immersion into a protein 
solution. A more detailed description can be found in [25]. 
2.4. Radioactive labeling of lysozyme with 125I 
Lysozyme was labeled using the chloramine T method. In the following, the preparation of a 
1 mg/ml lysozyme solution is exemplarily described. 2.00 µl Na125I (1.5-2 MBq) were added 
to 1 ml of a 1 mg/ml solution of lysozyme in PBS. After the addition of 100 µl of a 0.2 mg/ml 
chloramine T solution, the mixture was shaken for 10 min. In order to stop the reaction, 
100 µl of a 4 mg/ml sodium metabisulfite solution was mixed and shaken with the lysozyme 
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solution for 2 min. Products and educts were separated on a PD-10 column and lysozyme 
was eluted using a phosphate-buffered saline (PBS) pH 7.4. The resulting solution was a 
700 µg/ml lysozyme solution in PBS, pH 7.4, with a specific protein bound activity > 95%, 
which was used at different dilutions for all adsorption and binding experiments.   
2.5. Adsorption and immobilization of lysozyme at HA ceramic surfaces 
The adsorption experiments were carried out with mPEG grafted ceramic discs that were 
prepared as described in 2.2.4. Modified ceramic samples (n=3) were immersed in 2 ml of an 
aqueous solution of lysozyme (100 µg/ml). The protein was allowed to adsorb overnight to 
assure completed adsorption. Then discs were washed with 2 ml water to remove non-
adsorbed protein and dried under vacuum.  
The immobilization of 125I-lysozyme to PEGylated ceramic discs was performed in sodium 
tetra borate solution (0.1 M; pH 9.3) (scheme 2). The protein was used in a concentration of 
10 µg/ml. The covalent binding of lysozyme and PEG acetaldehyde was carried out in the 
presence of sodium cyanoborohydride to result in a stable secondary amine. HA ceramics, 
silanized ceramics and PEGgrafted ceramics without sodium cyanoborohydride served as 
control groups to distinguish between adsorbed and immobilized lysozyme. Samples (n=3) 
were immersed in protein solution over night. Discs were first washed with water and in a 
second step, washed with 1 % sodium dodecylsulfate in PBS to determine the amount of 
irreversibly attached protein. After each washing step, samples were submitted to scintillation 
to determine the amount of protein that was present on the surface. The samples were 
placed in polyvials (Zinsser Analytik, Frankfurt, Germany) and submitted to scintillation using 
a NaI(Tl)-Scintillation-Detector (Ortec, Oak Ridge, USA). The GammaVision-32 software 
package (Version 5.2, Ortec, Oak Ridge, USA) was used for data analysis.   
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Scheme 2: Surface modification: attachment of PEG acetaldehyde and subsequent binding 
of proteins (i.e. lysozyme) covalently to the surface. 
 
2.6. Enzymatic activity of lysozyme  
The enzymatic activity of lysozyme at the surface of the discs was assessed by a method 
described by Klaeger et al. [26]. The discs were immersed in a lysozyme solution (10 µg/ml) 
overnight to allow for complete adsorption and immobilization. The reaction conditions were 
as described in 2.4 using non-labeled lysozyme. The enzymatic activity was assessed by the 
coupled reaction of lysozyme and ß-N-acetylglucosaminidase to remove the sugar residues 
from (PNP-(GlcNAC)
 5) resulting in free p-nitrophenol. Samples were incubated at 37°C and 
allowed to react for 5 hours until a considerable amount of the substrate was cleaved. A 
standard curve was performed and the amount of released p-nitrophenolat was measured by 
a micro plate reader (CS 9301, Shimadzu) at 405 nm.  
2.7. Contact angle measurements 
To assess changes in surface wettability, water contact angles of the surfaces were 
measured before protein adsorption and immobilization and after the subsequent washing 
steps. The measurements were performed on OCA 15 (dataphysics, Filderstadt, Germany), 
using the sessile drop method with 1 µl drops of ddH2O. 
Chapter 4                                                 Lysozyme immobilization on PEGmodified ceramics                                                                                                                                                    
- 62 - 
2.8. Statistical analysis 
All measurements were collected (n=3) and expressed as means ± standard deviation (SD). 
Single factor analysis of variance (ANOVA) was used in conjunction with a multiple 
comparison test (Tukey test) to assess the statistical significance. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 4                                                 Lysozyme immobilization on PEGmodified ceramics                                                                                                                                                    
- 63 - 
3. Results  
The first part of the study investigated the adsorption behavior of the model protein lysozyme 
to unmodified and mPEGgrafted ceramic discs. As first step of surface modifications, the HA 
ceramic discs were aminosilanized to allow for further conjugation steps and subsequently, 
mPEG acetaldehydes of varying molecular weights were grafted to the amino groups by the 
formation of a schiff base followed by reduction of the intermediate resulting in a secondary 
amine (Scheme 1).  
3.1. Adsorption of lysozyme on mPEG grafted ceramic discs  
The protein resistance of mPEG grafted ceramic discs was investigated using lysozyme as a 
model protein. mPEG of molecular weight of 750 to 5000 Da were attached to the surfaces. 
In order to investigate the chemical composition of the surfaces prior to and after protein 
adsorption XPS-survey scans were recorded (Fig. 1 a-e). After silanization, a signal from 
nitrogen was detected on the samples indicated by a small peak at 400 eV in the inserted 
spectra (Fig. 1 b) that was not present on untreated ceramics (Fig. 1 a). The signal was still 
present after grafting mPEGs of varying molecular weight (Fig. 1 c, d and e). While on HA 
ceramic discs prior to surface modification, the nitrogen content was below 1%, on silanized 
ceramics, the mean nitrogen content increased to 2.3% of atomic composition and 
decreased again after PEGgrafting by all three PEG chain lengths to 1.3 - 1.8%. Although 
there is a tendency that the longer PEG chains reduce the nitrogen content of the uppermost 
surface layers, a quantitative interpretation of the results is difficult as all these values are 
below the limit for exact analysis.  
After adsorption of lysozyme, the N 1s signal was strongly increased in all experimental 
groups, which indicates adsorption of the protein to the surfaces (Fig. 2 a-e). The atomic 
concentration of nitrogen was ranging from 5 to 8% of total elemental composition. This 
indicates that none of the PEG derivatives was capable to suppress the adsorption of 
lysozyme completely.  
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Fig. 1: XPS survey scans of pure surfaces prior to protein adsorption: a) HA ceramic 
b) silanized ceramic c) mPEG 750 d) mPEG 2000 and e) mPEG 5000 grafted ceramic. The 
peak at binding energies of 550 eV corresponds to the O 1s electron, while the peaks at 350 
and 450 eV correspond to the Ca 2p, 400 eV to the N 1s, 250 eV to the C 1s, 200 and 150 
eV to the P 2p and 175 and 125 eV to the Si 2p electrons, respectively. Inserted spectra 
show the nitrogen signal (N 1s) as a measure of protein adsorption at high resolution.  
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Fig. 2: XPS survey scans of discs after protein adsorption: a) HA ceramics b) silanized 
ceramics c) mPEG 750 d) mPEG 2000 and e) mPEG 5000. The peak at binding energies of    
550 eV corresponds to the O 1s electron, while the peaks at 350 and 450 eV correspond to 
the Ca 2p, 400 eV to the N 1s, 250 eV to the C 1s, 200 and 150 eV to the P 2p and 175 and 
125 eV to the Si 2p electrons, respectively.  Inserted spectra show the nitrogen signal (N 1s) 
as a measure of protein adsorption at high resolution.  
 
A quantitative comparison of protein adsorption assessed by nitrogen content in the 
uppermost surface layers was carried out for the untreated ceramic as well as mPEG 750 
and mPEG 5000 coated samples (Fig. 3). The nitrogen content is significantly increased by 
the adsorption of lysozyme but a significant difference between ceramics treated with 
different PEG chain lengths after protein adsorption was not detected.  
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Fig. 3: Percentage of nitrogen in the atomic composition of the uppermost surface layers on 
the respective surfaces before ( ) and after ( ) protein adsorption as determined by XPS 
survey scans. At all the surfaces, a significant increase in nitrogen content was found after 
immersion in a solution of lysozyme, but none of the PEGylated ceramic discs was suitable 
to suppress protein adsorption completely. indicates significant differences (n=3; p<0.05). 
 
 
 
 
 
 
 
3.2. Suitability for protein attachment: stability of PEG acetaldehydes under protein 
grafting conditions 
In order to prove whether PEG acetaldehyde was suitable for covalent binding of proteins 
after attachment to the surface, the stability of the aldehyde-function under surface grafting 
conditions was assessed by 1H-NMR-spectroscopy. For these experiments mPEG (2000 Da) 
was chosen as a model compound. The methylether singlet (δ = 3.41 ppm) served as 
internal standard for the integration of the signals. Fig. 4 shows the 1H-NMR spectrum of 
mPEG acetaldehyde diethylacetal after synthesis.  By integration of signal 2 to signal 5 a 
degree of substitution of 80% was determined.  
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Fig. 4: 1H-NMR spectrum of mPEG acetaldehyde diethylacetal monomethylether). Peaks 3 
and 4 are due to solvent residues (DMSO and water, respectively). 
 
After acidic hydrolysis, mPEG acetaldehyde diethylacetal was converted to the 
corresponding acetaldehyde as indicated by the typical singlet signal of the aldehyde proton 
6 (Fig. 5 a). A degree of substitution of 72 % was determined by integration of the peaks for 
the aldehyde singlet (δ = 9.57 ppm) relative to the methylether singlet (δ = 3.41 ppm). 
Hydrolysis was not completed as a residue of the diethylacetal was observed (δ = 1.11 ppm, 
indicated by arrow).   
Spectrum 5 b was recorded after stirring a mPEG acetaldehyde solution at pH 9.3 overnight 
in the presence of sodium cyanoborohydride (Fig. 5 b). The spectrum clearly displays the 
aldehyde singlett at 9.57 ppm. Peak integration revealed a content of mPEG acetaldehyde of 
80 %. The increase in degree of conversion could be explained by completed hydrolysis after 
stirring over night. Additional peaks, despite the solvent residues, indicating the formation of 
by-products or destruction of the compound were not detected. 
Chapter 4                                                 Lysozyme immobilization on PEGmodified ceramics                                                                                                                                                    
- 68 - 
0.01.02.03.04.05.06.07.08.09.010.0
(ppm)
a)
b)
12
3
4
56
O
O O
n3
2
4
36
 
 
Fig. 5: 1H-NMR spectra of mPEG acetaldehyde: after hydrolysis (B) and after stirring under 
surface attachment conditions (C). The signal at 9.57 ppm is characteristical for the aldehyde 
proton (6) as well as signal 4 which corresponds to the C-atom next to the aldehyde 
functional group. Peak 5 is the solvent residual peak (CDCl3). 
 
3.3. Immobilization of lysozyme using PEG acetaldehyde as spacer molecule 
The XPS results clearly showed that the adsorption of the model protein was not completely 
suppressed by PEG layers. But, according to the literature, stabilizing effects of a PEG layer 
on attached proteins were expected. Therefore, ín the second part, the covalent 
immobilization of lysozyme by using PEG acetaldehyde as a spacer molecule was examined 
with focus on the determination of the influence of immobilization method on biological 
activity of the attached protein.  As shown in scheme 1, ceramic discs were aminosilanized 
and the surfaces were modified with PEG acetaldehyde to allow for covalent attachment of 
proteins via the second aldehyde functional group. 
3.3.1. Contact angle measurements 
Water contact angle measurements of the surfaces were carried out after each subsequent 
modification step to assess modifications in the chemical composition (Fig. 6). The contact 
angle of ceramic discs was increased by silanization from 65° to 70° and slightly reduced 
again after PEGgrafting. After adsorption of lysozyme contact angles for the untreated and 
silanized ceramics were reduced. The changes in contact angle for the PEGgrafted ceramic 
discs compared to silanized ceramics were not significant after lysozyme adsorption in any of 
the experimental groups. Washing with SDS containing buffer further reduced the contact 
angle in all experimental groups to a level of 20° to 40°. 
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Fig. 6: Contact angle measurements of the surfaces investigated in this study after different 
modification steps (
 
 surfaces prior to protein adsorption,  surfaces after protein adsorption 
and samples after washing with 1% SDS in PBS). DPEG encodes for PEG acetaldehyde, 
while 2k and 4k correspond to the respective PEG chain length (2000 Da vs. 4000 Da). 
 
3.3.2. XPS survey scans after attachment of lysozyme to surfaces modified with PEG 
acetaldehyde 
XPS-survey scans after using PEG acetaldehyde to covalently attach protein revealed that 
lysozyme was deposited on a PEG dialdehyde (Mw = 2000 Da) grafted ceramic, indicated by 
the N 1s signal in the inserted spectrum (Fig. 7 a). Unfortunately, after washing the sample 
with a 1% SDS solution, the protein seemed almost completely desorbed from the surface 
within the detection limits of the method (Fig. 7 b). 
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Fig. 7: XPS survey scans for surfaces with covalently attached lysozyme via PEG dialdehyde 
(2k)-spacers. The peak at binding energies of 550 eV corresponds to the O 1s electron, while 
the peaks at 350 and 450 eV correspond to the Ca 2p, 400 eV to the N 1s, 250 eV to the C 
1s, 200 and 150 eV to the P 2p and 175 and 125 eV to the Si 2p electrons, respectively. 
Inserted spectra show the nitrogen signal (N 1s) as a measure of protein adsorption at high 
resolution. a) Sample washed with water and b) sample washed with water and a solution of 
1% SDS in PBS. In Fig. 7a, a clear signal for the N1s electrons can be observed, which 
indicates that lysozyme adsorbed or was immobilized. As shown in Fig. 7b it can completely 
be removed by SDS (within the detection limits of the method).  
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3.3.3. Immobilization of 125I-lysozyme on PEGgrafted ceramic discs 
To overcome the limitations of the XPS study with regard to the determination of the amount 
of protein that was deposited on the differently treated ceramic discs, experiments with 
radiolabeled lysozyme were carried out (Fig. 8). After immersion into a protein solution over 
night, the deposited amount of lysozyme was ranging from 0.1 to 0.3 µg for the individual 
surfaces which corresponds to 0.05 to 0.15 µg/cm2. The highest amount was detected on the 
silanized ceramic discs. After PEGgrafting, the mass of protein on the surface was 
decreased in all cases but the reduction was only significant for the groups with covalently 
bound protein. As observed in the contact angle measurements, the results for the 
PEGgrafted surfaces displayed again high standard deviations indicating an inhomogeneous 
structure of the surfaces (Fig. 8 a). After washing the samples with 1% SDS in PBS to 
remove reversibly bound protein, the remaining amount was considered to be the 
“immobilized” mass of the protein (Fig. 8 b).  
By treating the samples with surfactant, the mass of protein was reduced to below 0.1 µg per 
sample which is equal to app. 0.05 µg/cm2. Based on the assumption that 1.5 µg/cm2 
represent a monolayer of lysozyme [27;28], this shows that  3.4 % of the surface are protein-
covered. Again, on the silanized ceramics more protein was detected than on untreated and 
on PEGgrafted ceramics. But using PEG spacers for covalent attachment, the amount of 
remaining protein was comparable to silanized ceramics, while on simply PEGgrafted 
surfaces less protein adsorbed. On silanized ceramics and by covalent attachment the 
amount of protein was significantly higher than on pure HA ceramic, but the differences 
between adsorbed and covalently attached protein on PEG grafted surfaces were not 
significant. 
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Fig. 8: Adsorption and attachment of 125I-lysozyme: a) surfaces after protein binding, washed 
with bidistilled water and b) washed with 1 % SDS in PBS.  indicates significant differences 
to control (HA ceramics) (n=3; p<0.05). 
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3.3.4. Enzymatic activity 
The enzymatic activity of lysozyme immobilized on the surfaces was investigated. The 
enzyme activity assay showed again the highest amount of active protein on silanized 
ceramics, while on all PEGgrafted surfaces the mass of protein was reduced. When grafting 
conditions were suitable for covalent attachment, the determined lysozyme activity increased 
again. Results displayed high standard deviations and therefore differences were not 
statistically significant. 
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Fig. 9: Enzymatic activity of adsorbed and immobilized lysozyme after washing the samples 
with water. Differences were not significant, but in tendency we found, that more active 
lysozyme was deposited on the surfaces after covalent binding. Nevertheless, activity of 
covalently attached lysozyme did not exceed the values for lysozyme adsorbed to 
unmodified and silanized ceramic discs.  
 
 
 
 
 
 
The % share of active lysozyme of total protein was calcutated by refering the values for the 
activity of lysozyme to the mass of protein determined by the experiments with radiolabeled 
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lysozyme (Tab. 1). On HA ceramics and silanized ceramics at least 74% of lysozyme 
remained active. The active part of lysozyme that was adsorbed to mPEGgrafted ceramics 
corresponded to 30% of total protein. When lysozyme was attached via PEGspacers the 
enzymatic activity of lysozyme 80-100% remained active. 
 
Type of surface HA 
ceramics 
silanized 
ceramics 
DPEG 2k 
rev. 
DPEG 4k 
rev. 
DPEG 2k 
irrev. 
DPEG 4k 
irrev.  
active lysozyme/  
total lysozyme  [%] 84 ± 52 74 ± 42 34 ± 7 31 ± 3 117 ± 67 80 ± 53 
 
Tab. 1: % share of active lysozyme at the surface of the discs after adsorption and reversible 
(rev.) or irreversible (irrev.) attachment to the surfaces. The active part of the protein 
determined by the enzymatic activity assay is given relative to the total amount of protein 
determined by binding experiments with 125I-lysozyme and removing of weakly bound protein 
with water. 
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4. Discussion 
The objective of the study was to investigate the suitability of PEGylated HA ceramic discs 
for the immobilization of a protein and at the same time to achieve selective interactions via 
the suppression of unspecific adsorption. In general, by PEGylation of surfaces three main 
purposes are followed: First of all, bioinert surfaces can be created by complete suppression 
of protein adsorption [8]. Another aim is the creation of surfaces suitable only for a specific 
type of interactions for example selective cell adhesion [3] when the PEG surface is suitable 
for covalent attachment [29]. Furthermore, PEG tethers are suitable spacers for protein 
attachment as they are promoting stability of the attached protein [19]. 
In order to create surfaces that were capable of defined stimulation of attached cells the 
potential of PEG modified hydroxyapatite ceramic surfaces was investigated. The protein 
lysozyme was chosen due to similarities in physicochemical properties with some growth 
factors, the availability, ease of radioactive labeling and well-known mechanism of enzymatic 
action that allows for the investigation of impact of the immobilization method on protein 
activity [30].  
Lysozyme adsorbed to all the surfaces, unmodified or PEGgrafted, as clearly shown by XPS 
data (Fig. 2), represented by an increase in nitrogen content of the uppermost surface layers. 
None of the investigated mPEGs with chain lengths varying from 750 to 5000 Da was 
capable to prevent protein adsorption completely when attached to the surface. A 
quantitative comparison of nitrogen content of untreated ceramic, mPEG 750 and mPEG 
5000 grafted samples before and after protein adsorption revealed no significant differences 
in terms of protein adsorption.  
In comparison to other proteins lysozyme displayed enhanced adsorption to PEG-coated 
surfaces, which was explained by the relatively low molecular weight (14600 Da) [31]. Thus, 
for surface shielding to suppress lysozyme adsorption, PEG layers apparently have to be 
more densely packed as for the rejection of other proteins. Compared to values reported in 
the literature, the water contact angles of the PEG grafted surfaces remained relatively high 
[4;11] indicating an incomplete coverage with hydrophilic polymer. In order to improve the 
shielding efficacy of the created PEG layer, alternative methods were suggested in literature 
as “cloud point grafting” [31], the use of branched PEGs [32] and the creation of 
interpenetrating networks by grafting a copolymer of polyacrylamide and PEG to surfaces 
[33]. However, preliminary experiments with rat marrow stromal cells (rMSC) have shown, 
that cell adhesion could be reduced by grafting of mPEG 5000 to HA ceramic discs [34]. 
As HA ceramics is a material favoring osseointegration and comprising bone bonding 
properties [21], it is disputable if a complete shielding of the surface is desirable. Additional 
advantages of the material would vanish by suppression of all unspecific interactions. 
Hydroxyapatite is known to be efficiently adsorbing many proteins in comparison to other 
materials relevant for hard-tissue replacement, which is considered to be responsible for the 
Chapter 4                                                 Lysozyme immobilization on PEGmodified ceramics                                                                                                                                                    
- 76 - 
excellent osseointegration properties [35]. Nevertheless, PEG modification of surfaces has 
beneficial effects on adsorbed proteins, such as promoting stability and reorganization of 
adsorbed fibronectin [12]. By the presence of the hydrophilic and uncharged PEG molecules 
interactions of adsorbed proteins with the surface could be avoided or attenuated [36;37]. 
Therefore we investigated as a second advantage of PEGylation the stabilizing effect of the 
PEG layer on attached or adsorbed lysozyme. However, comparing the enzymatic activity of 
lysozyme adsorbed to unmodified and to PEGgrafted ceramic discs, lysozyme lost enzymatic 
activity, which was not prevented by PEGylation (Fig. 9).  
A third purpose of PEGylation is the application as spacer molecule to the immobilize 
proteins as a method to retain the protein at the application site and prevent uncontrolled 
desorption. Therefore, we investigated the suitability of PEG acetaldehyde grafted surfaces 
for immobilization of lysozyme. PEG acetaldehydes were used as homobifunctional linkers 
as they were reported to lead to an effective protein-resistant coating [31;38;39] and to 
efficiently PEGylate lysozyme [23]. The reductive amination was performed following a 
protocol from the literature described to obtain high yields [24]. However, the mass of protein 
deposited on all types of surfaces was below the mass of lysozyme that would create a 
monolayer according to literature [28]. The highest amount was determined on the silanized 
surfaces, the most hydrophobic ones in our study. The samples were washed with 1% SDS 
in PBS to distinguish between reversibly and irreversibly attached lysozyme.  A significant 
increase in protein amount deposited on the surface was obtained after irreversibly attaching 
lysozyme using PEGspacers relative to unmodified ceramics. The chain length of the 
respective PEG derivative did not influence the amount of protein that was deposited. 
However, grafting of homobifunctional polymers was reported to lead to the formation of 
looplike structures, due to reaction of both aldehydes with the surface [40]. To achieve more 
homogeneously structured surfaces and higher amounts of attached protein, the use of 
heterobifunctional PEG would be a valuable tool as they would first react with the surface, by 
one functional group, and then with the protein by another type of reaction.  
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5. Conclusion 
Modifying the surface of HA ceramic discs by grafting of mPEG acetaldehydes with a 
molecular weight range from 750 to 5000 Da did not completely suppress the adsorption of 
lysozyme. When using PEG acetaldehyde as a spacer molecule for covalent attachment of 
lysozyme, protein mass was increased relative to pure ceramics, and in tendency, the protein 
retained its enzymatic activity to a higher extent compared to adsorbed protein. However, 
results where not significant, probably due to inhomogeneous structure of the modified 
surfaces. Additionally, the highest amount of protein was found after adsorption of lysozyme 
to silanized ceramics, with acceptable enzymatic activity. To conclude, considering the 
relatively low mass of protein that has been attached more efficient immobilization methods 
have to be examined. 
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Abstract  
The immobilization of biomolecules on biomaterial surfaces allows for the control of their 
localization and retention. In numerous studies, proteins have been simply adsorbed to 
enhance the biological performance of various materials in vivo. We investigated the 
potential of immobilized proteins compared to adsorbed proteins on hydroxyapatite (HA) 
ceramic discs in an in vitro approach. A novel method for protein immobilization was 
evaluated using the aminobisphosphonates pamidronate and alendronate, as anchors and 
was compared to the established silanization technique. Lysozyme and bone morphogenetic 
protein-2 (BMP-2) were used to assess the suitability of the two methods for protein 
immobilization with regard to the enzymatic activity of lysozyme and to the capacity of BMP-2 
to stimulate the osteoblastic differentiation of C2C12 mouse myoblasts. After immobilization, 
a 2.5 fold increase in enzymatic activity of lysozyme was observed compared to the control. 
The alkaline phosphatase activity per cell stimulated by immobilized BMP-2 was 2.5 fold 
higher [9 x 10-6 I.U.] than the adsorbed growth factor [2-4 x 10-6 I.U.]. With regard to the 
increase in protein activity, both immobilization procedures lead to equivalent results. Thus, 
the bisphosphonate-based surface modification represents a safe and easy alternative for 
covalent attachment of proteins to HA surfaces. 
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1. Introduction 
To ensure the long-term success of an endosseous implant, it is mandatory to obtain and 
maintain a stable bone-biomaterial interface [1]. With the goal of creating biomimetic 
materials that are capable of defined interactions with cells [2], interest in surface 
modification methods to stimulate cell function and tissue formation at the interface has 
increased in recent years [3]. The delivery of growth factors directly to the bone-implant 
interface, for example using coating techniques or drug delivery devices, represents a 
promising strategy to influence and control healing and fixation of implants [4]. Among 
others, bone morphogenetic protein-2 (BMP-2) has gained significant interest as a prominent 
factor in bone repair, due to its strong osteoinductive capacity in vivo both in orthotopic and 
ectopic sites [5;6]. 
During the last 5 years, in vivo studies have revealed that the osseointegration of implants is 
strongly accelerated and improved when BMP-2 is adsorbed on the surface of titanium or 
hydroxyapatite ceramics [7-9], incorporated by mixing with biomaterials such as in a self-
setting bone-cement [10], or applied as a coating formed by co-precipitation of BMP-2 with 
calcium phosphate crystals [11]. More sophisticated approaches, which avoid subjecting the 
protein to aqueous environments during processing, include the incorporation of BMP-2 in 
biodegradable polymers such as poly (lactic acid) (PLA) and poly (lactic-co-glycolic acid) 
(PLGA) either as coatings on titanium screws [12], gelatin sponges [13], or as microparticles 
in a calcium phosphate cement [14].  
Although in vivo studies have demonstrated the enormous benefit of biomimetic coatings on 
the osseointegration process, proteins, when adsorbed or incorporated, may suffer from 
uncontrolled release and risk of degradation. This has been clearly demonstrated through in 
vivo and vitro release studies of various growth factors - including BMP-2 - that were 
preadsorbed to different materials including ceramics, polymers, and composite materials 
[15;16]. Covalent immobilization of the protein on the material surface may overcome these 
drawbacks and achieve prolonged retention of the growth factors at their site of action. 
Chemically immobilized BMP-2, including BMP-2 either adsorbed or covalently attached to 
aminosilanized titanium implants, induced new bone formation more efficiently than pure 
titanium in the presence of soluble BMP-2 in adult rabbits [17]. Recently, a chitosan 
membrane with immobilized BMP-2 was shown to induce a dramatic increase in alkaline 
phosphatase activity in the mouse osteoblastic MC3T3 cell line in an in vitro study [18].  
The issues outlined above are of significant concern in the modification of hydroxyapatite 
(HA) ceramics. HA ceramics are particularly interesting biomaterials for bone replacement 
and have been used as a coating on devices and as the inorganic part of composite 
materials, due to their similarity to the inorganic phase of bone, osteoconductive properties, 
mechanical stability, and ease of processing into scaffolds of various types and shapes 
[19;20]. A hinderance to the creation of biomimetic surfaces by the immobilization of growth 
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factors, HA ceramics suffer from a lack of functional groups. This chemical inflexibility can 
usually be overcome, however, through aminosilanization techniques that provide 
aminogroups needed for the covalent attachment of peptides and proteins [21;22]. 
Unfortunately, the formation of the silane layer alters the material surface properties, 
potentially diminishing the beneficial effects on osseointegration [23;24]. Therefore, we were 
looking for alternative methods for the covalent immobilization of proteins on hydroxyapatite 
surfaces. Bisphosphonates seemed to be a promising tool for the modification of 
hydroxyapatite ceramic surfaces as they show a high affinity for calcified tissues [25], which 
can be utilized to guide conjugated proteins to bone mineral [26;27], and beneficial effects on 
the proliferation and maturation of osteoblasts in vitro [28;29]. It is well-established that the 
structure of two phosphonates linked by a single carbon atom is responsible for the high 
binding affinity to bone mineral via the formation of highly stable complexes [30]. Derivatives 
with amine groups can furthermore be used for tethering proteins and peptides to coated 
surfaces. In addition, surface immobilized bisphosphonates stimulated bone formation 
around tibia implants and improved the mechanical fixation of stainless-steel screws in 
vivo [31;32].  
The main objective of our study was to evaluate the potential of bisphosphonates to provide 
amine groups to immobilize proteins on hydroxyapatite ceramic surfaces. Two 
aminobisphosphonates, pamidronate and alendronate, were used to assess the suitability of 
the approach in comparison to the well-established aminosilanization technique. 
Hydroxyapatite ceramic discs served as model surfaces and lysozyme was used as a model 
protein for BMP-2, due to its similar physico-chemical characteristics [33], availability, and 
the convenience of radioactive labeling. Finally, BMP-2 was immobilized by both methods 
and its biological activity assessed using C2C12 mouse myoblasts. 
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2. Materials and Methods 
2.1. Materials 
Hydroxyapatite (HA) ceramic discs were provided by the Friedrich-Baur-Research Institute 
for Biomaterials (Bayreuth, Germany). The ceramic discs had a density of 99% of the 
theoretical density and consisted of phase pure HA of high crystallinity. 
Sodium pamidronate was obtained from Ofichem (Ter Apel, Netherlands). Alendronate was 
purchased from Sigma-Aldrich (Steinheim, Germany). Aminopropyltriethoxysilane (APTES) 
was purchased from Sigma-Aldrich (Steinheim, Germany) and freshly distilled prior to use. 
Toluene was purchased from Merck (Darmstadt, Germany) and dried by azeotropic 
distillation prior to use. 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDAC), sulfo-N-
hydroxysuccinimide (sulfo-NHS), succinic anhydride, sodium hydrogen phosphate, sodium 
dihydrogen phosphate, N-morpholinoethanesulfonate (MES), sodium cyanoborohydride, 
dimethyl sulfoxide (DMSO),  sodium citrate, and lysozyme (50,000 units/mg) were bought 
from Sigma-Aldrich (Steinheim, Germany). 0.1 M hydrochloric acid, sodium tetra borate 
decahydrate, sodium carbonate, and chloramine T were purchased from Merck (Darmstadt, 
Germany). Iodine-125 - as an alkaline solution of NaI (37 MBq/ml) - and PD 10 columns were 
purchased from Amersham Biosciences (Freiburg, Germany). Sodium dodecylsulfate (SDS) 
and phosphate-buffered saline (PBS) were obtained from Invitrogen (Karlsruhe, Germany). 
P-nitrophenyl penta-N-acetyl-β-chitopentaoside (PNP-(GlcNAC)5) was purchased from 
Seikagaku Corp. (Tokyo, Japan). β-N-acetylglucoaminidase from Jack Beans was purchased 
from Sigma-Aldrich (Steinheim, Germany).  C2C12 mouse myoblasts were obtained from 
DSZM (Dt. Sammlung für Zellkulturen und Mikroorganismen, Braunschweig, Germany). 
Dulbecco’s modified Eagle medium (DMEM; low glucose) was purchased from Sigma 
(Steinheim, Germany). Fetal bovine Serum (FBS) and antibiotics (Penicillin G/Streptomycin) 
were purchased from Invitrogen (Karlsruhe, Germany). Bone Morphogenetic Protein-2 (BMP-
2) was produced by Scil Proteins (Halle, Germany). Water was of double distilled quality. All 
reagents were of analytical grade and used as received unless otherwise noted. 
2.2. Surface modification of HA ceramics 
2.2.5. Aminosilanization 
HA ceramic discs were washed with ethanol immediately prior to use. The aminosilanization 
of the discs was carried out in dry toluene. Briefly, 12 ceramic discs (diameter 15 mm) were 
placed in a reaction vessel, 40 ml of dry toluene were added, and the temperature was 
increased to 120° C. Freshly distilled aminopropylt riethoxysilane (APTES) was then added to 
a 1.5% (v/v) concentration and the reaction was held at 120° C for 4 hours in argon 
atmosphere. After 4 hours, the samples were thoroughly rinsed with toluene and chloroform 
and dried under vacuum (Scheme 1).  
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• Aminosilanization of HA ceramic discs in toluene (120°C, argon atm.)
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Scheme 3: Creation of amino-groups at the surface of HA ceramics by the formation of an 
aminosilane layer that would allow for further conjugation steps. 
 
2.2.6. Adsorption of aminobisphosphonates 
HA ceramic discs were placed in beakers containing an aqueous solution of pamidronate or 
alendronate of a concentration of 1 mg/ml (3 ceramic discs per 10 ml bisphosphonate 
solution). The beakers were shaken at room temperature for 4 hours on an orbital shaker 
(Edmund Bühler GmbH, Tübingen, Germany) set at 20 rpm. The samples were washed 
three times with distilled water, dried, and stored under vacuum until further use (Scheme 2).  
 
Adsorption of alendronate (A) or pamidronate (P) to HA ceramic from aequous solutions
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Scheme 4: Creation of amino-groups at the surface of HA ceramic that would allow for 
further conjugation steps by the adsorption of the aminobisphosphonates pamidronate and 
alendronate from aequous solutions. 
 
2.2.7. Attachment of sulfo-N-hydroxysuccinimide (s-NHS) 
The amino-functionalized ceramic discs were activated for covalent binding of proteins 
following a protocol described by Puleo et al. [33] with some modifications (Scheme 3). First, 
the amino groups were transferred to carboxylate groups by the reaction with succinic 
anhydride. To this end, 3-8 ceramic discs were placed in a beaker containing 30 ml of 
sodium phosphate buffer (0.1 M; pH 7.4). Succinic anhydride was dissolved in DMSO and 
added to the ceramic discs. The reagent was used in a 10-fold excess of the number of 
amino groups that, according to the literature, represents a monolayer on the silanized 
ceramic [33] and reacted over 3 hours. Discs were rinsed with water and dried.  
In a second step, 3-8 discs were placed in a beaker containing 30 ml of MES-buffer (0.1 M; 
pH 5). The activation of the carboxylate-groups with EDAC and sulfo-NHS in a molar ratio of 
2:5 was carried out over 4 hours. EDAC was used in 10-fold excess to the number of amino 
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groups that represents a monolayer on the silanized ceramics according to the literature [33]. 
The discs were washed with distilled water, dried, and stored under vacuum until further use.  
 
• Reaction with succinic anhydride in phosphate-buffer (0.1 M, pH 7)
NH 2
NH 2
NH 2
NH 2
O
O
O
+ 2
NH 2
NH
NH 2
NH
O
CO OH
O
CO OH
• EDAC:s-NHS (2:5) in MES-buffer (0.1M,  pH 5.5)
NH2
NH
NH2
NH
O
COOH
O
COOH
+
N C
N NH + N OH
O
O
HO3S
• Reaction with protein in MES-buffer (0.1 M; pH 5.5)
+ H2N--protein
NH2
NH
NH2
NH
O
COOH
O
O
HN--proteinNH2
NH
NH2
NH
O
COOH
O
O
3
O
N
O SO H
O
NH2
NH
NH2
NH
O
COOH
O
O
3
O
N
O SO H
O
„sil_s-NHS“;                        
„Pam_s-NHS“; „Al_s-NHS“
„Pam_COOH“; „Al_COOH“
 
 
Scheme 5: Surface modification of aminated HA ceramic surfaces by carbodiimide coupling 
chemistry. For protein immobilization, surface amino groups were reacted with succinic 
anhydride and the resulting carboxyl groups were transferred to succinic active esters 
(sil_s-NHS; Pam_s-NHS; Al_s-NHS). 
 
2.3. Radioactive labeling of lysozyme with 125I 
Lysozyme was labeled using the chloramine T method. For the preparation of a 1 mg/ml 
lysozyme solution, 2 µl Na125I (1.5-2 MBq) were added to 1 ml of a 1 mg/ml solution of 
lysozyme in PBS. After the addition of 100 µl of a 0.2 mg/ml chloramine T solution, the 
mixture was shaken for 10 minutes. In order to stop the reaction, 100 µl of a 4 mg/ml sodium 
metabisulfite solution was mixed and shaken with the lysozyme solution for 2 minutes. The 
resulting solution was purified using a PD-10 column containing Sephadex G-25 M and 
lysozyme was eluted with PBS (pH 7.4). The resulting solution was a 700 µg/ml 125I-lysozyme 
solution in PBS (pH 7.4) with a specific activity > 95%, which was used at different dilutions 
for all adsorption and binding experiments. 
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2.4. Immobilization of lysozyme at HA ceramic surfaces 
The reaction of the Sil_s-NHS coupled ceramic discs with lysozyme was performed in MES 
buffer (0.1 M; pH 5). The protein was used at a concentration of 10 or 20 µg/ml. The discs 
were washed with water and a solution of 1% sodium dodecylsulfate (SDS) in PBS. Discs 
with radiolabeled lysozyme were submitted to scintillation to determine the amount of protein 
bound, while discs with non-labeled lysozyme were used to investigate the enzymatic 
activity.  
The samples were placed in polyvials (Zinsser Analytik, Frankfurt, Germany) and submitted 
to scintillation using a NaI(Tl) Scintillation Detector (Ortec, Oak Ridge, USA). The 
GammaVision-32 software package (Version 5.2, Ortec, Oak Ridge, USA) was used for data 
analysis.   
2.5. Enzymatic activity of lysozyme  
The enzymatic activity was assessed using a method described by Klaeger et al. [34]. The 
ceramic discs were immersed in a 10 µg/ml solution of lysozyme in 0.1 M MES buffer (pH 
5.5) and allowed to react overnight. The samples were rinsed thoroughly with water and 
placed in 24 well plates. The enzymatic activity was assessed by the coupled reaction of 
lysozyme and ß-N-acetylglucosaminidase to cleave the sugar residues from (PNP-(GlcNAC)
 
5) resulting in free p-nitrophenol. Samples were incubated at 37°C and allowed to react for 5 
hours until a considerable amount of the substrate was cleaved. A standard curve was 
recorded and the amount of released p-nitrophenolate was measured with a microplate 
reader (CS 9301, Shimadzu) at 405 nm.  
2.6. Contact angle measurements 
To assess changes in surface wettability, the surface water contact angles were measured 
before protein adsorption/immobilization and after the subsequent washing steps. The 
measurements were performed on OCA 15 (dataphysics, Filderstadt, Germany), using the 
sessile drop method with 1 µl drops of ddH2O. 
2.7. Cell culture 
C2C12 cells were thawed and expanded once in growth media (Dulbecco`s modified eagle 
medium (DMEM), 15% fetal bovine serum (FBS), and antibiotics (100 U/ml of Penicillin G 
and 100 µg/ml of Streptomycin)). Aliquots of 300,000 cells were frozen in DMEM containing 
20% FBS and 10% DMSO.  
For the BMP-2 testing experiment, protocols described by Katagiri et al. were followed [35]. 
Briefly, aliquots of cells were thawed and maintained in growth media at 37°C in a humidified 
atmosphere of 5% CO2 in air (Figure 1). To examine the effects of BMP-2 and ceramic 
surface modifications, cells were seeded at a density of 2 x 104 cells/cm2 and cultured in 
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growth media. On day 1, the growth medium was replaced by low mitogen media (DMEM, 
5% FBS, and antibiotics) with various concentrations of BMP-2. Cells were kept in low 
mitogen media for a total of 6 days. Media was changed every second day. BMP-2 was 
supplemented either only on day 1 or with every media change. On day 6, cell culture media 
was removed; the cells were washed with PBS and stored at -21°C until the samples were 
analyzed.  
 
 
ALP- and 
DNA-Assay; 
staining 
Day -6 0 -3 3 1 5 6 
Thawing of  
cells  Passage 
Seeding in 
well-plates 
Feeding +/- BMP-2 
15% FBS 5% FBS 
harvest 
proliferation exposure to BMP-2 
 
Fig. 1: Cell culture of C2C12 mouse myoblasts. Experimental setup to examine the effects of 
BMP-2 supplemented to cell culture medium and various surface treatments of HA ceramic 
on the osteoblastic differentiation of C2C12 cells. 
 
2.8. Von Kossa staining 
To asses the mineralization of the C2C12 mouse myoblasts after 6 days of supplementation 
with BMP-2, von Kossa staining was performed. Cells were fixed for 12 hours with 10% 
formaldehyde in PBS. After rinsing with water, cells were incubated with a 5% aqueous silver 
nitrate solution and exposed to natural light. After rinsing thoroughly with water and a 5% 
aqueous sodium thiosulfate solution, cells were counterstained with a 0.5% Safranin O 
solution for 30 seconds. Images of stained cells were taken with a digital camera (DS-U1, 
Nikon; Düsseldorf, Germany). 
2.9. DNA assay 
To measure the total amount of DNA per sample and subsequently determine the cell 
number, a fluorometric assay was performed (DNA-QF, Sigma). For the assay, the frozen 
samples were kept on ice and cells were scraped off the surface with disposable cell 
scrapers (Biochrom, Germany). Cells were dispersed in 0.8 ml of EDTA-solution (10 mM, pH 
12.3). After sonication in an ice bath for 10 min, 0.2 ml of a KH2PO3 solution (1 M) were 
added to each sample. The DNA assay was performed as described in the protocol provided 
by Sigma. For individual DNA measurements, 2 ml of a Hoechst 33258 dye solution (100 
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ng/ml) and 30 µl of sample were used. DNA standards (calf thymus, Sigma) and cell 
standards were prepared and examined in parallel. A conversion factor of 19 pg DNA/cell 
was determined and used to determine cell number. Samples were measured on a RF-1501 
Spectrofluorimeter (Shimadzu, Munich, Germany). 
2.10. Alkaline phosphatase assay 
For the determination of alkaline phosphatase activity, a protocol described by Lieb et al. 
[36;37] was followed with minor modifications. The frozen samples were kept on ice and 
scraped off the surface using disposable cell scrapers. Cells were dispersed in 1 ml Tris 
(hydroxymethyl) aminomethane buffer (1 M, pH 8.0). The collected cell suspensions were 
sonicated in an ice bath for ten minutes and stored on ice until analysis. 0.5 ml of cell lysate 
were added to 0.5 ml of 2-amino-2-methyl-1-propanol-buffer (1.5 M, pH 10.3) and 0.5 ml of 
p-nitrophenyl phosphate (pNP) solution (4 mg/ml). Samples were incubated at 37°C for 30 
minutes. Alkaline phosphatase converted the colorless pNP to the yellow-colored p-
nitrophenolate. The enzymatic reaction was stopped with 10 ml of a 0.05 N sodium hydroxide 
solution. The hydrolyzed pNP was measured with a photometer (Uvikon 941, Kontron 
Instruments, Munich, Germany) at 405 nm and the amount of enzyme was quantified by 
comparison with a standard curve. Alkaline phosphatase levels were normalized to the cell 
number using the cell counts determined by the DNA assay. 
2.11. Statistical analysis 
All measurements were collected (n=3 for radiolabeled lysozyme, n=3 for enzyme activity of 
lysozyme, n=3 for DNA, and n = 4 for ALP) and expressed as means ± standard deviation 
(SD). Single factor analysis of variance (ANOVA) was used in conjunction with a multiple 
comparison test (Tukey test) to assess the statistical significance. 
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3. Results  
Several authors correlated surface water contact angles with cell response and protein 
adsorption [38-40]. Therefore, we first assessed the wettability of surfaces after the 
subsequent modification steps (Figure 2). 
3.1. Water contact angles on HA surfaces 
The contact angle of untreated ceramic discs (60°) was significantly increased (up to 70°) 
after silanization, indicating the formation of a hydrophobic layer on the surface. It remained 
at the same level after activation with sulfo-NHS (sil_s-NHS). After adsorption of lysozyme, 
contact angles of all groups decreased to about 30-45° and remained in the same range after 
reversibly bound protein was removed from the surface by washing with a 1% SDS solution. 
After SDS washing, the lowest contact angle value of 30° was measured on unmodified 
ceramic discs, while the silanized and sil_s-NHS modified surfaces maintained significantly 
higher contact angles (50°). These results indicate  that the silane layer remained intact.  
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Fig. 2: Water contact angles for untreated surfaces and surfaces after adsorption/binding of 
lysozyme at a concentration of 10 µg/ml.  untreated surfaces;  after adsorption/binding of 
lysozyme;   after washing the samples with 1% SDS in PBS.  indicates significant 
differences (p<0.05; n=15). 
 
In contrast, the adsorption of the two aminobisphosphonates, pamidronate and alendronate, 
from aqueous solutions and the subsequent activation by carbodiimide chemistry lead to 
extremely hydrophilic surfaces: Contact angles were reduced from 60° for the unmodified HA 
ceramic to 20° and 30° for the pamidronate and alen dronate modified samples, respectively 
(Figure 3). 
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Fig. 3: Water contact angles of untreated ceramic discs and activated discs modified by 
adsorption of pamidronate and alendronate. Significant differences are indicated by 
(p<0.05; n=5). 
 
3.2. Immobilization of  125I-lysozyme on HA ceramic surfaces 
To investigate the potential of the amine-functionalized HA ceramic to immobilize proteins, 
lysozyme was used as a model protein. 10 µg/ml and 20 µg/ml lysozyme solutions were used 
and the protein was allowed to adsorb or react overnight. After washing with distilled water, 
the discs treated with 20 µg/ml of protein maintained higher amounts per sample than the 10 
µg/ml discs, indicating an incomplete coverage of the surface with protein when treating with 
10 µg/ml or the formation of multilayers after immersion in a 20 µg/ml solution [33;41] 
(Figure 4a). On the silanized ceramic, less protein was found compared to pure ceramic and 
sil_s-NHS activated ceramic. The significant increase in protein mass from silanized to 
activated ceramic suggests a covalent attachment of protein to the disc surfaces.  
After washing with SDS, a total mass of 200 ng lysozyme remained on the activated discs 
(sil_s-NHS), irrespective of whether a 10 µg/ml or 20 µg/ml solution of lysozyme was used 
(Figure 4b). The mass of protein that remained on the samples after washing with the 
surfactant solution was considered the immobilized protein. When a concentration of 10 
µg/ml was used, the adsorption of lysozyme to HA ceramic and silanized ceramic resulted in 
significantly lower amounts of protein than the covalent attachment. The same tendency was 
observed for protein immobilization from a 20 µg/ml solution.  
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Fig. 4: HA ceramics activated by aminosilanization: Adsorption and binding of 125I-lysozyme.  
a) Adsorbed and immobilized lysozyme using two different concentrations (  20 µg/ml and  
10 µg/ml) after washing the samples with distilled water. Significant differences (indicated by 
; p<0.05; n=3) were measured among the samples incubated with 20 µg/ml. The same 
tendency was observed between the samples incubated with 10 µg/ml.  
b) Adsorbed and immobilized lysozyme using two different concentrations ( 20 µg/ml and  
10 µg/ml) after washing the samples with 1% SDS in PBS.  indicates significant differences 
(p<0.05; n=3).The total amount of immobilized lysozyme is about 200 ng per sample. 
Asorption of lysozyme (20 µg/ml) to HA ceramics was not determined (n.d.) 
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Fig. 5: Surface modifications of HA ceramics by the use of aminobisphosphonates: 
a) Adsorption and binding experiments of 125I-lysozyme to unmodified and bisphosphonate-
modified HA ceramic discs. Significant differences were not detected, equivalent amount of 
the protein adsorbed to all the discs.  
b) Lysozyme deposited on the discs after washing with 1% SDS in PBS. Significant 
differences are indicated by (p<0.05; n=3). 
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Using aminobisphosphonates to activate ceramic surfaces for covalent attachment, 
comparable amounts of lysozyme was deposited on the variously modified ceramic discs 
(Figure 5a). After washing the samples with a surfactant-containing buffer, the amount of 
protein on the pure HA surface was significantly lower than on the discs that have been 
activated for covalent attachment (Figure 5b).  Again the mass of lysozyme that was 
considered immobilized on the Pam_s-NHS and Al_s-NHS samples was about 200 ng per 
disc. 
3.3. Enzymatic activity of lysozyme immobilized on the surfaces 
The enzymatic activity of lysozyme on the surfaces was investigated after immobilization and 
subsequent washing with water (Figure 6) and compared to the quantitative measurements 
of radioactively labeled protein (Table 1). Lysozyme was completely inactivated by treatment 
with SDS, so no results were obtained for the activity of the immobilized protein (data not 
shown). The activity of covalently attached lysozyme was significantly higher than the activity 
on surfaces loaded by adsorption, regardless of whether it was bound after silanization or 
with a bisphosphonate. 
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To be continued next page 
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Fig. 6: Enzymatic activity assay of surface immobilized lysozyme. 
a) Surface modification by aminosilanization: the protein deposited on the sil_s-NHS was 
significantly more active compared to HA ceramic and silanized ceramic (p<0.01; n=3; 
indicated by ). 
b) Surface modification with aminobisphosphonates: highest activity compared to controls 
was demonstrated by immobilized lysozyme (Pam_s-NHS; Al_s-NHS). Significant 
differences are indicated by (p<0.01; n=3). 
 
 
The percent share of active lysozyme in total protein was calculated by dividing the values 
for the activity of lysozyme by the mass of protein determined by the radioactive binding 
experiments (Table 1). These results suggest that the protein layer on samples activated by 
aminosilanization for covalent attachment remained almost completely active, while the 
activity on surfaces that allow only for adsorption is decreased to 43% for untreated ceramics 
and 26% for the silanized ceramics. Immobilization by the two aminobisphosphonates lead to 
approximately 100% active protein, while on untreated ceramic discs only 43% was active 
and on the discs coupled with inactivated succinic acid (“Pam_COOH”; “Al_COOH”) 82% 
and 72% active protein was determined, respectively. 
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Table 2: The active part of the immobilized lysozyme relative to the total amount of protein 
determined by radioactive measurements. When immobilized, the active part of lysozyme 
corresponds to approx. 100% of the protein that was deposited on the samples. 
 
 
HA 
ceramics 
Sil_NH2  Sil_s-NHS Pam_ 
COOH 
Pam_ 
s-NHS 
Al_COOH Al_s-NHS 
43 ± 9 26 ± 10 116 ± 46     Active 
lysozyme/ 
total 
lysozyme [%] 43 ± 2 
  
82 ± 15 97 ± 22 72 ± 6 93 ± 13 
 
3.4. Effect of BMP-2 on the osteoblastic differentiation of C2C12 cells  
As the experiments with lysozyme have demonstrated that the bisphosphonate-based 
surface modification method is suitable to bind proteins to HA surfaces and even preserves 
the protein activity to a higher extent than by simple adsorption, we intended to elucidate 
whether these positive effects would also hold for the immobilization of BMP-2, a growth 
factor widely used for surface coatings to improve the osseointegration of implants.  
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Fig. 7: Dose-dependent increase of alkaline phosphatase activity per cell after 
supplementation of BMP-2 to C2C12 mouse myoblasts either on day 1 („1x“) or on day 1 and 
following with every media change („3x“). 
 
Alkaline phosphatase activity was taken as a measure for different amounts of active BMP-2 
[42;43]. When applied as a solution to cells in polystyrene well-plates, a clearly dose 
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dependent effect in alkaline phosphatase activity per cell was observed after 6 days of 
supplementation of different concentrations of BMP-2 to the cell culture media (Figure 7). 
This dose-dependency was found for a one-time application of BMP-2 on day 1 as well as for 
a continuous cultivation with BMP-2 in cell culture media over 6 days. In our study, 
comparably high levels of alkaline phosphatase activity of 10 * 10-6 I.U./cell were reached 
either by the supplementation of 5000 ng once or 500 ng three times. However, even a 
single dose of 300 ng or continuous supplementation with 100 ng in the media over 6 days 
led to a significant increase of ALP activity compared to the control. Von Kossa staining 
revealed that the supplementation of the lowest doses in the study was sufficient to cause a 
change in cell morphology (Figure 8). While C2C12 mouse myoblasts grew in parallel 
bundles, the supplementation of BMP-2 led to the formation of cobblestone-like patterns.   
 
  
   A) 300 ng/ml (3x)   B) 100 ng/ml (3x) 
  
   C) 300 ng/ml (1x)   D) without BMP-2 
  
Fig. 8: Von Kossa staining of C2C12 mouse myoblasts cultured for 6 days with various 
concentrations of BMP-2.Mineralization (bone nodules) was not observed after this period of 
time, but cell morphology changed from the formation of parallel bundles (D) to cobblestone-
like patterns (A, B and C).  
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3.5. Effect of HA ceramics on the osteoblastic differentiation of C2C12 cells 
Cells were seeded on untreated ceramic discs to investigate if the material itself had an 
impact on the level of alkaline phosphatase activity of the cells. C2C12 cells on cell culture 
plastic (TCPS) did not express ALP after 6 days of culture and unmodified HA ceramic 
surfaces were not capable of inducing an expression of the marker of osteoblastic 
differentiation (Figure 9). While cells on both surfaces showed increased ALP activity with the 
supplementation of BMP-2 in the cell culture medium (300 ng, 3x), the cells responded 
equally on both types of surfaces. 
-0.5
0
0.5
1
1.5
2
2.5
3
3.5
4
without BMP-2 300 ng (3x) without BMP-2 300 ng (3x)
AL
P 
/ c
e
ll
[I.U
.
*
10
-
6 ]
Cells on ceramicsCells on TCPS  
AL
P 
/ c
e
ll
[I.U
.
*
10
-
6 ]
AL
P 
/ c
e
ll
[I.U
.
*
10
-
6 ]
 
Fig. 8: Comparison of ALP activity on day 6 of cells cultured on TCPS and HA ceramic. The 
cells on ceramic responded to a supplementation of 300 ng BMP-2 in solution in an 
equivalent manner while neither the cultivation on TCPS nor on pure HA ceramic lead to a 
significant expression of the differentiation marker. 
 
3.6. Alkaline phosphatase activity stimulated by adsorbed and immobilized BMP-2 
C2C12 cells were cultivated for 6 days on ceramic discs coated with BMP-2 using the two 
different surface modification techniques. Immobilization of the growth factor led to a 
dramatic increase in alkaline phosphatase activity (Figure 10 a-c). On day 6 alkaline 
phosphatase activity per cell reached values of 10*10-6 I.U. after stimulation by covalently-
bound BMP-2, irrespective of the immobilization technique that had been applied. Simply 
adsorbing BMP-2 to the samples was not as effective as covalent attachment. Surface 
functionalization by aminosilanization and by aminobisphosphonates was comparably 
efficient with regard to the stimulation of osteoblastic differentiation of C2C12 cells.  
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After protein immobilization by the silanization procedure, ALP values were 2.5 fold higher 
than stimulated from simply adsorbed protein on unmodified or silanized HA surfaces. BMP-2 
adsorbed to silanized ceramics had the lowest capacity to stimulate alkaline phosphatase 
expression. These results correlate perfectly with the results for the enzyme activity of 
lysozyme.  
Comparable results for BMP-2 and lysozyme were also found when aminobisphosphonates 
were used for surface modification. Again a 2.5 fold increase in ALP expression was 
obtained by immobilizing BMP-2. Modification by either pamidronate or alendronate lead to 
an increase of protein activity when adsorbing to samples modified with bisphosphonate and 
subsequent reaction with succinic acid anhydride (“Pam_COOH”; “Al_COOH”) relative to 
absorption to the unmodified ceramics, although the effect was only significant in the case of 
pamidronate.  
 An influence of surface modification on the proliferation of C2C12 cells was not detected; 
cell numbers for the different experimental groups were equivalent to the values obtained for 
unmodified hydroxyapatite ceramics (data not shown), which is well in accordance with the 
literature [35].  
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Fig. 10: Alkaline phosphatase activity of C2C12 mouse myoblasts cultured for 6 days on 
samples with immobilized BMP-2. a) BMP-2 immobilized after aminosilanization. b) BMP-2 
immobilized by pamidronate (Pam) and c) BMP-2 immobilized by alendronate (Al) as an 
anchoring molecule. Immobilized BMP-2 by any of the investigated methods performed 
superiorly compared to simply adsorbed protein. Significant differences are indicated by 
(p<0.05). 
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4. Discussion 
The main goal of this study was to evaluate the potential of a novel surface modification 
technique for Ca-rich ceramics using bisphosphonates. This novel approach was compared 
with the well-established silanization technique [21].  
Regarding the manufacturing process, the surface modification with aminobisphosphonates 
provides several advantages over the silanization procedure: The bisphosphonate 
modification can be performed at room temperature in aqueous solutions, which is a clear 
advantage with regard to toxicity concerns or sterilization of the excipients, and would 
particularly simplify the production of biomimetic surfaces under aseptic conditions. For the 
covalent immobilization of lysozyme and BMP-2, a two-step zero-length cross-linking 
strategy has been applied [44], where only one component, in our case the amino-
functionalized ceramic discs, had to be exposed to the cross-linker (Scheme 3). After 
modification, ceramic samples could be stored under dry conditions and growth factors 
attached immediately prior to cell seeding or implantation (Scheme 3: “Sil_s-NHS”, “Pam_s-
NHS”; “Al_s-NHS”).  
By measuring the water contact angles of the ceramic samples, we assessed changes in 
surface composition that might influence the adsorption behavior of proteins. As 
demonstrated in Figures 2 and 3, both aminosilanization and adsorption of 
aminobisphosphonates clearly changed the contact angle of the surfaces compared to the 
unmodified ceramics. However, a correlation between contact angle and the amount of 
adsorbed or immobilized protein was not discernable, as demonstrated by the experiments 
with 125I-lysozyme (Figures 4a and 5a).  
When determining the amount of attached lysozyme, the samples suited for covalent 
immobilization (“Sil_s-NHS”, “Pam_s-NHS”, and “Al_s-NHS”) displayed highest values 
(Figures 4a and 5a). However, a significant increase compared to unmodified ceramic was 
not detected. The samples were then washed with a 1% SDS solution in PBS, to remove 
reversibly bound protein and to determine the mass of immobilized protein. The total mass of 
lysozyme was reduced to approximately 200 ng, indicating a high amount of adsorbed 
lysozyme. But the residual amount of lysozyme on discs suited for covalent immobilization 
(“Sil_s-NHS”, “Pam_s-NHS” and “Al_s-NHS”) was significantly increased compared to 
control (“HA ceramics”) for both modification procedures (Figures 4b and 5b).  
As a well-studied enzyme, whose structure and mechanisms of action are known [45], 
lysozyme allows for an examination of the effects of immobilization on biological activity. The 
enzyme activity assay clearly demonstrated that protein activity was not reduced by covalent 
immobilization by either modification principle: silanization or bisphosphonate-based 
functionalization. Relating lysozyme activity to amount of protein, an improved stability and 
performance of immobilized compared to adsorbed protein was found (Table 1). As lysozyme 
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had been used as model protein for BMPs before [33;46], both techniques were found 
promising for immobilization of BMP-2 with retention of its biological activity.  
The biological activity of immobilized BMP-2 was assessed by the well-established 
stimulation of the osteoblastic differentiation of C2C12 mouse myoblasts [35]. Their response 
in terms of alkaline phosphatase expression to different doses of BMP-2 was the basis for 
measuring the biological efficacy of the growth factor. While in most studies a continuous 
exposure to BMP-2 over the whole culture period of 6 days was applied, we have shown that 
a single dose of BMP-2 on day one could induce similar values of alkaline phosphatase per 
cell (Figure 7). However, the required doses were 10 fold higher to reach comparable levels 
of ALP by single stimulation. 
An enhanced stimulation of ALP activity per cell by immobilized BMP-2 compared to 
adsorbed BMP-2 was observed after modifying the surfaces both by silanization and using 
bisphosphonate anchors.  
Several reasons could explain this observation: First, more protein could have been 
deposited on the surface after covalent attachment, as our results have demonstrated that 
stimulation by a single, but higher, dose lead to similar expression of ALP as continuous 
supplementation. Second, the covalently attached BMP-2 could function more effectively 
than the adsorbed protein. This is in accordance with the results for lysozyme and might be 
explained by a directed presentation of the growth factor after covalent attachment, whereas 
adsorbed protein would be  randomly oriented. Third, the ceramic discs, silanized or 
bisphosphonate-modified, could serve as a drug release system for the protein with 
continuous release into the cell culture medium. This is of particular interest as a sustained 
(pseudo-zero order) release of BMP-2 from gelatin coatings was demonstrated to be the 
most effective inducer of the differentiation of bone marrow cells when several time-
dependent release profiles were compared [47]. In any case, the stimulation of alkaline 
phosphatase expression was profoundly enhanced by using the conditions for immobilizing 
BMP-2 to the surfaces. 
In previous studies, the beneficial effects of hydroxyapatite on osteoblastic differentiation of 
bone marrow cells in vitro and bone ingrowth in vivo have been demonstrated [48-51] and 
bisphosphonates have been shown to lead to increased expression of ALP in osteoblasts 
[28;29;52;53]. However, in the experiments presented here, the level of alkaline phosphatase 
expression of C2C12 cells was not stimulated or increased by the ceramic surfaces (Figure 
9), or by the bisphosphonate coating (Figure 10 b, c).  
To summarize, we have shown that lysozyme and BMP-2 were successfully immobilized on 
the surface of HA ceramic discs and, in addition to the well-known silanization procedure, the 
immobilization by aminobisphosphonates as a novel principle was demonstrated and 
displayed equivalent efficacy.  
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5. Conclusion 
By the use of aminobisphosphonates as anchoring molecules a novel method for the 
immobilization of proteins to HA ceramic surfaces has been investigated and compared to 
the well-known aminosilanization procedure. We have shown that pamidronate and 
alendronate allowed for the immobilization of proteins on hydroxyapatite ceramic surfaces by 
the use of carbodiimide-coupling chemistry. Although for lysozyme no striking effect on the 
amount of immobilized protein was found, the performance of immobilized protein was 
superior compared to adsorbed protein in terms of the enzymatic activity of lysozyme and 
stimulation of osteoblastic differentiation of C2C12 cells by BMP-2. Therefore, we suggest 
the use of aminobisphosphonates as a novel and simple principle for surface 
functionalization towards the design of biomimetic coatings for hydroxyapatite that might also 
be applied to other Ca-rich inorganic or composite materials. Furthermore, for in vivo use, the 
implant integration process could be supported by the pharmacological effects of the 
bisphosphonates on osteoblasts and osteoclasts, which would have to be substantiated by 
additional experiments.   
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Abstract 
Hydroxyapatite is widely used in bone replacement as coating on materials for hard tissue 
repair or inorganic phase of composite materials. Methods for the functionalization of 
hydroxyapatite surfaces are of particular interest to immobilize molecules at the bone-implant 
interface or achieve covalent bonding of organic to inorganic phase of composite materials. 
The aminobisphosphonate pamidronate was adsorbed to hydroxyapatite powders to obtain 
particles with amino groups on the surface that were accessible for further conjugation steps. 
Furthermore, an adsorption study was carried out revealing that within a range of 0-
20 mmol/L the number of amino groups on the surface can be controlled by the 
concentration of the bisphosphonate solution. The adsorption of pamidronate cannot be 
described by the Langmuir type of adsorption. After removing reversibly bound pamidronate 
by washing the samples, the amount of bisphosphonate levels at 1.3 µmol/m². As alternative 
route to surface functionalization, particles were obtained by precipitation in the presence of 
pamidronate. X-ray diffraction patterns revealed that particles were composed of brushite 
(CaHPO4 • 2 H2O) and these particles were suitable for further conjugation steps. However, 
the precipitation process needs further optimization towards the control of particle size and 
type of calcium phosphate. By adsorption and co-precipitation particles were obtained with 
amino groups on the surface that were accessible for the attachment of the amine-reactive 
model compound TNBS. 
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1. Introduction 
Selective drug delivery to the skeletal system becomes very important in certain bone related 
diseases such as osteoporosis, bone fractures and infections [1]. Hydroxyapatite (HA) is a 
particularly interesting material as drug carrier or for bone replacement as it resembles the 
natural inorganic phase of bone [2-4]. Due to their similarity to the mineral phase of bone, HA 
particles were used as solid part of composite materials for hard tissue repair in combination 
with synthetic or natural polymers [5]. The interface between organic filler material and 
inorganic part of such composites influences the stability of the construct [6]. To improve the 
properties of the composite the interfacial bond strength was increased by modifying 
hydroxyapatite surfaces to allow for their covalent attachment to the polymeric filler [7-11]. 
Furthermore, hydroxyapatite particles have been used as drug carriers for local delivery of 
drugs after adsorption or incorporation, such as antibiotics [12], proteins [13-15], or 
bisphosphonates [16]. In certain cases, covalent attachment of drugs to HA surfaces would 
be favorable for the delivery of drugs to bone or the bone-implant interface favoring a 
prolonged retention at the site of action [17;18]. In order to enable covalent attachment of 
drugs, HA surfaces have been modified using silane-coupling chemistry and hexamethylene 
diisocyanates, methods that are limited in stability of the created bonds, poor control of the 
reaction and toxicity concerns of the educts, respectively [9;10;19-21]. Therefore, alternatives 
were searched allowing additionally for a control of the number of functional groups per 
surface area. This possibility of controlling the number of binding sites is of particular interest 
for the attachment of adhesive peptides [22]. 
Bisphosphonates, well-known as inhibitors of bone resorption [23], accumulate in bone and 
calcified tissues as a consequence of their high affinity to hydroxyapatite [24;25]. Depending 
on the structure of the bisphosphonate derivative, bi- or tridentate interactions with 
hydroxyapatite are observed [26]. Due to the strong affinity of bisphosphonates to 
hydroxyapatite, it was hypothesized that adsorbed amino-bisphosphonates can serve as a 
platform for covalent attachment to HA surfaces. In this study, the adsorption of the 
aminobisphosphonate pamidronate (Fig. 1) was investigated as a novel method for the 
creation of functional groups on HA surfaces. The dye trinitrobenzenesulfonic acid (TNBS) 
was attached as a model compound to prove the suitability of pamidronate modified 
hydroxyapatite for further conjugation steps. The type of adsorption was determined and the 
number of amino groups accessible for covalent attachment of molecules was measured by 
the ninhydrin method.  
As an alternative route to functionalized particles the precipitation of HA in the presence of 
pamidronate was investigated. By this approach, we additionally aimed for the control of 
particle size, morphology and degree of crystallinity, as bisphosphonates were shown to 
inhibit the growth of HA crystals [27] and enable variations in zeta potential depending on the 
adsorbed derivative [28]. The particles were characterized by X-ray diffraction (XRD) to 
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determine phase composition and crystallinity, and scanning electron microscopy (SEM) to 
examine particle size and morphology. Finally, the suitability for covalent attachment of the 
HA/pamidronate co-precipitate was assessed by attachment of TNBS as a model compound. 
 
 
 
  
 
Fig.1: The aminobisphosphonate pamidronic acid.   
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2. Materials and Methods 
2.1. Materials 
Hydroxyapatite (HA) powder was a gift from Merck Biomaterials (Darmstadt, Germany). 
Disodium 3-amino-1-hydroxypropylidene-1,1-bisphosphonate (disodium pamidronate) was 
obtained from Ofichem (Ter Apel, the Netherlands). Trinitrobenzenesulfonic acid (TNBS), 
2,2′-dihydroxy-2,2′-biindan-1,1′,3,3′-tetrone (hydrindantin), ammonium peroxodisulfate, 
calcium hydroxide and 1,2,3-indanetrione (ninhydrin) were purchased from Sigma-Aldrich 
(Steinheim, Germany). Dimethylene sulfoxide (DMSO), di-sodium tetra-borate decahydrate, 
potassium chloride, Titriplex III, sodium heptamolybdate, lithium hydroxide, hydrazinium 
sulfate, acetic acid, phosphoric acid and tin (II) chloride dihydrate were purchased from 
Merck (Darmstadt, Germany). 6-Amino hexanoic acid was purchased from CARL Roth 
GmbH (Karlsruhe, Germany). For all experiments double distilled water (ddH2O) was used. 
All chemicals were of analytical grade. 
2.2. Specific surface area of hydroxyapatite powder 
Analysis of the surface area of the powders was performed according to the method of 
Brunauer-Emmet-Teller (BET) using the Accelerated Surface Area and Porosimetry System 
ASAP 2010 of Micromeritics Instrument Corp. (Norcross, USA). 100 mg of the powder 
sample were analyzed using nitrogen as adsorptive. A surface area of 67.16 ± 0.04 m²/g was 
determined. This value was used for further calculations. 
2.3. Attachment of a model compound: TNBS-Assay  
To investigate the presence of amino groups at the surface of HA powders after adsorption 
of pamidronate, a colorimetric assay described in the literature was used [29]. NH2 groups on 
the surfaces were determined by the reaction with 2,4,6-trinitrobenzenesulfonic acid (TNBS). 
Samples of 100 mg were incubated in Eppendorf cups with 1.5 ml of a 0.1 % solution of 
TNBS in 3% sodium borate solution at 70°C for 15 mi n. The suspensions were centrifuged at 
12000 rpm (Centrifuge 5415R; Eppendorf, Hamburg, Germany). The supernatant was 
discarded and replaced by 1.5 ml distilled water. After shaking, the samples were centrifuged 
again. The washing procedure was repeated 5 times until the rinsing water was colorless. 
Photographs of the resulting colored powders were taken for documentation.  
2.4. Adsorption study  
Sodium pamidronate was dissolved in distilled water in concentrations ranging from 
0.05 mmol/L up to 100 mmol/L. 150 mg hydroxyapatite powder and 1.5 ml of the 
pamidronate solution were added to a glass vessel and the suspension was shaken 
overnight at room temperature on an orbital shaker (Edmund Bühler GmbH, Tübingen, 
Germany) set at 20 rpm. The HA suspension was centrifuged at 12000 rpm (Centrifuge 
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5415R; Eppendorf, Hamburg, Germany) and aliquots of the supernatant were processed as 
described in 2.5. (pamidronate assay). The amount of remaining free bisphosphonate in the 
supernatant was determined by the pamidronate assay and the amount of adsorbed 
pamidronate was calculated. The hydroxyapatite samples loaded with pamidronate were 
dried and aliquots were used for TNBS and ninhydrin assay. 
2.5. Determination of organic phosphates - pamidronate assay 
The method of Ames et al. for the determination of total phosphate content in samples of 
organic origin was used with some modifications [30]. An aliquot of the supernatant solutions 
of 2.4 was added to 400 µl of a 4% (w/v) aequous ammonium peroxodisulfate solution in a 
glass vessel. The samples were reduced to ashes at 200°C over night. The ashes were 
dissolved in 500 µl of an aequous solution of potassium chloride (0.02 M) and EDTA (0.3 M).  
Ammonium heptamolybdate was dissolved in a 3.5% sulfuric acid to gain a 1% (w/v) 
solution. 120 µl of the molybdate reagent were added to the phosphate solution. The 
resulting heteropolyoxomolybdate was reduced to a blue colored product by adding 120 µl of 
a hydrazinium sulfate/ tin (II) chloride solution in 3% sulfuric acid.  Samples were checked for 
inorganic phosphate dissolved from hydroxyapatite by preparing the assay without the 
oxidation step and values were subtracted from the absorbance of the samples after 
oxidation. The whole process was checked for free phosphate, e.g. from glass vessels, by 
analyzing distilled water. A calibration curve was prepared starting with solutions of known 
pamidronate concentration. The absorbance of samples was read in microtest-plates with a 
microplate reader (CS-9301 PC, Shimadzu, Munich, Germany) at 700 nm. In order to 
determine the resulting number of amino groups per area dependent on the initially used 
concentration of pamidronate the initial concentrations were plotted against the resulting 
number of pamidronate molecules per m². 
2.6. Quantification of surface amino groups – ninhydrin assay 
The hydroxyapatite powders loaded with pamidronate from the adsorption study (2.4.) were 
washed with 1.5 ml of bidistilled water. The powder was separated by centrifugation and 
dried under vacuum. For each sample 20.0 mg of HA (n=3 per experimental group) were 
immersed in a vial of a parallel synthesis block (synthesis 1, Heidolph, Germany). The 
ninhydrin reagent was prepared as follows: 2.4 g of ninhydrin and 0.36 g of hydrindantin 
were dissolved in 90 ml DMSO and mixed with 30 ml of a lithium acetate buffer (4 M, pH 5.2) 
[31]. 5 ml of this reagent were added to each sample. The reaction mixture was heated to 
105° C and shaken at 800 rpm. The reaction of ninhy drin with primary amines results in a 
violet color. The samples were filtrated, diluted with 10 ml of ethanol (50% v/v) and the 
absorbance was read on a Photometer (Uvikon 941, Kroton Inst., Munich, Germany) at 570 
nm. A calibration curve was prepared using 6-amino-hexanoic acid as a standard. 
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2.7. Calculation of adsorbed pamidronate and plotting of isotherm 
The amount of pamidronate (mmol) adsorbed per m² on HA powder (Q) was calculated by 
the difference between the initial (C1) and the equilibrium (Ceq) pamidronate concentration 
(mmol/L) using equation (1):  
 
                                         Q = [(C1 – Ceq) x V] / (W x S)                                                       (1) 
      
Where V is the volume of the solution (1.5 ml), W is the mass of the adsorbent (HA; 150mg), 
and S is the specific surface area of the adsorbent.  
To determine if the isotherm followed a Langmuir type of adsorption, the equilibrium 
concentrations (Ceq) were plotted against the resulting number of pamidronate molecules per 
cm² and the quotient of Ceq/Q was plotted against the equilibrium concentration Ceq. This plot 
results in a straight line if the adsorption isotherm fits the Langmuir model of adsorption 
[32;33]. 
2.8. Calculation of the surface area covered by pamidronate 
To estimate the surface area covered by pamidronate the size of a pamidronate molecule 
was determined with the software package SYBYL (version 7.1; Tripos GmbH, Munich, 
Germany). Reports from literature were followed stating that the phosphonates and the 
hydroxyl function are oriented towards the surface (PPO) [26], or the phosphonates and the 
amino group are involved in surface binding (PPN) as described in [34]. The area of the 
triangle formed by these functional groups was computed as an estimation of the area 
covered by a pamidronate molecule. 
2.9. Precipitation of HA particles 
Hydroxyapatite particles were prepared by a wet chemical precipitation method following 
reaction (1) proposed in the literature [35]:  
 
10 Ca(OH)2 + 6 H3PO4 → Ca10(PO4)6(OH)2 + 18 H2O                           (1) 
 
0.74 g Ca(OH)2 were dissolved in 20 ml water (0.5 mol/l) and stirred on a magnetic stirrer at 
400 rpm (Heidolph MR 3001K; Nürnberg, Germany). The solution was heated to 40 °C or 
60 °C and thermostated in a water bath. 20 ml of di lute phosphoric acid (0.3 mol/l) were 
added dropwise under stirring. 
In a third reaction, particles were precipitated in the presence of pamidronate at a 
concentration of 0.7 mg/ml at 40 °C. The resulting particle suspensions were centrifuged, the 
supernatant was decanted and the precipitates were dried under vacuum. 
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2.10. Characterization of particles  
2.10.1 Light microscopy 
The resulting suspensions were analyzed by light microscopy (Axiovert, Zeiss, Germany). 
Images were taken with a digital camera (DS-U1, Nikon; Düsseldorf, Germany). The TNBS 
reaction was performed on the samples to determine if there were amino groups present on 
the surface as described in 2.3. 
2.10.2 Scanning electron microscopy 
The morphology of particles was investigated by scanning electron microscopy (SEM). The 
particles were mounted on aluminum stubs using conductive carbon tape (LeitTape; Plannet 
GmbH; Wetzlar, Germany) and coated with a layer of 1.4 nm gold-palladium (SEM auto-
coating unit E2500; Polaron Equipment ltd.; Watford, UK). The micrographs were obtained at 
5.0 kV on a scanning electron microscope (JSM 840, Jeol; Eching, Germany). 
2.10.3 X-ray powder diffraction  
The precipitated particles were characterized by X-ray powder diffraction techniques. Flat 
samples in transmission geometry were analyzed on a STOE STADI-P (STOE, Darmstadt, 
Germany). Cu-Kα1 radiation was used (λ = 1.5406 Å; Ge monochromatized) and a θ-range 
from 10-90 °θ was analyzed. Phase composition of samples was determined by the 
WinXPow software package (STOE 2000). X-ray diffraction patterns obtained from literature 
served as reference patterns for hydroxyapatite [36] and brushite [37]. 
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3. Results 
3.1. Adsorption study of pamidronate 
To prove the hypothesis, that by adsorption of aminobisphosphonates amino groups were 
deposited on hydroxyapatite surfaces that were suitable for further conjugation steps, 
pamidronate was adsorbed to hydroxyapatite and the amine-reactive dye TNBS was 
attached. After washing the powders until the water was colorless, the samples showed 
differences in intensity of yellow color depending on the concentration of pamidronate that 
had been used for adsorption (Fig. 2). Hydroxyapatite powder that had not been pretreated 
with pamidronate served as control: After immersion in a TNBS solution and washing, the 
yellow colored dye was completely removed and the hydroxyapatite powder remained white.   
  
7.5 mmol/L
15 mmol/L
0 mmol/L
1.5 mmol/L
75 mmol/L
150 mmol/L 
112.5 mmol/L
37.5 mmol/L
 
Fig. 2: TNBS-reaction performed after adsorption of pamidronate from solutions with different 
concentrations. From left to right the intensity of yellow color is strongly increased with rising 
amount of pamidronate indicating an increase in functional groups present on the surface. 
 
 
To determine the type of adsorption of pamidronate an adsorption study was performed 
assessing the equilibrium concentration of pamidronate by a pamidronate assay [30]. The 
adsorption study revealed that the amount of pamidronate and consequently the number of 
amino groups per surface area was dependent on the concentration of pamidronate within 
the tested range of concentrations (Fig. 3 A). After washing the samples once with water to 
remove reversibly bound pamidronate, the ninhydrin assay was performed. By this method, 
the number of remaining primary amines on the surface was assessed and plotted against 
the initial concentration of the pamidronate solution (Fig.3 B).    
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Fig.3: Adsorption study of pamidronate on HA powder: A) pamidronate assay: amounts of 
pamidronate in the supernatant were determined and adsorbed amounts were calculated.   
B) ninhydrin method: determination of remaining primary amines on the surface after 
washing the HA powders with water. 
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The results for the adsorption of pamidronate showed that amino groups for covalent 
attachment can be deposited on the surface of HA. Below initial pamidronate concentrations 
of 10 mmol/L, the number of surface amino groups was directly proportional to the 
concentration of the pamidronate solution and pamidronate adsorbed completely to the 
hydroxyapatite surface.  
Using the ninhydrin method, the remaining number of amino groups after washing the 
samples with distilled water was determined. These remaining pamidronate molecules were 
regarded as irreversibly attached. The results for the ninhydrin assay displayed clearly that 
by washing the number of pamidronate molecules per area was reduced compared to the 
initially adsorbed amount and leveled at 1.3 µmol/m².  
To determine if the adsorption of pamidronate would fit the Langmuir model of adsorption, 
which is based on the assumption that adsorption cannot proceed beyond monolayer 
coverage [33] data were plotted as described in [32]. Obviously, the type of adsorption did 
not fit the Langmuir type of isotherm as the plot Ceq versus Q did not reach a plateau (Fig. 4 
A) and the plot Ceq versus Ceq/Q did not result in a linear correlation (Fig. 4 B).  
  
A 
0
0.002
0.004
0.006
0.008
0.01
0 20 40 60 80 100
Ceq [mmol/L]
Q 
[m
m
o
l/m
²]
 
B 
R2 = 0.6279
0
4000
8000
12000
16000
0 20 40 60 80 100
Ceq [mmol/L]
Ce
q/
Q
 
[m
²/L
]
 
Fig.4: The isotherm was plotted to determine if it followed a Langmuir type of adsorption 
isotherm as described in [32].  
 
 
The degree of surface coverage was estimated by calculations using the two different 
orientations of pamidronate towards hydroxyapatite surfaces that were described in the 
literature [26;34]. 100 % surface coverage would correspond to 0.053 mmol/m2 when 
pamidronate adsorbed with the two phosphonates and the hydroxyl function. 0.04 mmol/m² 
would represent a monolayer when additionally the amino group is oriented towards the 
surface (Table 1). The maximum surface concentration of pamidronate determined by the 
pamidronate assay was 0.008 mmol/m². This would correspond to a surface coverage of 15 
or 20 %, respectively. 
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Table 1: The area covered by pamidronate was determined using the different orientations 
towards the surface that are described in literature. These values were used to compute the 
% surface coverage at the maximum adsorption of pamidronate as determined by the 
pamidronate and the ninhydrin assay. 
 
Orientation of 
pamidronate to 
HA surface 
 
Area covered 
by 1 mmol 
pamidronate 
 
Amount to 
cover 1 m² 
 
% surface coverage 
pamidronate assay 
(C1= 100 mmol/L) 
 
% surface coverage  
ninhydrin assay 
(C1= 100 mmol/L) 
PPO* [26] 
 
19 m²/mmol 
 
 
0.053 mmol 
 
 
15 % 
 
 
3.2 % 
 
 
PPN** [34] 
 
25 m²/mmol 0.04 mmol 20 % 4.3 % 
 
* pamidronate oriented towards the hydroxyapatite surface with the phosphonates and the hydroxyl function (PPO) 
** pamidronate oriented towards the hydroxyapatite surface with the phosphonates and the amino group (PPN) 
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3.2. Precipitation of particles 
As advanced route to obtain functionalized hydroxyapatite surfaces, the precipitation of 
calcium phosphate particles was investigated aiming to influence particle characteristics 
additionally. In contrast to literature [35], the precipitation did not result in particles of 
nanometer size. Light microscopy revealed differences in particle morphology (Fig. 5 A-C): 
the particles precipitated at 40 °C appeared amorph ous (Fig. 5 A) while particles precipitated 
at 60 °C appeared as needle-shaped crystals (Fig. 5  B). Particle precipitation in the presence 
of pamidronate at 40 °C resulted in crystalline par ticles that were smaller than the particles 
precipitated at 40 and 60 °C (Fig. 5 C). 
 
A
 
C
 
B
 
D
 
 
Fig. 5: Light microscopy images of calcium phosphate particles precipitated under different 
conditions: A) 40 °C B) 60 °C C) 40 °C in the presence of pamidronate. Scale bars r epresent 
200 µm. D) TNBS-reaction performed with particles A, B and C. 
 
The TNBS reaction was performed on all three samples (Fig. 5 D). The particles that were 
precipitated in the presence of pamidronate were suitable for attachment of the dye TNBS 
indicating the presence of primary amines at the particle surfaces. 
Particles were further characterized by scanning electron microscopy (SEM) (Fig. 6). The 
observations of light microscopy were confirmed. Particles precipitated at 40 °C were 
amorphous (Fig. 6 a, b). By precipitation at 60 °C (Fig. 6 c, d) and precipitation in the 
presence of pamidronate (Fig. 6 e, f), particles of needle-like shapes were formed. The 
particles that were formed in the presence of pamidronate were smaller than the other two 
samples. All samples formed aggregates.  
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a) 
 
 
b) 
 
c) 
 
d) 
 
e) 
 
f) 
 
 
Fig. 6: Scanning electron microscopy images of particles: a) and b) precipitated at 40 °C; 
c) and d) precipitated at 60 °C and e) and f) preci pitated at 40 °C in the presence of 
pamidronate. Images in the left column were recorded in 100x magnification while images in 
the right column were recorded in 3000x magnification. 
X-ray diffraction patterns of the samples revealed that the particles precipitated at 40 °C 
resembled the X -ray diffraction pattern of hydroxyapatite (Ca10(OH)2(PO4)6) (Fig. 7), whereas 
the particles precipitated at 60 °C were in good ac cordance with the pattern of brushite 
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(CaHPO4 • 2H2O) (Fig. 8). In the X-ray diffraction patterns, the observation that particles 
precipitated at 40 °C were less crystalline than pa rticles precipitated at 60 °C was confirmed 
as indicated by the broad reflexes in the pattern of the 40 °C sample.  
The precipitation in the presence of pamidronate was performed at 40 °C as these conditions 
have led to the formation of hydroxyapatite. Again the X-ray diffraction pattern of the particles 
resembled the pattern of brushite (Fig. 9). When compared to the pattern of the particles 
precipitated at 60 °C, additional reflexes or diffe rences due to the incorporation of 
pamidronate into the structure of the calcium phosphate modification were not observed.   
 
 
Fig .7: X-ray diffraction pattern of particles precipitated at 40 °C and reference pattern of 
hydroxyapatite according to literature [36]. 
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Fig. 8: X-ray diffraction pattern of particles precipitated at 60 °C and reference pattern of 
brushite derived  from literature [37]. 
 
 
 
Fig. 9: X-ray diffraction pattern of particles precipitated at 40 °C in the presence of 
pamidronate and reference pattern of brushite from literature [37]. 
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4. Discussion 
The objective of this study was to investigate the functionalization of hydroxyapatite particles 
by the aminobisphosphosphonate pamidronate towards covalent attachment of molecules. 
The creation of functional groups that would allow for further conjugation steps on the 
surface of hydroxyapatite particles is therefore useful for strengthening the interface between 
organic and inorganic part of composite materials. Additionally, covalent attachment provides 
a possibility to retain drugs delivered to the bone-implant interface at their site of action. Two 
methods for the functionalization were compared: the adsorption of the amino-
bisphosphonate pamidronate to the surface of HA particles and the co-precipitation of 
hydroxyapatite in the presence of pamidronate.  
The adsorption isotherm of the aminobisphosphonate pamidronate was determined to 
estimate the maximum loading of particles with the bisphosphonate and the possibility of 
controlling the number of amino groups on the surface that were accessible for further 
conjugation steps. The adsorption of pamidronate did not follow the Langmuir model of 
adsorption as indicated by the lack of linear correlation in Fig. 4 B. Following the Langmuir 
isotherm [33], adsorption cannot proceed beyond monolayer coverage [38].  A determination 
of the irreversibly bound pamidronate after washing the powders using the ninhydrin method 
revealed that the surface concentration of pamidronate leveled at 1.3 µmol/m². The number 
of amino groups was reduced relative to the results for the pamidronate assay indicating that 
parts of the bisphosphonate were reversibly attached. Furthermore, this suggests that a 
saturation of binding sites on the surface of hydroxyapatite occurs at 1.3 µmol/m². Further 
adsorption may be due to the formation of multilayers on the surface. However, by theoretical 
calculations based on different conformations of pamidronate described in the literature when 
neighboring hydroxyapatite surfaces [26;34], a maximum surface coverage of 15 % to 20 % 
was determined. A model exceeding the Langmuir type of adsorption is provided by the 
Frumkin isotherm, stating that interactions such as attraction or repulsion can occur between 
adsorbed species [38;39]. But, from the data presented here, further conclusions concerning 
the type of adsorption and the model of isotherm can not be drawn.  
However, the adsorption study clearly demonstrated that the number of amino groups is 
proportional to the initially used concentration of pamidronate within a certain range of 
concentrations (0-10 mmol/L). The results of the ninhydrin assay, performed after washing 
the samples, demonstrated clearly that amino groups remained on the surface of the HA 
powder and that they were accessible for covalent attachment of amine-reactive molecules. 
Both methods, pamidronate and ninhydrin assay, demonstrated that within a certain range of 
concentrations (0-20 mmol/L) the number of primary amines created on the surface can be 
controlled thus enabling the control of surface density of attached molecules.  
The precipitation of HA particles intended to obtain particles with structural, morphological 
and compositional characteristics suitable for their potential application in the biomedical 
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field. The presence of bisphosphonates during precipitation has recently been demonstrated 
to influence particle properties such as size and zeta potential [28]. The particles obtained 
under varied conditions were clearly different in morphology, degree of crystallinity and 
particle size. X-ray diffraction revealed that amorphous forms of hydroxyapatite were 
obtained at 40 °C, whereas brushite (CaHPO 4 • 2H2O) was formed when particles were 
precipitated at 60 °C or in the presence of pamidro nate. Brushite one of the possible 
intermediate phases in the process of precipitation of hydroxyapatite and can be transferred 
to hydroxyapatite by calcination [40].                                        
However, even though the obtained phase was not hydroxyapatite, the surface of the 
particles was functionalized by adsorbed pamidronate molecules as indicated by the 
persisting yellow color of attached TNBS (Fig. 5 D). The X-ray diffraction pattern resembles 
the brushite phase and does not differ remarkably in reflexes from the pattern of the 60 °C 
particles. This indicates that pamidronate was solely adsorbed on the surface and not 
integrated in the 3D-structure of the resulting crystals. Furthermore, the diffraction pattern 
shows no reflections due to crystalline modifications of pamidronate. Precipitation in the 
presence of pamidronate resulted in smaller particles as determined by light microscopy and 
SEM (Fig. 5 and 6), which is in agreement with literature [28].  
In order to investigate the particle precipitation and the influences of pamidronate on particle 
composition, size, morphology, zeta potential, and surface functionalization more deeply, a 
systematic study with variation of different parameters should be performed. Nevertheless, 
using the two methods, adsorption and co-precipitation, amine-functionalized particles were 
obtained that were suitable for the conjugation of model compounds.  
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5. Conclusion 
By adsorption of the aminobisphosphonate pamidronate, the surface of hydroxyapatite 
powder was functionalized. The number of functional groups was directly proportional to the 
equilibrium concentration of pamidronate within a range of 0-2 µmol/m² and they were 
accessible for the conjugation of a model compound. This is a promising result towards 
surface grafting of biomolecules, such as cytokines or adhesive peptides, or the creation of a 
stable interface bonding of organic and inorganic phases in composite materials. By co-
precipitation of hydroxyapatite with pamidronate, particles with amino groups on the surface 
were obtained that were accessible for the immobilization of a model compound. However, 
the needle-like shape and micrometer-scaled size of the particles might not be advantageous 
for the application as bone filler or inorganic part of composites. Therefore, the adsorption 
method is suggested to create functional groups on HA particle surfaces using pamidronate.  
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Abstract 
Drug and nanoparticle transport in tissues in vivo is hindered by many obstacles thus limiting 
therapeutic efficacy. For a deeper understanding of the key factors, models for the in vitro 
testing of novel therapeutic approaches, such as drug delivery devices, are of particular 
interest. To improve the formulation of nanoparticles, i.e. for cancer therapy, there is a need 
for simple in vitro cell culture models mimicking a three-dimensional cellular context and 
analytical techniques to rapidly monitor drug and particle uptake and distribution throughout 
tissues. 
Therefore, confocal microscopy was evaluated to determine nanoparticle interactions with 
cells in 2D and 3D cell culture. Spheroids of the human colon carcinoma cell line HCT-116 
were used. 500 cells were initiated to reach a diameter of app. 400 µm after 4 days of 
culture. The growth rate of these spheroids was determined to be 100 µm in diameter per 24 
hours. Fluorescent nanoparticles of 100 and 200 nm served as model colloids. Fluorescence 
measurements revealed an increase of cell-associated particles over a period of 4 hours in 
2D cell culture, while observations with confocal microscopy revealed that particles were 
hardly internalized by the cells in monolayer culture. The use of confocal microscopy for the 
analysis of spheroids is limited by the optical density of the spheroid tissue that allows only 
for gathering information of the outer layers of the spheroid (30-50 µm penetration depth). 
However, differences in particle penetration inside the outer layer of the spheroids were 
determined as 200 nm particles proceeded faster than 100 nm particles. To conclude, 
confocal microscopy would be a valuable tool for the comparison of tissue penetration rates 
of various particle formulations in spheroids with a slower growth rate. 
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1. Introduction 
In the treatment of cancer, surgical resection of tumors offers the best chance for cure. In 
order to improve survival rates and for the treatment of tumors that are not accessible for 
surgery, radiotherapy and chemotherapy are adjuvants [1]. Chemotherapy can be 
significantly improved by using suitable drug delivery strategies [2]. Numerous in vivo 
investigations have shown that biodistribution profiles of anticancer drugs can be controlled 
by their entrapment in colloidal carriers such as nanoparticles [3]. In general, drug delivery to 
tumors by nanoparticles has a variety of advantages: Due to the enhanced permeation and 
retention effect, the particles accumulate in the tumor, leading to significantly higher drug 
concentrations in the neoplastic tissue [3]. Nanoparticles can furthermore increase the half-
life of a drug compared to drug solutions. The prolonged release of a drug from the particles 
at the site of action might lead to a continuous and more effective inhibition of tumor growth. 
For particular drugs, such as paclitaxel, the problem of poor solubility in aqueous solutions 
can be overcome by using nanoparticles. Additionally, for some drugs toxic side effects can 
be avoided: encapsulated doxorubicin, for example, is less nephrotoxic than the free drug in 
solution [4].  
Most of the in vitro cell culture studies for drug delivery systems for cancer therapy are 
carried out in monolayer cell culture. As it is becoming more and more apparent that 
monolayer cultures of tumor cells cannot completely represent the characteristics of a three-
dimensional solid tumor [5], there is a need for alternative culture systems for rapid and easy 
in vitro testing of novel tumor therapies [6]. The similarity of multicellular tumor spheroids 
(MCTS) with the initial avascular growth stage of malignancies makes them a suitable model 
for the testing of new anti-tumor drugs [7]. Drug distribution inside a spheroid is limited by 
diffusion, which mimics the in vivo situation and might be one explanation for the fact that the 
drug response of a spheroid differs from the drug response of a monolayer culture [8]. The 
investigation of nanoparticles as drug delivery system in MCTS would provide a better in vitro 
model to study uptake and distribution of the particles in a three-dimensional cell formation. 
Therefore, we monitored the uptake of fluorescent nanoparticles as a model system by 
spheroids using confocal laser scanning microscopy (CLSM). Our spheroids were made of 
transfected cells of the human colon carcinoma cell line HCT-116 expressing the green 
fluorescent protein (GFP). This allowed using confocal microscopy as a technique for rapid 
characterization of nanoparticle penetration to identify parameters critical for particle 
formulation.  
To characterize the interactions of fluorescent nanoparticles with spheroids particles with a 
negative surface charge were chosen intending to prevent uptake inside the cells and 
investigate passive diffusion inside tissue only [9;10]. Particles of 100 nm and 200 nm size 
were chosen as model colloids [11-14]. The interactions of nanoparticles with cells in two and 
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three dimensional cell culture were investigated with confocal microscopy and fluorescence 
spectrometry. In addition to this non-invasive approach, cryo-sections of spheroids were 
prepared.  
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2. Materials and Methods 
2.1. Materials 
Agarose “for routine use” was bought from Sigma-Aldrich (Steinheim, Germany). Fluorescent 
nanoparticles (Fluospheres®; carboxylate-modified nanospheres; λex 540 nm, λem 560 nm) 
were obtained from Molecular Probes (Invitrogen, Karlsruhe, Germany). Particle sizes were 
100 and 200 nm and zeta potential was of -55 mV. Particles were supplied as 2% solids in 
aqueous dispersion. Dulbecco’s modified eagle media (DMEM) and fetal bovine serum (FBS) 
were purchased from PAN Biotech (Aidenbach, Germany). Triton X-100, sodium hydroxide 
(NaOH) and sodium chloride (NaCl) were obtained by Merck (Darmstadt, Germany). 
Phosphate-buffered saline (PBS) and antibiotics (Penicillin G/Streptomycin) were purchased 
from Invitrogen (Karlsruhe, Germany). Killik frozen section media was obtained by Bioptica 
(Milan, Italy). Cell culture flasks (T75, T25) were bought from Sarstedt AG (Nürnberg, 
Germany) and 96-well plates were purchased from Becton Dickinson Labware (Heidelberg, 
Germany). Water was of double distilled quality. All reagents were of analytical grade and 
used as received unless something different is stated. 
2.2. Cell line and cell culture 
The human colon carcinoma cell line HCT-116 GFP was obtained from ATCC. HCT-116 
cells expressing the green fluorescent protein (HCT-116 GFP) were obtained from Dr. 
Rachel Cowen and Dr. Alain Pluen, School of Pharmacy, University of Manchester, UK.  
Cells were cultured in Dulbecco`s modified eagle media (DMEM), 10% fetal bovine serum 
(FBS) and antibiotics (100 U/ml of Penicillin G and 100 µg/ml of Streptomycin) and 
maintained at 37 °C in a humidified atmosphere of 5 % CO2 in air. Cells were passaged every 
3-4 days and seeded in a density of 16000 cells/cm². No more than 20 passages were used. 
2.3.  Spheroid cultivation 
HCT-116 spheroids were made applying a liquid overlay technique using agarose-coated 96-
well plates (50 µl 1.5% (w/v) agarose/well), and 500-2000 exponentially growing tumor cells 
per well in a total volume of 200 µl cell-culture media [15]. After an initiation period of 4 days, 
100 µl media was aspirated and replaced by fresh media. Spheroids were harvested on day 
4 and used for further experiments. 
2.4. Spheroid growth 
For the determination of spheroid growth, photographs of spheroids (n=12) were taken every 
24 hours starting on day 4 over a period of 5 days totally using a Leica DMIRB microscope 
(Leica Microsystems, Bensheim, Germany). Pictures of spheroids were taken with a digital 
camera (DS-U1, Nikon; Düsseldorf, Germany) and analyzed for mean diameter with the 
EclipseNet software (Version 1.20.0; Laboratory Imaging Ltd., Prague, Czech Republic). 
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2.5. Determination of particle size and zeta potential 
Particle size and zeta potential of model nanoparticles were determined with a Zetasizer 
HSA (Malvern Instruments GmbH; Herrenberg, Germany). 50 µl of particle suspension were 
diluted in 2 ml of the respective media (1 mM sodium chloride, PBS buffer, DMEM media 
without FBS, DMEM with FBS). Refractive index and viscosity of the respective media were 
determined for the calculation of the results.  
2.6. Determination of cell-associated fluorescence in monolayer culture 
HCT-116 GFP cells were seeded in 96 well-plates in a density of 50 000 cells per cm² and 
incubated until they formed a confluent monolayer. Having reached confluence, the culture 
media was replaced by media containing nanoparticles in which the cells were incubated at 
37 °C for 1-4 hours (n=6). Different ratios of cell s to nanospheres were used for the two 
particle sizes: a) the same mass of polystyrene per cell, resulting in different ratios of cells to 
nanospheres: 100 nm 1:500000, 200 nm 1:62500. b) the same ratio of cells to nanospheres 
(1:5000). The experiment was terminated by washing the cell monolayer three times with 
phosphate-buffered saline (PBS, pH 7.4) to eliminate excess particles which were not 
entrapped by the cells. Cell membrane was permeabilized with 0.5% Triton X-100 in 0.2 N 
aqueous NaOH to expose the internalized nanoparticles for the quantitative measurement. 
Cell-associated particles were quantified by analyzing the cell lysate in a GENios pro 
microplate reader (Tecan; Crailsheim, Germany) using and excitation wavelength of 485 nm 
and an emission wavelength of 590 nm. Uptake was expressed as the percentage of 
fluorescence associated with cells versus the amount of fluorescence present in the feed 
solution. 
2.7. Particle uptake in monolayer culture (2D) 
HCT-116 GFP cells were seeded in chamber coverglasses and allowed to attach over night. 
The next day, cell culture media was removed, cells were washed once with PBS and then 
media was added containing fluorescent nanoparticles in a ratio of 5000 particles per cell. To 
assure constant pH during analysis by microscope, HEPES buffer was added to result in a 
final concentration of 10 mM. Particle uptake in 2D culture was monitored with confocal 
microscopy as described in 2.9. 
2.8. Particle uptake in spheroids (3D) 
Spheriods (500 cells per well) were initiated in a total volume of 200 µl media. After 4 days 
100 µl media were aspirated and replaced by 100 µl fresh media supplemented with 1 µl of 
the nanoparticle suspensions. Media was gently mixed and spheroids were incubated with 
nanospheres at 37°C. At defined points of time sphe roids (n=3) were harvested and 
analyzed either by confocal microscopy as described in 2.9 or by cryo sections as described 
in 2.10. 
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2.9. Confocal laser scanning microscopy (CLSM) 
For the CLSM experiments, a Zeiss Axiovert 200M microscope coupled to a Zeiss LSM 510 
scanning device was used (Carl Zeiss Co., Ltd., Germany). The inverted microscope was 
equipped with a Plan – Apochromat 40x, a Plan – Apochromat 63x and a Plan-Neofluar 
20x/0.5 objective. An argon laser with 488 nm was used to excite GFP and a Helium Neon 
laser was used to excite the nanoparticles at 543 nm. The fluorescence was imaged in the 
multitracking modus using a band-pass filter of 425-525 nm to detect GFP and a long-pass 
filter of 585 nm to detect nanoparticles fluorescence.  
For observations of monolayers, cells were placed in 8-well Lab-Tek™ chambered cover 
glasses (Nunc GmbH & Co. KG, Germany) at an initial density of 80,000 cells in a volume of 
400 µl culture media. For maintaining a pH of 7.4, 20 mM HEPES was supplied. After 18 
hours, the media was changed, nanoparticles were added and measurements were directly 
performed in each well at 37° C. The thickness of t he optical sections was between 0.7 and 
1.2 µm.  
For taking confocal images of spheroids, they were harvested 4 days after initiation, placed 
on cover glasses with 100 µl of media and measured at 37° C. The z-stack mode was used 
to investigate the penetration of nanoparticles inside the spheroids. Z-stacks were performed 
with a thickness of optical sections of 2.1 µm. The permeation depth of nanoparticles was 
determined by the number of slices displaying nanoparticle fluorescence in the center of the 
spheroid.  
2.10. Cryo sections 
Spheroids were harvested and fixed in 2.5% glutaraldehyde in PBS. Spheroids were 
immersed in a solution containing 15% sucrose (w/v) overnight. 3 to 5 spheroids were placed 
in a plastic ring (diameter 0.5 cm), water was removed and the ring was then filled with Killik 
frozen section media. Cylinders with spheroids were shock frozen in liquid nitrogen and 
stored at -80°C until cutting and analysis. Samples  were cryo-sectioned to 15 µm thickness 
(HM 550 OMP, Microm, Walldorf, Germany). The median slice of a spheroid was analyzed 
by confocal laser scanning microscopy. 
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3. Results 
3.1. Spheroid cultivation and growth 
The transfected cell line HCT-116 GFP formed perfectly round spheroids in liquid overlay 
over a broad range of cell numbers (Fig. 1). 500 cells per well were enough to reach a 
spheroid diameter of 400 µm 4 days after initiation. Below a diameter of 400 µm a central 
necrosis due to limitations in supply with nutrients is not expected [16]. Therefore spheroids 
with an initial cell number of 500 cells were used for the experiments with nanospheres. 
 
A B C
 
 
Fig.  1: HCT-116 GFP spheroids 4 days after initiation: A) 500 cells B) 1000 cells C) 2000 
cells were initially seeded per well. Scale bars represent 200 µm. 
 
The growth of the spheroids was monitored over 5 days (Fig. 2). During this time period the 
growth proceeded linear and did not reach a plateau. Spheroids with smaller initial cell 
numbers grew faster than spheroids with higher cell numbers. The addition of fluorescent 
nanoparticles to the culture media when spheroids were initiated did not affect the growth 
rate of the spheroids as there were no significant differences in the respective growth curves. 
The average growth rate for spheroids with an initial cell number of 500 cells was 100 µm in 
diameter per 24hours 
 
Chapter 7                                                                      Nanoparticles in 2D and 3D cell culture                                                                                            
                                                                                                                                                     
- 139 - 
300
400
500
600
700
800
900
1000
3.0 4.0 5.0 6.0 7.0 8.0 9.0
time [days]
sp
he
ro
id
di
am
et
er
[µm
]
sp
he
ro
id
di
am
et
er
[µm
]
 
 
Fig. 2: Growth of HCT-116 GFP spheroids over 5 days (n=12). Different cell numbers were 
initially seeded: 2000 cells per well 1000 cells per well and 500 cells per well. 
Additionally, fluorescent nanoparticles suspension (1 µl) was added to the cell culture media 
to wells containing 500 cells: 500 cells and 100 nm particles; 500 cells and 200 nm 
particles. Spheroid growth was not affected by the presence of nanoparticles in the culture 
media. 
 
3.2. Size, size distribution and zeta potential of model nanoparticles 
Size and zeta potential of the fluorescent particles were characterized in various media (Tab. 
1) as the surface charge was assumed to be an important parameter determining uptake and 
cell-membrane association of particles [9]. Intending to minimize uptake of particles by cells, 
negatively charged polystyrene particles were used with a zeta potential of -55 mV according 
to the manufacturer. Particles of particle size 100 and 200 nm were used, which is a common 
size range for drug loaded nanoparticles in cancer treatment. Measurements in different 
media (1 mM NaCl, PBS-buffer and DMEM) affirmed the size and narrow size distribution of 
the particles as expressed by the polydispersity index. However, in cell culture media 
containing serum proteins (DMEM + FBS) the size of the particles increased due to the 
adsorption of serum proteins to the particles’ surfaces. Zeta potential of the particles 
continuously increased with increasing ion content of dispersant (PBS) and further increased 
in cell culture media (DMEM) to result finally in a zeta potential of -11.2 mV for 100 nm and 
-8.3 mV for 200 nm particles under the conditions for the experiments with monolayer cell 
culture and spheroids (DMEM + FBS). 
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Table 3: Particle size and zeta potential of fluorescent nanoparticles of a) 100 and b) 200 nm 
in different media determined by laser light scattering. An increase in particle size and 
polydispersity index is observed in serum containing media (DMEM + FBS) due to coating of 
nanoparticles with serum proteins. Zeta potential is decreased by media containing ions, 
amino acids and proteins from -50-60 mV initially to approximately -10 mV.  
 
  Mean particle size [nm] Polydispersity index Zeta potential [mV] 
a) 1 mM NaCl 104.6   ± 0.4 0.04   ± 0.01 -51.9   ± 0.7 
 
PBS-buffer 102.1   ± 0.1 0.03   ± 0.01 -41.5   ± 0.8 
 
DMEM 101.4   ± 1.3 0.03   ± 0.01 -33.3   ± 3.8 
 
DMEM + FBS 152.2   ± 2.8 0.21   ± 0.02 -11.2   ± 4.4 
 
   
b) 1 mM NaCl 200.7   ± 0.6 0.02   ± 0.01 -58.4   ± 2.2 
 
PBS-buffer 185.7   ± 1.3 0.03   ± 0.01 -44.2   ± 0.1 
 
DMEM 191.2   ± 4.2 0.03   ± 0.01 -40.6   ± 1.3 
 
DMEM + FBS 226.1   ± 0.4 0.1     ± 0.02   -8.3   ± 3.4 
 
 
 
3.3. Cell-associated particles in monolayer cell culture 
To investigate if HCT-116 GFP would internalize the fluorescent model particles, cells were 
seeded in 96-well plates and incubated at 37 °C wit h nanospheres. Ratios of cells to 
nanospheres were calculated to assure the same mass of polystyrene per cell (Fig. 3a) and 
the same number of particles per cell (Fig. 3b) for both particle sizes. 
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Fig.  3: The percentage of cell associated particles was determined after incubation of HCT-
116 GPF cells with nanoparticles of 100 nm ( ) and 200 nm ( ) in different ratios cells to 
nanospheres (n=6): a) the same mass of polystyrene per cell was taken resulting in different 
ratios of cells to nanospheres: 100 nm 1:500000, 200 nm 1:62500.  b) the same ratio of cells 
to nanospheres was taken for both particle sizes (1:5000). 
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After 4 hours cells in Fig. 3 a) have taken up 28% of the 100nm particles while cells in Fig. 3 
b) have taken up only 0.27%. Both values correspond to approximately 1350 particles that 
were associated to one cell assuming that cell proliferation over a period of 4 hours is 
negligible and the cells were already confluent when the experiment was started. After 4 
hours the cells internalized 0.2% of the 200 nm particles in Fig. 3 a) (initial ratio 1:62500) and 
1.65% of the particles in Fig. 3 b) (initial ratio 1:5000). This corresponds to a rate of 125 vs. 
82 nanoparticles associated to or internalized by each cell, respectively. 
3.4. Particle uptake in 2D cell culture monitored by confocal laser scanning 
microscopy 
 
a) 
 
b) 
 
c) 
 
d) 
 
e) 
 
f) 
 
 
Fig.  4: Time series of HCT-116 GFP cells with nanospheres (ratio 1:5000) in media 
monitored by confocal laser scanning microscopy: a) 100nm, 1h b) 100nm, 2h c) 100nm, 4h 
d) 200 nm, 1h e) 200 nm, 2h and f) 200nm, 4h.  
 
The increase in cell associated particles over the observation time of 4 hours was confirmed 
by confocal microscopy pictures (Fig. 4). Particles of 100 and 200 nm were used in a ratio of 
5000 particles per cell. The number of particles associated with the cell membranes was 
increased time-dependently (white arrows). Particles inside cells were rarely detected after 4 
hours and mainly observed in the rounded, most likely dead cells. 
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3.5. Uptake and distribution of nanoparticles in 3D cell culture 
Uptake and distribution of nanospheres in three dimensional spheroids was monitored with 
confocal microscopy using the z-stack mode with optical slices of 2.1 µm. Fig. 5 shows z-
stacks of the first 30 µm of spheroids incubated with particles of 100 nm (Fig. 5 a,b) and 200 
nm (Fig. 5 c,d). The confocal pictures of the nanoparticles (red channel) were overlaid with 
the transmission pictures to indicate spheroid size. 15 min after starting the incubation (Fig. 5 
a,c) the spheroid slices were not colored by the red particles. After 8 hours of incubation (Fig. 
5 b,d) the whole cross sectional areas of the individual slices were evenly colored by red 
nanoparticles, the last image representing a penetration depth of 30 µm.  
 
a) 
 
b) 
 
c) 
 
d) 
 
 
Fig.  5: Confocal microscopy images (z-stacks) of spheroids incubated with nanospheres: a) 
100 nm particles 15 min; b) 100 nm particles after 8hours. c)  200 nm particles, 15 min d) 
200 nm particles after 8 hours. Optical slices of a thickness of 2.1 µm were shown over 31.5 
µm in total. 
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While the particles of 200 nm filled the outer layers of the spheroid (first 30 µm depth of 400 
µm in total) the 100 nm particles did only penetrate as far as 18 µm. The observation that 
particles of 100 nm penetrated more slowly than particles of 200 nm was followed over the 
whole period of 8 hours (Fig. 6).  
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Fig.  6: Penetration of particles in spheroids (n=3): 100 nm  200 nm. a) depth of penetration 
of  particles vs. incubation time. b) depth of penetration of particles vs. spheroid growth 
during 8 hours. The penetration of 200 nm particles seems to proceed faster than the uptake 
of 100 nm particles.  
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When penetration depth was plotted vs. time it became clearly visible that 200 nm particles 
proceeded faster into the spheroid. When penetration depth was plotted vs. growth a profile 
with two phases was detected: for the first 4 hours penetration proceeded faster than growth, 
then spheroid growth proceeded faster than particle uptake. 
3.6. Cryo sections 
To verify the observations of confocal microscopy and to gather further information on 
particle penetration inside spheroids, cryo sections of spheroids were prepared after 
incubating spheroids with nanospheres for different time periods. In preliminary experiments 
a method for cryo sectioning was established to preserve the cellular structure of the 
spheroids and the fluorescence of GFP at the same time. Cryo sections were prepared of 
spheroids that were initiated with nanospheres in cell culture media and of spheroids that 
were incubated with nanospheres for 15 min and for 8 hours. 
Fig. 7 shows cryo sections of spheroids that were incubated with particles of 100 nm size. 
Pictures in the left column are taken with 20fold magnification and show only the red channel 
(nanoparticle fluorescence) while pictures in the right column are taken with 63fold 
magnification and represent an overlay of red channel (nanoparticle fluorescence) and green 
channel (GFP, cells). The even red color of the sections in the right column is due to 
artefacts of the preparation technique. Therefore, nanoparticles can only be observed in Fig. 
7 a) as brighter areas. In the higher magnification nanoparticles are visible as small yellow 
dots and are clearly distributed over the first 50 µm from the edge towards the center that are 
shown in the picture. However, in the sections of spheroids that have been incubated with 
particles for 15 min or 8 hours not a single particle was detected. 
In contrast, when 200 nm particles were used, particles were clearly visible over the whole 
cross section of spheroids that were initiated with particles in culture media (Fig. 8 a). A 
higher concentration of particles at the edge of the section is observed. After incubation for 
15 min no particles were visible but after 8 hours incubation time a ring of particles is visible 
around the edge of the spheroid section. However, particles did not penetrate deeper inside 
a spheroid than 20 µm. 
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a) 
 
b) 
 
c) 
 
d) 
 
e) 
 
f) 
 
 
Fig.  7: Cryosections of spheroids incubated with nanospheres (100 nm). a,b) Particles in cell 
culture media when spheroids were initiated. c,d) spheroids 15 min in contact with particle 
solution. e,f) spheroids 8hoursin contact with particle solution. a,c,e) the red channel with the 
particle fluorescence is shown (20x magnification); b,d,f) overlay of red and green channel 
are shown (63x magnification). 
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a) 
 
b) 
 
c) 
 
d) 
 
e) 
 
f) 
 
 
Fig.  8: Cryosections of spheroids incubated with nanospheres (200 nm). a,b) Particles in cell 
culture media when spheroids were initiated. c,d) spheroids in contact with particle solution 
for 15 min. e,f) spheroids in contact with particle solution for 8 hours. a,c,e) the red channel 
with the particle fluorescence is shown (20x magnification); b,d,f) overlay of red and green 
channel are shown (63x magnification). 
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4. Discussion 
To elucidate the suitability of multicellular tumor spheroids for in vitro investigation of anti-
tumor drug delivery systems we investigated the interactions of fluorescent nanoparticles 
with monolayers and spheroids of the human adenocarcinoma cell line HCT-116. As we 
intended to use confocal laser scanning microscopy for the elucidation of particle diffusion 
processes into spheroids transfected cells expressing green fluorescent protein as a marker 
were used. As model nanoparticles carboxylate-modified polystyrene nanospheres with a 
negative surface charge were used intending to minimize particle internalization and 
adhesion to negatively charged cell membranes. However, under the conditions of the cell 
culture experiments, particles were coated with serum proteins as clearly shown by laser 
light scattering and zeta potential increased to approximately -10 mV. Therefore, 
internalization of the particles or interactions with the cell membranes can not be excluded. 
The particle uptake by cell monolayers was investigated by fluorescence measurements of 
cell lysates and by confocal microscopy. Assessing the cell-associated fluorescence after 
incubation of a cell monolayer with nanospheres the 100 nm particles were internalized to a 
higher extent than the 200 nm particles. In these experiments, the percent uptake of particles 
by cells was strongly dependent on the size of particles. Although different ratios of cells to 
particles were used, the absolute number of particles internalized per cell was constant for 
each particle size. A time-dependent saturation of cells with particles might be the 
explanation, which has to be substantiated by further experiments to clarify if there is a 
maximum of possible uptake of particles of a defined size per cell.  In addition to the high 
rate of cell-associated particles determined by fluorescence measurements, in confocal 
microscopy a strong increase in particles that were assembled at the cell membrane over 4 
hours was detected. However, hardly any particles were observed inside the cells by 
confocal microscopy. 
The investigation of particle diffusion inside three-dimensional cell agglomerates was 
performed with spheroids initiated with 500 cells and having reached a diameter of 400 µm 
after 4 days in culture. Spheroids of HCT-116 GFP initiated with 500 cells per well grew 100 
µm in diameter per 24 hours and this growth rate was not affected by the addition of 
nanoparticles to the cell culture media. Over the observation time of nanoparticle diffusion 
into the spheroid of 8 hours the spheroids grew 33 µm in diameter. This means that we look 
at a new layer of cells at every point of the observation with confocal microscopy. Due to 
limitations of the microscope, pictures can only be detected up to a maximum depth of 50 µm 
while a cross section through the center of the spheroid can not be analyzed. In the upper 
layers, the 200 nm particles proceeded faster than the 100 nm particles. To gain information 
about the interior of a spheroid and how far particles would penetrate cryo sections were 
prepared. Although the chemical fixation method leads to a good preservation of the cells, it 
Chapter 7                                                                      Nanoparticles in 2D and 3D cell culture                                                                                            
                                                                                                                                                     
- 148 - 
can not be excluded that the preparation method influenced the profile of nanoparticles 
distribution inside a spheroid. During the incubation steps particles might be washed out or 
the diffusion into the spheroid might continue. However, only 200 nm particles were 
internalized in cells on the outer layers of the spheroid while 100 nm particles were not 
detected in the respective cryo-sections. This is in accordance with the faster proceeding of 
200 nm particles into the spheroid that was observed by confocal microscopy. Reasons for 
this result have to be elucidated by further experiments. 
Confocal microscopy would be a suitable method for monitoring diffusion processes at least 
in the uppermost layers of slowly growing spheroids or tissue objects. However, to elucidate 
the diffusion process in spheroids of fast growing cell lines there is a strong need for 
alternative methods, for example the preparation of cryo-sections with optimal preservation 
of the diffusion profile and the cellular structure at the same time. The search for the optimal 
method continues to gain information about particle distribution in the extracellular matrix or 
gaps between the cells of a spheroid. The preparation method applied here provides 
information about intracellular particles and it can be hypothesized that the 200 nm particles 
were internalized in cells on the outer layer of a spheroid. 
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5. Conclusions 
Confocal microscopy is a suitable means for rapid monitoring of diffusion processes of 
nanoparticles inside slowly growing spheroids at least in the outer layers of the cell 
agglomerates. However, spheroids of the fast growing cell line HCT-116 GFP grew more 
rapidly than particles were transported into the interior of a spheroid. In the outer layers of 
the spheroid particles were incorporated into the structure either by internalization or simple 
embedding in the growing cell structure. When monolayers of HCT-116 were observed, 
particles were hardly internalized. To elucidate diffusion processes in fast growing spheroids 
alternative methods such as the time-consuming cryo-sections have to be used. Cryo-
sections of spheroids showed that particles were present inside the cells. A preparation 
method to gain information about particle distribution outside the cells has to be established. 
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1. Summary 
With the goal of controlling the events at the bone-implant interface, it was the main objective 
of this thesis to provide a basis for the conjugation of cell stimulating molecules or targeting 
motifs to the surface of hydroxyapatite ceramic discs and particles. To this end, several 
methods for surface functionalization have been investigated for the attachment of 
biomolecules. 
First, a method was established to modify the surfaces of hydroxyapatite ceramic discs by 
using aminopropyltriethoxysilane (APTES) to create an amino group-containing layer that 
would allow for further conjugation steps. As the suppression of non-specific cell adhesion, 
commonly achieved by surface grafting of uncharged and hydrophilic polymers such as 
poly(ethylene glycol) (PEG), is a prerequisite for inducing specific interactions, a synthesis 
protocol for PEG acetaldehyde was adopted from the literature, leading to a storable 
intermediate (PEG acetaldehyde diethylacetal) and compounds of varying molecular weight 
were synthesized. The mPEG derivatives were covalently attached to the amino groups 
present at the silanized ceramic surface and surfaces were characterized by water contact 
angle and XPS measurements. Depending on the molecular weight of the respective 
polymer, the mPEG-grafted surfaces performed differently with regard to hydrophobicity and 
adhesion of rat marrow stromal cells (rMSCs). The longer the PEG chain, the more 
hydrophilic were the surfaces. Cell adhesion was reduced after PEGylation with mPEG 
acetaldehyde of 5000 Da, but not completely suppressed (Chapter 2).  
In order to investigate protein immobilization on the surfaces, a procedure was established 
for the radiolabeling of lysozyme with 125Iodine. By using the labeled compound, relative 
quantitative measurements of small amounts of protein on the surface of HA ceramic discs 
were possible. A washing procedure to distinguish between reversibly bound and strongly 
adsorbed lysozyme was established. This experimental set up allowed for the investigation 
and comparison of different strategies for protein immobilization on the surfaces. Despite 
reports in the literature, labeling of BMP-2 was not successful (Chapter 3).  
The immobilization of the protein lysozyme by the use of PEG spacers intended to utilize 
several advantages that are described for PEG modified surfaces, including the suppression 
of non-specific adsorption and the support of protein stability and biological activity. HA 
ceramic discs were modified by grafting mPEG acetaldehydes with a molecular weight range 
from 750 to 5000 Da. The adsorption of lysozyme was not completely suppressed by 
PEGylation as determined by XPS measurements. When using PEG acetaldehyde (2000 
and 4000 Da) as a spacer molecule for the covalent attachment of lysozyme, more protein 
was deposited by immobilization relative to adsorption to HA ceramics. In general, the 
immobilized protein retained its enzymatic activity to a higher extent compared to adsorbed 
protein. However, the amounts of immobilized protein were relatively low and the results 
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were not significant, probably due to the inhomogeneous structure of the modified surfaces 
(Chapter 4).  
As the immobilization via PEG tethers did not result in satisfying amounts of immobilized 
lysozyme, the attachment to aminosilanized ceramic surfaces using carbodiimide coupling 
chemistry was investigated. Additionally, the aminobisphosphonates pamidronate and 
alendronate were used as anchoring molecules as a novel method for the immobilization of 
proteins to HA ceramic surfaces and compared to the well-known aminosilanization 
procedure. Lysozyme was successfully immobilized by employing both principles and the 
enzymatic activity of immobilized protein was significantly increased compared to adsorbed 
lysozyme. Therefore, the potential of the amine-functionalized HA surfaces to immobilize 
BMP-2 was investigated. In a cell culture study, the biological activity of immobilized BMP-2 
compared to adsorbed BMP-2 was elucidated. Immobilized BMP-2 significantly increased the 
expression of ALP in C2C12 cells. The novel bisphosphonate-based method was found to be 
as efficient as the well-established aminosilanization (Chapter 5).  
To gain deeper insight into the adsorption behavior of the aminobisphosphonate pamidronate 
on hydroxyapatite surfaces, an adsorption study was performed. Using adsorption 
techniques, the number of functional groups on the surface could be controlled within a 
range of 0-2 µmol/cm². As alternative route to functionalized surfaces, particles were 
precipitated in the presence of pamidronate. By adsorption and by co-precipitation of 
hydroxyapatite with pamidronate, functionalized particles were obtained that were accessible 
for the immobilization of a model compound (Chapter 6). 
In order to elucidate particle transport and diffusion processes in cells and tissues, we 
investigated the use of confocal microscopy for rapid monitoring of uptake and distribution of 
nanoparticles in multicellular tumor spheroids. Confocal microscopy provided information 
about particle transport into the outer layers of a spheroid (30-50 µm). Fluorescent model 
nanoparticles were incorporated or embedded into the outer layers of the growing spheroids 
of the cell line HCT-116. The transport of particles inside a spheroid was monitored over a 
time period of 8 hours. 200 nm particles proceeded faster than 100 nm particles (Chapter 7).  
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2. Conclusions 
In conclusion, this thesis contributed to the development of surface modification methods for 
Ca-rich inorganic materials in order to achieve a selective cell response.  
Although PEGylation with PEG acetaldehyde did not suppress cell adhesion or lysozyme 
adsorption completely, a modulation of the surface properties was achieved. The shielding 
efficacy of the PEG layer might further be improved by alternative methods that have been 
suggested in the literature [1-3]. Although lysozyme was immobilized by PEG tethers, 
particular advantages in terms of the amount or increased stability of the immobilized protein 
were not determined. By varying grafting conditions, these results may be further optimized 
and more homogeneously structured surfaces might be obtained.  
By employing smaller spacer molecules, such as succinic acid, larger amounts of protein 
were attached. Carbodiimide coupling chemistry was shown to attach proteins to HA ceramic 
surfaces with retention of their biological activity. It was clearly demonstrated that the 
biological performance of immobilized protein was superior to adsorbed protein both for 
lysozyme and BMP-2 in terms of the enzymatic activity of lysozyme and stimulation of 
osteoblastic differentiation of C2C12 cells by BMP-2. In addition to the well-established 
silanization procedure, proteins were immobilized using the bisphosphonates pamidronate 
and alendronate with equivalent efficacy. This novel method combines three approved and 
effective principles for enhanced osseointegration of implants: hydroxyapatite coating, 
surface-immobilized bisphosphonates, and localized delivery of BMP-2. Further 
investigations should focus on a deeper understanding of the stability of the bisphosphonate 
binding and a quantification of the functional groups as well as the attached BMP-2.  
The bisphosphonate-based surface modification method is also applicable to other calcium 
phosphates, such as brushite, and allows for a control of functional groups within a certain 
concentration range. For a control of particle size, morphology, and zeta potential the 
precipitation procedure of the particles has to be improved. However, hydroxyapatite or 
calcium phosphate particles have a potential for many applications including composite 
materials for hard tissue replacement, drug delivery, and gene delivery. Nanophase materials 
are of particular interest as they resemble the inorganic phase of bone that consists of 
nanocrystals.  
A tool for rapid monitoring of diffusion processes of fluorescent nanoparticles inside a three-
dimensional cell culture model is provided by confocal micoscopy. The spheroid model is 
perfectly suited for these investigations due to its well-defined geometry. However, to 
elucidate diffusion processes in fast growing spheroids, alternative methods, such as the 
time-consuming cryo-sections, have to be used. To compare diffusion profiles of particles of 
different characteristics, the use of spheroids of slowly growing cell lines is suggested. 
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3. Outlook 
Delivery strategies for growth factors will play a major role in the field of bone tissue 
engineering [4] with a focus on biomaterials that additionally act as delivery devices for cell 
stimulators [5]. Interesting future research approaches for surface modifications include the 
use of sulfated polysaccharides, such as heparin [6] for attachment of growth factors, such 
as BMP-2, by their heparin binding site [7]. The use of DNA encoding for growth factors will 
be of key interest, intending to let cells at the interface produce the adequate growth factors 
for osteoblastic differentiation [8]. A potential application for hydroxyapatite nanoparticles 
might be the delivery of DNA [9]. All these improvements represent steps towards the goal of 
“smart materials” that are capable of reacting upon external stimuli like natural bone [10]. 
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Abbreviations 
 
AFM Atomic force microscopy 
APTES Aminopropyl-triethoxysilane 
ATP Adenosine triphosphate 
BET Brunauer-Emmet-Teller  
BMP Bone morphogenetic protein 
BMP-2 Bone morphogenetic protein-2 
BP Bisphosphonate 
BSA Bovine serum albumine 
CDCl3 Deuterated chloroform 
CLSM Confocal laser scanning microscopy 
2D Two dimensional 
3D Three dimensional 
Da Dalton 
DMEM Dulbecco’s modified eagle medium 
DMSO Dimethylene sulfoxid 
DMSO-d6 Deuterated dimethylene sulfoxid 
DNA Deoxyribonucleic acid 
DPEG Poly(ethylene glycol) acetaldehyde 
ECM Extracellular matrix 
EDAC 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EDTA Ethylenediaminetetraacetic acid 
EGF Epidermal growth factor 
EPR-effect Enhanced permeation and retention effect 
ESI-MS Electrospray ionization – mass spectrometry 
FGF Fibroblast growth factor 
FBS Fetal bovine serum 
GFP Green fluorescent protein 
GPC Gel permeation chromatography 
HA Hydroxyapatite 
HCl Hydrochloric acid 
HEPES N-(2-Hydroxyethyl)piperazine-N’-(2-ethanesulfonic acid) 
hemisodium salt 
1H-NMR 1H nuclear magnetic resonance spectroscopy 
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HPLC-MS High performance liquid chromatography combined with a 
mass spectroscopy detector 
IGF Insulin-like growth factor 
I.U.  International Units 
λem Emission wavelength of a fluorescent dye 
λex Excitation wavelength of a fluorescent dye 
m/z Mass per charge ratio 
Maldi-ToF Matrix assisted laser desorption/ionization time of flight mass 
spectroscopy 
MCTS Multicellular tumor spheroid 
MDR Multidrug resistance 
mPEG Poly(ethylene glycol) monomethylether 
mPEGAc Poly(ethylene glycol) monomethylether acetaldehyde 
MPS Mononuclear phagozyte system 
Mw Molecular weight 
Na2SO4 Sodium sulfate 
N-BP Aminobisphosponate 
NCE New chemical entities 
PBS Phosphate-buffered saline 
PEG Poly(ethylene glycol)  
PI Polydispersity index 
R.F.U Relative fluorescence units 
RGD Arginine-glycin-aspartic acid 
rMSC Rat marrow stromal cells 
SD Standard deviation 
SDS Sodium dodecylsulfate 
SEC Size exclusion chromatography 
SEM Scanning electron microscopy 
s-NHS Sulfo-N-Hydroxysuccinimide 
T-25 flask 25-cm² flask 
TCP Tricalcium phopshate 
TGF Transforming growth factor 
TGF-ß Transforming growth factor –ß 
TMS Tetramethylsilane 
TNBS Trinitrobenzenesulfonic acid 
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Tris buffer Tris(hydroxymethyl)aminomethane buffer 
VEGF Vascular endothelial growth factor 
XPS X-ray photoelectron spectroscopy 
XRD X-ray diffraction 
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